*********** PTASSAMj00 ******** FILEIN user.vek ../../CSA/PIK_SPRITE/ ULMN 3 3o4g_o00 ACYLAMINO-ACID-RELEASING ENZYME user 1 3 # 1 A 445 SER A 24 SER^? 14.86 O2 EDO A 88 A 524 ASP A 27 ASP.? 4.81 O2 EDO A 88 A 556 HIS A 26 HIS.? 12.31 O2 EDO A 88 coo 12.47 10.19 -6.98 12.48 12.40 -7.89 -27.05 44.01 0.12 -28.54 42.91 1.70 coo 3.92 10.81 -9.94 5.89 11.57 -9.70 -26.65 50.87 6.95 -25.73 50.39 8.79 coo 7.59 13.76 -7.91 9.53 12.97 -7.82 -27.15 43.88 6.97 -27.62 42.01 6.19 3o4g_o00 source 3O4G ACYLAMINO-ACID-RELEASING ENZYME : 1 hits 3o4g_o00 naa= 3 ULMN 3 3qwd_o00 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 1 3 # 1 A 98 SER A 24 SER^? 14.86 O2 EDO A 88 A 123 HIS A 26 HIS.? 12.31 O2 EDO A 88 A 172 ASP A 27 ASP.? 4.81 O2 EDO A 88 coo 45.74 29.80 42.79 47.58 31.06 41.64 -27.05 44.01 0.12 -28.54 42.91 1.70 coo 44.17 25.61 37.60 45.21 25.56 35.81 -27.15 43.88 6.97 -27.62 42.01 6.19 coo 39.85 24.35 34.94 41.12 25.58 33.83 -26.65 50.87 6.95 -25.73 50.39 8.79 3qwd_o00 source 3QWD ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT: 1 hits 3qwd_o00 naa= 3 ULMN 4 1df9_c00 BOWMAN-BIRK TYPE TRYPSIN INHIBITOR user 1 4 # 1 A 51 HIS B 26 HIS.? 29.20 O1 EDO A 88 A 75 ASP B 27 ASP.? 26.46 C2 EDO A 88 A 135 SER B 24 SER^? 25.27 O1 EDO A 88 A 153 GLY B 58 GLY~? 16.42 C2 EDO A 88 coo 82.73 13.99 81.18 84.11 13.14 79.85 -1.78 55.32 -10.54 -0.01 54.91 -11.57 coo 79.95 16.88 76.33 81.62 16.87 77.62 -4.76 50.56 -10.13 -3.07 50.63 -8.85 coo 87.55 10.17 77.17 86.98 9.59 79.47 -10.38 58.47 -10.73 -8.49 59.58 -11.78 coo 79.86 4.56 77.77 79.43 4.83 78.44 -8.62 54.48 -0.50 -9.18 54.97 -0.85 1df9_c00 source 1df9 BOWMAN-BIRK TYPE TRYPSIN INHIBITOR : 1 hits 1df9_c00 naa= 4 ULMN 4 1df9_c01 BOWMAN-BIRK TYPE TRYPSIN INHIBITOR user 1 4 # 1 B 351 HIS A 26 HIS.? 12.31 O2 EDO A 88 B 375 ASP A 27 ASP.? 4.81 O2 EDO A 88 B 435 SER A 24 SER^? 14.86 O2 EDO A 88 B 453 GLY A 58 GLY~? 9.83 O2 EDO A 88 coo 54.71 8.03 87.61 53.52 9.76 87.62 -27.15 43.88 6.97 -27.62 42.01 6.19 coo 53.92 7.16 81.61 55.46 6.68 82.99 -26.65 50.87 6.95 -25.73 50.39 8.79 coo 49.39 13.14 88.07 51.43 12.26 89.08 -27.05 44.01 0.12 -28.54 42.91 1.70 coo 58.03 17.63 86.84 58.65 17.09 86.95 -17.11 46.78 5.39 -17.45 46.41 4.77 ULMN 4 1df9_c01 BOWMAN-BIRK TYPE TRYPSIN INHIBITOR user 2 4 # 2 B 351 HIS B 26 HIS.? 29.20 O1 EDO A 88 B 375 ASP B 27 ASP.? 26.46 C2 EDO A 88 B 435 SER B 24 SER^? 25.27 O1 EDO A 88 B 453 GLY B 58 GLY~? 16.42 C2 EDO A 88 coo 54.71 8.03 87.61 53.52 9.76 87.62 -1.78 55.32 -10.54 -0.01 54.91 -11.57 coo 53.92 7.16 81.61 55.46 6.68 82.99 -4.76 50.56 -10.13 -3.07 50.63 -8.85 coo 49.39 13.14 88.07 51.43 12.26 89.08 -10.38 58.47 -10.73 -8.49 59.58 -11.78 coo 58.03 17.63 86.84 58.65 17.09 86.95 -8.62 54.48 -0.50 -9.18 54.97 -0.85 1df9_c01 source 1df9 BOWMAN-BIRK TYPE TRYPSIN INHIBITOR : 2 hits 1df9_c01 naa= 4 ULMN 4 1hpl_c00 LIPASE (E.C.3.1.1.3) (TRIACYLGLYCEROuser 1 4 # 1 A 77 PHE B 70 PHE~? 11.90 O1 EDO A 88 A 153 LEU A 84 LEU~? 5.14 O1 EDO A 88 A 176 ASP A 41 ASP.? 14.91 O1 EDO A 88 A 263 HIS B 67 HIS~? 12.87 O1 EDO A 88 coo 49.46 51.93 11.85 50.12 53.23 14.23 -8.93 59.39 6.56 -11.26 59.36 5.03 coo 48.47 51.01 3.83 49.10 52.90 2.99 -16.49 57.21 11.25 -15.20 57.40 9.49 coo 40.04 48.33 9.02 39.08 50.19 9.48 -14.25 67.95 8.57 -13.10 69.71 8.75 coo 43.45 51.20 11.32 44.32 50.94 9.50 -9.98 64.51 7.37 -11.90 65.11 7.97 1hpl_c00 source 1hpl LIPASE (E.C.3.1.1.3) (TRIACYLGLYCEROL HYDROLAS: 1 hits 1hpl_c00 naa= 4 ULMN 4 1hpl_c01 LIPASE (E.C.3.1.1.3) (TRIACYLGLYCEROuser 1 4 # 1 B 77 PHE B 70 PHE~? 11.90 O1 EDO A 88 B 153 LEU A 84 LEU~? 5.14 O1 EDO A 88 B 176 ASP A 41 ASP.? 14.91 O1 EDO A 88 B 263 HIS B 67 HIS~? 12.87 O1 EDO A 88 coo 29.53 52.84 46.76 28.82 54.35 44.53 -8.93 59.39 6.56 -11.26 59.36 5.03 coo 30.35 52.10 54.81 29.94 54.08 55.45 -16.49 57.21 11.25 -15.20 57.40 9.49 coo 38.97 49.40 49.54 39.78 51.32 48.96 -14.25 67.95 8.57 -13.10 69.71 8.75 coo 35.23 51.95 47.14 34.55 51.97 49.04 -9.98 64.51 7.37 -11.90 65.11 7.97 1hpl_c01 source 1hpl LIPASE (E.C.3.1.1.3) (TRIACYLGLYCEROL HYDROLAS: 1 hits 1hpl_c01 naa= 4 ULMN 4 1moq_c00 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 1 4 # 1 481 GLU B 10 GLU^? 22.83 O2 EDO A 88 485 LYS B 12 LYS.? 22.50 O2 EDO A 88 488 GLU B 11 GLU^? 16.09 O2 EDO A 88 603 LYS A 31 LYS~? 12.16 C1 EDO A 88 coo 24.49 18.95 6.71 25.16 18.17 4.85 -29.59 50.76 -9.46 -29.70 50.98 -11.60 coo 21.77 13.74 4.55 26.03 15.07 4.05 -33.93 48.03 -5.83 -30.65 43.44 -8.38 coo 22.93 13.34 0.22 24.67 14.21 1.12 -32.33 52.63 -2.59 -33.86 53.51 -1.46 coo 31.74 12.46 -4.74 33.15 13.34 0.17 -30.40 57.71 4.72 -33.78 58.75 8.98 1moq_c00 source 1moq GLUCOSAMINE 6-PHOSPHATE SYNTHASE : 1 hits 1moq_c00 naa= 4 ULMN 4 1o04_c00 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 1 4 # 1 A 192 LYS A 35 LYS~? 3.82 C1 EDO A 88 A 268 GLU B 11 GLU^? 16.09 O2 EDO A 88 A 302 SER A 24 SER^? 14.86 O2 EDO A 88 A 399 GLU A 59 GLU~? 11.45 O2 EDO A 88 coo 85.01 60.31 56.44 83.15 64.89 56.44 -27.16 62.03 7.83 -24.89 58.41 11.08 coo 71.86 54.60 60.61 70.38 53.71 61.84 -32.33 52.63 -2.59 -33.86 53.51 -1.46 coo 68.68 62.06 66.08 69.52 59.75 65.97 -27.05 44.01 0.12 -28.54 42.91 1.70 coo 66.34 67.16 63.84 67.47 65.57 63.06 -22.28 43.98 3.30 -23.32 43.37 5.05 1o04_c00 source 1o04 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAL PRECURSO: 1 hits 1o04_c00 naa= 4 ULMN 4 1o04_c01 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 1 4 # 1 B 192 LYS A 35 LYS~? 3.82 C1 EDO A 88 B 268 GLU B 11 GLU^? 16.09 O2 EDO A 88 B 302 SER A 24 SER^? 14.86 O2 EDO A 88 B 399 GLU A 59 GLU~? 11.45 O2 EDO A 88 coo 54.45 47.08 36.74 56.53 48.29 32.40 -27.16 62.03 7.83 -24.89 58.41 11.08 coo 67.17 40.71 41.61 68.49 39.13 42.13 -32.33 52.63 -2.59 -33.86 53.51 -1.46 coo 70.41 37.34 33.01 69.41 36.86 35.23 -27.05 44.01 0.12 -28.54 42.91 1.70 coo 73.06 40.82 28.87 71.88 41.23 30.58 -22.28 43.98 3.30 -23.32 43.37 5.05 1o04_c01 source 1o04 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAL PRECURSO: 1 hits 1o04_c01 naa= 4 ULMN 4 1o04_c02 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 1 4 # 1 C 192 LYS A 35 LYS~? 3.82 C1 EDO A 88 C 268 GLU B 11 GLU^? 16.09 O2 EDO A 88 C 302 SER A 24 SER^? 14.86 O2 EDO A 88 C 399 GLU A 59 GLU~? 11.45 O2 EDO A 88 coo 83.30 16.28 88.61 85.25 11.75 88.79 -27.16 62.03 7.83 -24.89 58.41 11.08 coo 79.88 15.02 74.11 80.06 15.36 72.02 -32.33 52.63 -2.59 -33.86 53.51 -1.46 coo 87.46 9.36 71.39 86.33 11.53 71.37 -27.05 44.01 0.12 -28.54 42.91 1.70 coo 87.65 3.44 72.32 86.49 4.99 73.13 -22.28 43.98 3.30 -23.32 43.37 5.05 1o04_c02 source 1o04 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAL PRECURSO: 1 hits 1o04_c02 naa= 4 ULMN 4 1o04_c03 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 1 4 # 1 D 192 LYS A 35 LYS~? 3.82 C1 EDO A 88 D 268 GLU B 11 GLU^? 16.09 O2 EDO A 88 D 302 SER A 24 SER^? 14.86 O2 EDO A 88 D 399 GLU A 59 GLU~? 11.45 O2 EDO A 88 coo 51.91 3.68 69.52 49.61 2.30 73.71 -27.16 62.03 7.83 -24.89 58.41 11.08 coo 55.94 16.93 75.09 55.86 19.04 75.37 -32.33 52.63 -2.59 -33.86 53.51 -1.46 coo 48.09 18.43 80.84 49.40 18.94 78.77 -27.05 44.01 0.12 -28.54 42.91 1.70 coo 47.32 15.81 86.19 48.62 15.41 84.58 -22.28 43.98 3.30 -23.32 43.37 5.05 1o04_c03 source 1o04 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAL PRECURSO: 1 hits 1o04_c03 naa= 4 ULMN 4 1o04_c04 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 1 4 # 1 E 192 LYS A 35 LYS~? 3.82 C1 EDO A 88 E 268 GLU B 11 GLU^? 16.09 O2 EDO A 88 E 302 SER A 24 SER^? 14.86 O2 EDO A 88 E 399 GLU A 59 GLU~? 11.45 O2 EDO A 88 coo 52.46 147.49 107.94 50.14 148.75 103.77 -27.16 62.03 7.83 -24.89 58.41 11.08 coo 57.01 134.41 102.36 57.01 132.29 102.10 -32.33 52.63 -2.59 -33.86 53.51 -1.46 coo 49.26 132.62 96.59 50.54 132.08 98.67 -27.05 44.01 0.12 -28.54 42.91 1.70 coo 48.52 135.25 91.24 49.73 135.67 92.87 -22.28 43.98 3.30 -23.32 43.37 5.05 1o04_c04 source 1o04 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAL PRECURSO: 1 hits 1o04_c04 naa= 4 ULMN 4 1o04_c05 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 1 4 # 1 F 192 LYS A 35 LYS~? 3.82 C1 EDO A 88 F 268 GLU B 11 GLU^? 16.09 O2 EDO A 88 F 302 SER A 24 SER^? 14.86 O2 EDO A 88 F 399 GLU A 59 GLU~? 11.45 O2 EDO A 88 coo 84.18 136.24 88.80 85.96 140.90 88.66 -27.16 62.03 7.83 -24.89 58.41 11.08 coo 80.72 137.29 103.27 80.90 136.95 105.39 -32.33 52.63 -2.59 -33.86 53.51 -1.46 coo 87.99 143.28 106.06 86.95 141.03 106.01 -27.05 44.01 0.12 -28.54 42.91 1.70 coo 87.94 149.19 105.12 86.87 147.57 104.33 -22.28 43.98 3.30 -23.32 43.37 5.05 1o04_c05 source 1o04 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAL PRECURSO: 1 hits 1o04_c05 naa= 4 ULMN 4 1o04_c06 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 1 4 # 1 G 192 LYS A 35 LYS~? 3.82 C1 EDO A 88 G 268 GLU B 11 GLU^? 16.09 O2 EDO A 88 G 302 SER A 24 SER^? 14.86 O2 EDO A 88 G 399 GLU A 59 GLU~? 11.45 O2 EDO A 88 coo 56.79 103.91 140.42 58.85 102.76 144.77 -27.16 62.03 7.83 -24.89 58.41 11.08 coo 69.06 110.82 135.59 70.39 112.47 135.16 -32.33 52.63 -2.59 -33.86 53.51 -1.46 coo 72.18 114.35 144.24 71.25 114.81 141.99 -27.05 44.01 0.12 -28.54 42.91 1.70 coo 75.14 110.89 148.28 73.91 110.46 146.63 -22.28 43.98 3.30 -23.32 43.37 5.05 1o04_c06 source 1o04 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAL PRECURSO: 1 hits 1o04_c06 naa= 4 ULMN 4 1o04_c07 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 1 4 # 1 H 192 LYS A 35 LYS~? 3.82 C1 EDO A 88 H 268 GLU B 11 GLU^? 16.09 O2 EDO A 88 H 302 SER A 24 SER^? 14.86 O2 EDO A 88 H 399 GLU A 59 GLU~? 11.45 O2 EDO A 88 coo 87.99 92.28 120.76 86.42 87.51 120.70 -27.16 62.03 7.83 -24.89 58.41 11.08 coo 74.53 97.35 116.61 73.03 98.14 115.35 -32.33 52.63 -2.59 -33.86 53.51 -1.46 coo 71.83 89.76 111.02 72.57 92.08 111.26 -27.05 44.01 0.12 -28.54 42.91 1.70 coo 69.74 84.60 113.28 70.77 86.22 114.09 -22.28 43.98 3.30 -23.32 43.37 5.05 1o04_c07 source 1o04 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAL PRECURSO: 1 hits 1o04_c07 naa= 4 ULMN 3 1a05_c00 3-ISOPROPYLMALATE DEHYDROGENASE user 1 3 # 1 A 140 TYR A 5 TYR^? 13.23 O2 EDO A 88 B 190 LYS A 31 LYS~? 12.16 C1 EDO A 88 B 222 ASP A 27 ASP.? 4.81 O2 EDO A 88 coo 7.17 16.59 41.26 8.01 19.20 40.73 -28.09 49.40 -2.46 -28.96 50.64 -0.10 coo 13.38 20.00 35.06 11.43 22.49 39.53 -30.40 57.71 4.72 -33.78 58.75 8.98 coo 9.76 26.58 38.10 11.63 25.78 38.76 -26.65 50.87 6.95 -25.73 50.39 8.79 ULMN 3 1a05_c00 3-ISOPROPYLMALATE DEHYDROGENASE user 2 3 # 2 A 140 TYR A 5 TYR^? 13.23 O2 EDO A 88 B 190 LYS A 55 LYS~? -3.15 O2 EDO A 88s B 222 ASP A 27 ASP.? 4.81 O2 EDO A 88 coo 7.17 16.59 41.26 8.01 19.20 40.73 -28.09 49.40 -2.46 -28.96 50.64 -0.10 coo 13.38 20.00 35.06 11.43 22.49 39.53 -20.05 50.35 3.45 -22.02 51.39 7.78 coo 9.76 26.58 38.10 11.63 25.78 38.76 -26.65 50.87 6.95 -25.73 50.39 8.79 ULMN 3 1a05_c00 3-ISOPROPYLMALATE DEHYDROGENASE user 3 3 # 3 A 140 TYR B 5 TYR^? 24.90 C2 EDO A 88 B 190 LYS B 31 LYS~? 34.04 C2 EDO A 88 B 222 ASP B 27 ASP.? 26.46 C2 EDO A 88 coo 7.17 16.59 41.26 8.01 19.20 40.73 -13.48 53.76 -13.02 -11.19 52.33 -13.67 coo 13.38 20.00 35.06 11.43 22.49 39.53 -7.49 44.50 -14.70 -1.79 44.49 -16.08 coo 9.76 26.58 38.10 11.63 25.78 38.76 -4.76 50.56 -10.13 -3.07 50.63 -8.85 ULMN 3 1a05_c00 3-ISOPROPYLMALATE DEHYDROGENASE user 4 3 # 4 A 140 TYR B 5 TYR^? 24.90 C2 EDO A 88 B 190 LYS B 55 LYS~? 22.80 C2 EDO A 88 B 222 ASP B 27 ASP.? 26.46 C2 EDO A 88 coo 7.17 16.59 41.26 8.01 19.20 40.73 -13.48 53.76 -13.02 -11.19 52.33 -13.67 coo 13.38 20.00 35.06 11.43 22.49 39.53 -10.41 51.47 -4.09 -5.84 50.62 -6.36 coo 9.76 26.58 38.10 11.63 25.78 38.76 -4.76 50.56 -10.13 -3.07 50.63 -8.85 1a05_c00 source 1a05 3-ISOPROPYLMALATE DEHYDROGENASE : 4 hits 1a05_c00 naa= 3 ULMN 3 1a05_c01 3-ISOPROPYLMALATE DEHYDROGENASE user 1 3 # 1 A 190 LYS A 31 LYS~? 12.16 C1 EDO A 88 A 222 ASP A 27 ASP.? 4.81 O2 EDO A 88 B 140 TYR A 5 TYR^? 13.23 O2 EDO A 88 coo -4.61 20.12 30.34 -2.74 22.65 25.95 -30.40 57.71 4.72 -33.78 58.75 8.98 coo -1.04 26.60 27.37 -2.94 25.93 26.69 -26.65 50.87 6.95 -25.73 50.39 8.79 coo 1.51 16.60 24.17 0.82 19.23 24.79 -28.09 49.40 -2.46 -28.96 50.64 -0.10 ULMN 3 1a05_c01 3-ISOPROPYLMALATE DEHYDROGENASE user 2 3 # 2 A 190 LYS A 55 LYS~? -3.15 O2 EDO A 88s A 222 ASP A 27 ASP.? 4.81 O2 EDO A 88 B 140 TYR A 5 TYR^? 13.23 O2 EDO A 88 coo -4.61 20.12 30.34 -2.74 22.65 25.95 -20.05 50.35 3.45 -22.02 51.39 7.78 coo -1.04 26.60 27.37 -2.94 25.93 26.69 -26.65 50.87 6.95 -25.73 50.39 8.79 coo 1.51 16.60 24.17 0.82 19.23 24.79 -28.09 49.40 -2.46 -28.96 50.64 -0.10 ULMN 3 1a05_c01 3-ISOPROPYLMALATE DEHYDROGENASE user 3 3 # 3 A 190 LYS B 31 LYS~? 34.04 C2 EDO A 88 A 222 ASP B 27 ASP.? 26.46 C2 EDO A 88 B 140 TYR B 5 TYR^? 24.90 C2 EDO A 88 coo -4.61 20.12 30.34 -2.74 22.65 25.95 -7.49 44.50 -14.70 -1.79 44.49 -16.08 coo -1.04 26.60 27.37 -2.94 25.93 26.69 -4.76 50.56 -10.13 -3.07 50.63 -8.85 coo 1.51 16.60 24.17 0.82 19.23 24.79 -13.48 53.76 -13.02 -11.19 52.33 -13.67 ULMN 3 1a05_c01 3-ISOPROPYLMALATE DEHYDROGENASE user 4 3 # 4 A 190 LYS B 55 LYS~? 22.80 C2 EDO A 88 A 222 ASP B 27 ASP.? 26.46 C2 EDO A 88 B 140 TYR B 5 TYR^? 24.90 C2 EDO A 88 coo -4.61 20.12 30.34 -2.74 22.65 25.95 -10.41 51.47 -4.09 -5.84 50.62 -6.36 coo -1.04 26.60 27.37 -2.94 25.93 26.69 -4.76 50.56 -10.13 -3.07 50.63 -8.85 coo 1.51 16.60 24.17 0.82 19.23 24.79 -13.48 53.76 -13.02 -11.19 52.33 -13.67 1a05_c01 source 1a05 3-ISOPROPYLMALATE DEHYDROGENASE : 4 hits 1a05_c01 naa= 3 ULMN 3 1a0j_c00 TRYPSIN user 1 3 # 1 A 57 HIS A 26 HIS.? 12.31 O2 EDO A 88 A 102 ASP A 27 ASP.? 4.81 O2 EDO A 88 A 195 SER A 24 SER^? 14.86 O2 EDO A 88 coo 25.57 41.22 61.68 24.18 39.98 62.50 -27.15 43.88 6.97 -27.62 42.01 6.19 coo 22.33 45.48 59.73 23.35 43.67 60.06 -26.65 50.87 6.95 -25.73 50.39 8.79 coo 20.90 36.72 61.65 22.18 37.53 63.52 -27.05 44.01 0.12 -28.54 42.91 1.70 1a0j_c00 source 1a0j TRYPSIN : 1 hits 1a0j_c00 naa= 3 ULMN 3 1a0j_c01 TRYPSIN user 1 3 # 1 B 57 HIS A 26 HIS.? 12.31 O2 EDO A 88 B 102 ASP A 27 ASP.? 4.81 O2 EDO A 88 B 195 SER A 24 SER^? 14.86 O2 EDO A 88 coo 44.08 45.58 52.81 45.86 46.55 52.85 -27.15 43.88 6.97 -27.62 42.01 6.19 coo 43.04 44.75 47.18 43.31 45.51 49.13 -26.65 50.87 6.95 -25.73 50.39 8.79 coo 48.11 50.52 52.24 48.62 48.46 53.13 -27.05 44.01 0.12 -28.54 42.91 1.70 1a0j_c01 source 1a0j TRYPSIN : 1 hits 1a0j_c01 naa= 3 ULMN 3 1a0j_c02 TRYPSIN user 1 3 # 1 C 57 HIS A 26 HIS.? 12.31 O2 EDO A 88 C 102 ASP A 27 ASP.? 4.81 O2 EDO A 88 C 195 SER A 24 SER^? 14.86 O2 EDO A 88 coo 34.37 41.18 73.21 34.04 43.09 73.87 -27.15 43.88 6.97 -27.62 42.01 6.19 coo 34.89 38.34 78.12 35.11 39.59 76.42 -26.65 50.87 6.95 -25.73 50.39 8.79 coo 36.16 46.87 75.66 34.01 46.43 74.59 -27.05 44.01 0.12 -28.54 42.91 1.70 1a0j_c02 source 1a0j TRYPSIN : 1 hits 1a0j_c02 naa= 3 ULMN 3 1a0j_c03 TRYPSIN user 1 3 # 1 D 57 HIS A 26 HIS.? 12.31 O2 EDO A 88 D 102 ASP A 27 ASP.? 4.81 O2 EDO A 88 D 195 SER A 24 SER^? 14.86 O2 EDO A 88 coo 8.19 15.01 95.72 7.78 16.53 97.01 -27.15 43.88 6.97 -27.62 42.01 6.19 coo 13.53 16.28 93.98 11.45 16.21 94.40 -26.65 50.87 6.95 -25.73 50.39 8.79 coo 6.63 21.03 97.42 6.71 19.20 98.95 -27.05 44.01 0.12 -28.54 42.91 1.70 1a0j_c03 source 1a0j TRYPSIN : 1 hits 1a0j_c03 naa= 3 ULMN 3 1a7u_c02 CHLOROPEROXIDASE T user 1 3 # 1 A 98 SER A 24 SER^? 14.86 O2 EDO A 88 A 228 ASP A 27 ASP.? 4.81 O2 EDO A 88 A 257 HIS A 26 HIS.? 12.31 O2 EDO A 88 coo 9.47 41.64 34.15 9.10 39.28 33.93 -27.05 44.01 0.12 -28.54 42.91 1.70 coo 2.03 38.95 28.44 3.60 38.60 29.83 -26.65 50.87 6.95 -25.73 50.39 8.79 coo 6.85 37.62 29.99 7.50 38.47 31.78 -27.15 43.88 6.97 -27.62 42.01 6.19 1a7u_c02 source 1a7u CHLOROPEROXIDASE T : 1 hits 1a7u_c02 naa= 3 ULMN 3 1a7u_c03 CHLOROPEROXIDASE T user 1 3 # 1 B 98 SER A 24 SER^? 14.86 O2 EDO A 88 B 228 ASP A 27 ASP.? 4.81 O2 EDO A 88 B 257 HIS A 26 HIS.? 12.31 O2 EDO A 88 coo 28.35 71.07 3.94 30.08 69.46 4.49 -27.05 44.01 0.12 -28.54 42.91 1.70 coo 31.11 65.98 -3.92 31.07 66.41 -1.82 -26.65 50.87 6.95 -25.73 50.39 8.79 coo 32.76 68.02 0.70 31.21 68.44 2.05 -27.15 43.88 6.97 -27.62 42.01 6.19 1a7u_c03 source 1a7u CHLOROPEROXIDASE T : 1 hits 1a7u_c03 naa= 3 ULMN 3 1a8q_c00 BROMOPEROXIDASE A1 user 1 3 # 1 94 SER A 24 SER^? 14.86 O2 EDO A 88 223 ASP A 27 ASP.? 4.81 O2 EDO A 88 252 HIS A 26 HIS.? 12.31 O2 EDO A 88 coo 40.95 0.07 3.20 39.54 1.39 4.66 -27.05 44.01 0.12 -28.54 42.91 1.70 coo 42.66 -2.61 12.07 41.85 -1.47 10.53 -26.65 50.87 6.95 -25.73 50.39 8.79 coo 41.54 1.64 9.09 40.82 1.05 7.19 -27.15 43.88 6.97 -27.62 42.01 6.19 1a8q_c00 source 1a8q BROMOPEROXIDASE A1 : 1 hits 1a8q_c00 naa= 3 ULMN 3 1a8s_c00 CHLOROPEROXIDASE F user 1 3 # 1 94 SER A 24 SER^? 14.86 O2 EDO A 88 224 ASP A 27 ASP.? 4.81 O2 EDO A 88 253 HIS A 26 HIS.? 12.31 O2 EDO A 88 coo 16.00 80.13 58.60 16.16 82.12 59.96 -27.05 44.01 0.12 -28.54 42.91 1.70 coo 8.47 84.84 62.27 10.52 84.40 62.08 -26.65 50.87 6.95 -25.73 50.39 8.79 coo 13.14 83.03 63.68 14.37 82.62 62.02 -27.15 43.88 6.97 -27.62 42.01 6.19 1a8s_c00 source 1a8s CHLOROPEROXIDASE F : 1 hits 1a8s_c00 naa= 3 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 1 3 # 1 33 ASP A 27 ASP.? 4.81 O2 EDO A 88 187 GLU B 11 GLU^? 16.09 O2 EDO A 88 229 LYS B 12 LYS.? 22.50 O2 EDO A 88 coo -52.57 56.60 47.75 -51.52 54.87 46.95 -26.65 50.87 6.95 -25.73 50.39 8.79 coo -45.08 48.37 46.81 -46.53 49.74 45.96 -32.33 52.63 -2.59 -33.86 53.51 -1.46 coo -47.40 44.36 48.48 -50.80 49.18 46.20 -33.93 48.03 -5.83 -30.65 43.44 -8.38 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 2 3 # 2 33 ASP A 28 ASP~? 11.68 O2 EDO A 88 187 GLU A 59 GLU~? 11.45 O2 EDO A 88 229 LYS A 55 LYS~? -3.15 O2 EDO A 88s coo -52.57 56.60 47.75 -51.52 54.87 46.95 -31.33 53.08 5.19 -32.37 54.22 3.74 coo -45.08 48.37 46.81 -46.53 49.74 45.96 -22.28 43.98 3.30 -23.32 43.37 5.05 coo -47.40 44.36 48.48 -50.80 49.18 46.20 -20.05 50.35 3.45 -22.02 51.39 7.78 1ald_c00 source 1ald ALDOLASE A (E.C.4.1.2.13) : 2 hits 1ald_c00 naa= 3 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 1 3 # 1 A 194 SER A 20 SER^? 23.95 O2 EDO A 88 A 292 ASP A 27 ASP.? 4.81 O2 EDO A 88 A 322 HIS A 15 HIS.? 36.41 C2 EDO A 88 coo 36.34 32.23 39.60 36.43 34.62 39.93 -22.75 45.49 -12.51 -25.02 46.25 -12.74 coo 19.73 19.18 41.39 21.50 18.65 40.34 -26.65 50.87 6.95 -25.73 50.39 8.79 coo 41.69 45.14 46.60 41.78 47.19 46.18 -10.83 48.67 -23.74 -8.99 48.18 -24.64 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 2 3 # 2 A 194 SER A 20 SER^? 23.95 O2 EDO A 88 A 292 ASP A 28 ASP~? 11.68 O2 EDO A 88 A 322 HIS A 15 HIS.? 36.41 C2 EDO A 88 coo 36.34 32.23 39.60 36.43 34.62 39.93 -22.75 45.49 -12.51 -25.02 46.25 -12.74 coo 19.73 19.18 41.39 21.50 18.65 40.34 -31.33 53.08 5.19 -32.37 54.22 3.74 coo 41.69 45.14 46.60 41.78 47.19 46.18 -10.83 48.67 -23.74 -8.99 48.18 -24.64 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 3 3 # 3 A 194 SER B 24 SER^? 25.27 O1 EDO A 88 A 292 ASP A 37 ASP~? 13.07 O1 EDO A 88 A 322 HIS A 15 HIS.? 36.41 C2 EDO A 88 coo 36.34 32.23 39.60 36.43 34.62 39.93 -10.38 58.47 -10.73 -8.49 59.58 -11.78 coo 19.73 19.18 41.39 21.50 18.65 40.34 -25.14 65.39 3.92 -25.04 66.91 2.43 coo 41.69 45.14 46.60 41.78 47.19 46.18 -10.83 48.67 -23.74 -8.99 48.18 -24.64 1aql_c02 source 1aql BILE-SALT ACTIVATED LIPASE : 3 hits 1aql_c02 naa= 3 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 1 3 # 1 B 194 SER A 20 SER^? 23.95 O2 EDO A 88 B 292 ASP A 27 ASP.? 4.81 O2 EDO A 88 B 322 HIS A 15 HIS.? 36.41 C2 EDO A 88 coo 35.42 71.28 22.94 36.24 69.06 22.37 -22.75 45.49 -12.51 -25.02 46.25 -12.74 coo 24.74 78.07 5.59 24.32 79.03 7.46 -26.65 50.87 6.95 -25.73 50.39 8.79 coo 48.81 64.16 26.34 49.30 62.16 26.73 -10.83 48.67 -23.74 -8.99 48.18 -24.64 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 2 3 # 2 B 194 SER A 20 SER^? 23.95 O2 EDO A 88 B 292 ASP A 28 ASP~? 11.68 O2 EDO A 88 B 322 HIS A 15 HIS.? 36.41 C2 EDO A 88 coo 35.42 71.28 22.94 36.24 69.06 22.37 -22.75 45.49 -12.51 -25.02 46.25 -12.74 coo 24.74 78.07 5.59 24.32 79.03 7.46 -31.33 53.08 5.19 -32.37 54.22 3.74 coo 48.81 64.16 26.34 49.30 62.16 26.73 -10.83 48.67 -23.74 -8.99 48.18 -24.64 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 3 3 # 3 B 194 SER B 24 SER^? 25.27 O1 EDO A 88 B 292 ASP A 37 ASP~? 13.07 O1 EDO A 88 B 322 HIS A 15 HIS.? 36.41 C2 EDO A 88 coo 35.42 71.28 22.94 36.24 69.06 22.37 -10.38 58.47 -10.73 -8.49 59.58 -11.78 coo 24.74 78.07 5.59 24.32 79.03 7.46 -25.14 65.39 3.92 -25.04 66.91 2.43 coo 48.81 64.16 26.34 49.30 62.16 26.73 -10.83 48.67 -23.74 -8.99 48.18 -24.64 1aql_c03 source 1aql BILE-SALT ACTIVATED LIPASE : 3 hits 1aql_c03 naa= 3 ULMN 3 1ax4_c04 TRYPTOPHANASE user 1 3 # 1 A 130 PHE A 23 PHE^? 14.66 O2 EDO A 88 A 223 ASP A 27 ASP.? 4.81 O2 EDO A 88 A 265 LYS A 85 LYS~? 4.81 O2 EDO A 88 coo 39.74 52.86 65.74 41.15 55.14 66.52 -23.10 44.35 -2.13 -21.44 43.58 -0.03 coo 30.70 47.50 67.53 29.83 49.47 67.39 -26.65 50.87 6.95 -25.73 50.39 8.79 coo 19.99 54.53 64.11 20.55 58.78 68.33 -19.67 57.49 14.47 -21.14 51.45 13.91 ULMN 3 1ax4_c04 TRYPTOPHANASE user 2 3 # 2 A 130 PHE A 30 PHE~? 14.44 O2 EDO A 88 A 223 ASP A 27 ASP.? 4.81 O2 EDO A 88 A 265 LYS A 85 LYS~? 4.81 O2 EDO A 88 coo 39.74 52.86 65.74 41.15 55.14 66.52 -29.96 56.34 -1.22 -29.15 55.58 -3.78 coo 30.70 47.50 67.53 29.83 49.47 67.39 -26.65 50.87 6.95 -25.73 50.39 8.79 coo 19.99 54.53 64.11 20.55 58.78 68.33 -19.67 57.49 14.47 -21.14 51.45 13.91 ULMN 3 1ax4_c04 TRYPTOPHANASE user 3 3 # 3 A 130 PHE A 30 PHE~? 14.44 O2 EDO A 88 A 223 ASP A 37 ASP~? 13.07 O1 EDO A 88 A 265 LYS A 85 LYS~? 4.81 O2 EDO A 88 coo 39.74 52.86 65.74 41.15 55.14 66.52 -29.96 56.34 -1.22 -29.15 55.58 -3.78 coo 30.70 47.50 67.53 29.83 49.47 67.39 -25.14 65.39 3.92 -25.04 66.91 2.43 coo 19.99 54.53 64.11 20.55 58.78 68.33 -19.67 57.49 14.47 -21.14 51.45 13.91 ULMN 3 1ax4_c04 TRYPTOPHANASE user 4 3 # 4 A 130 PHE B 23 PHE^? 19.87 C2 EDO A 88 A 223 ASP B 27 ASP.? 26.46 C2 EDO A 88 A 265 LYS B 85 LYS~? 25.46 C2 EDO A 88 coo 39.74 52.86 65.74 41.15 55.14 66.52 -14.23 56.53 -8.52 -14.72 53.85 -9.16 coo 30.70 47.50 67.53 29.83 49.47 67.39 -4.76 50.56 -10.13 -3.07 50.63 -8.85 coo 19.99 54.53 64.11 20.55 58.78 68.33 -1.24 41.95 -2.07 0.00 48.03 -2.24 ULMN 3 1ax4_c04 TRYPTOPHANASE user 5 3 # 5 A 130 PHE B 30 PHE~? 27.21 C2 EDO A 88 A 223 ASP B 27 ASP.? 26.46 C2 EDO A 88 A 265 LYS B 85 LYS~? 25.46 C2 EDO A 88 coo 39.74 52.86 65.74 41.15 55.14 66.52 -12.94 47.02 -15.56 -15.52 48.08 -15.37 coo 30.70 47.50 67.53 29.83 49.47 67.39 -4.76 50.56 -10.13 -3.07 50.63 -8.85 coo 19.99 54.53 64.11 20.55 58.78 68.33 -1.24 41.95 -2.07 0.00 48.03 -2.24 ULMN 3 1ax4_c04 TRYPTOPHANASE user 6 3 # 6 A 130 PHE B 30 PHE~? 27.21 C2 EDO A 88 A 223 ASP B 37 ASP~? 29.91 O2 EDO A 88 A 265 LYS B 85 LYS~? 25.46 C2 EDO A 88 coo 39.74 52.86 65.74 41.15 55.14 66.52 -12.94 47.02 -15.56 -15.52 48.08 -15.37 coo 30.70 47.50 67.53 29.83 49.47 67.39 -11.14 36.80 -11.01 -12.56 35.32 -11.54 coo 19.99 54.53 64.11 20.55 58.78 68.33 -1.24 41.95 -2.07 0.00 48.03 -2.24 ULMN 3 1ax4_c04 TRYPTOPHANASE user 7 3 # 7 A 130 PHE B 70 PHE~? 11.90 O1 EDO A 88 A 223 ASP A 41 ASP.? 14.91 O1 EDO A 88 A 265 LYS A 35 LYS~? 3.82 C1 EDO A 88 coo 39.74 52.86 65.74 41.15 55.14 66.52 -8.93 59.39 6.56 -11.26 59.36 5.03 coo 30.70 47.50 67.53 29.83 49.47 67.39 -14.25 67.95 8.57 -13.10 69.71 8.75 coo 19.99 54.53 64.11 20.55 58.78 68.33 -27.16 62.03 7.83 -24.89 58.41 11.08 1ax4_c04 source 1ax4 TRYPTOPHANASE : 7 hits 1ax4_c04 naa= 3 ULMN 3 1ax4_c05 TRYPTOPHANASE user 1 3 # 1 B 130 PHE A 23 PHE^? 14.66 O2 EDO A 88 B 223 ASP A 27 ASP.? 4.81 O2 EDO A 88 B 265 LYS A 85 LYS~? 4.81 O2 EDO A 88 coo 7.48 54.94 99.62 7.67 52.27 100.42 -23.10 44.35 -2.13 -21.44 43.58 -0.03 coo 10.43 61.66 91.81 9.80 60.04 90.61 -26.65 50.87 6.95 -25.73 50.39 8.79 coo 5.43 58.06 80.08 8.57 53.00 79.37 -19.67 57.49 14.47 -21.14 51.45 13.91 ULMN 3 1ax4_c05 TRYPTOPHANASE user 2 3 # 2 B 130 PHE A 30 PHE~? 14.44 O2 EDO A 88 B 223 ASP A 27 ASP.? 4.81 O2 EDO A 88 B 265 LYS A 85 LYS~? 4.81 O2 EDO A 88 coo 7.48 54.94 99.62 7.67 52.27 100.42 -29.96 56.34 -1.22 -29.15 55.58 -3.78 coo 10.43 61.66 91.81 9.80 60.04 90.61 -26.65 50.87 6.95 -25.73 50.39 8.79 coo 5.43 58.06 80.08 8.57 53.00 79.37 -19.67 57.49 14.47 -21.14 51.45 13.91 ULMN 3 1ax4_c05 TRYPTOPHANASE user 3 3 # 3 B 130 PHE A 30 PHE~? 14.44 O2 EDO A 88 B 223 ASP A 37 ASP~? 13.07 O1 EDO A 88 B 265 LYS A 85 LYS~? 4.81 O2 EDO A 88 coo 7.48 54.94 99.62 7.67 52.27 100.42 -29.96 56.34 -1.22 -29.15 55.58 -3.78 coo 10.43 61.66 91.81 9.80 60.04 90.61 -25.14 65.39 3.92 -25.04 66.91 2.43 coo 5.43 58.06 80.08 8.57 53.00 79.37 -19.67 57.49 14.47 -21.14 51.45 13.91 ULMN 3 1ax4_c05 TRYPTOPHANASE user 4 3 # 4 B 130 PHE B 23 PHE^? 19.87 C2 EDO A 88 B 223 ASP B 27 ASP.? 26.46 C2 EDO A 88 B 265 LYS B 85 LYS~? 25.46 C2 EDO A 88 coo 7.48 54.94 99.62 7.67 52.27 100.42 -14.23 56.53 -8.52 -14.72 53.85 -9.16 coo 10.43 61.66 91.81 9.80 60.04 90.61 -4.76 50.56 -10.13 -3.07 50.63 -8.85 coo 5.43 58.06 80.08 8.57 53.00 79.37 -1.24 41.95 -2.07 0.00 48.03 -2.24 ULMN 3 1ax4_c05 TRYPTOPHANASE user 5 3 # 5 B 130 PHE B 30 PHE~? 27.21 C2 EDO A 88 B 223 ASP B 27 ASP.? 26.46 C2 EDO A 88 B 265 LYS B 85 LYS~? 25.46 C2 EDO A 88 coo 7.48 54.94 99.62 7.67 52.27 100.42 -12.94 47.02 -15.56 -15.52 48.08 -15.37 coo 10.43 61.66 91.81 9.80 60.04 90.61 -4.76 50.56 -10.13 -3.07 50.63 -8.85 coo 5.43 58.06 80.08 8.57 53.00 79.37 -1.24 41.95 -2.07 0.00 48.03 -2.24 ULMN 3 1ax4_c05 TRYPTOPHANASE user 6 3 # 6 B 130 PHE B 30 PHE~? 27.21 C2 EDO A 88 B 223 ASP B 37 ASP~? 29.91 O2 EDO A 88 B 265 LYS B 85 LYS~? 25.46 C2 EDO A 88 coo 7.48 54.94 99.62 7.67 52.27 100.42 -12.94 47.02 -15.56 -15.52 48.08 -15.37 coo 10.43 61.66 91.81 9.80 60.04 90.61 -11.14 36.80 -11.01 -12.56 35.32 -11.54 coo 5.43 58.06 80.08 8.57 53.00 79.37 -1.24 41.95 -2.07 0.00 48.03 -2.24 ULMN 3 1ax4_c05 TRYPTOPHANASE user 7 3 # 7 B 130 PHE B 70 PHE~? 11.90 O1 EDO A 88 B 223 ASP A 41 ASP.? 14.91 O1 EDO A 88 B 265 LYS A 35 LYS~? 3.82 C1 EDO A 88 coo 7.48 54.94 99.62 7.67 52.27 100.42 -8.93 59.39 6.56 -11.26 59.36 5.03 coo 10.43 61.66 91.81 9.80 60.04 90.61 -14.25 67.95 8.57 -13.10 69.71 8.75 coo 5.43 58.06 80.08 8.57 53.00 79.37 -27.16 62.03 7.83 -24.89 58.41 11.08 1ax4_c05 source 1ax4 TRYPTOPHANASE : 7 hits 1ax4_c05 naa= 3 ULMN 3 1ax4_c06 TRYPTOPHANASE user 1 3 # 1 C 130 PHE A 23 PHE^? 14.66 O2 EDO A 88 C 223 ASP A 27 ASP.? 4.81 O2 EDO A 88 C 265 LYS A 35 LYS~? 3.82 C1 EDO A 88 coo -6.55 73.45 23.60 -6.77 71.48 21.66 -23.10 44.35 -2.13 -21.44 43.58 -0.03 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -26.65 50.87 6.95 -25.73 50.39 8.79 coo -4.44 67.20 42.32 -7.50 62.41 40.49 -27.16 62.03 7.83 -24.89 58.41 11.08 ULMN 3 1ax4_c06 TRYPTOPHANASE user 2 3 # 2 C 130 PHE A 23 PHE^? 14.66 O2 EDO A 88 C 223 ASP A 27 ASP.? 4.81 O2 EDO A 88 C 265 LYS A 85 LYS~? 4.81 O2 EDO A 88 coo -6.55 73.45 23.60 -6.77 71.48 21.66 -23.10 44.35 -2.13 -21.44 43.58 -0.03 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -26.65 50.87 6.95 -25.73 50.39 8.79 coo -4.44 67.20 42.32 -7.50 62.41 40.49 -19.67 57.49 14.47 -21.14 51.45 13.91 ULMN 3 1ax4_c06 TRYPTOPHANASE user 3 3 # 3 C 130 PHE A 30 PHE~? 14.44 O2 EDO A 88 C 223 ASP A 27 ASP.? 4.81 O2 EDO A 88 C 265 LYS A 85 LYS~? 4.81 O2 EDO A 88 coo -6.55 73.45 23.60 -6.77 71.48 21.66 -29.96 56.34 -1.22 -29.15 55.58 -3.78 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -26.65 50.87 6.95 -25.73 50.39 8.79 coo -4.44 67.20 42.32 -7.50 62.41 40.49 -19.67 57.49 14.47 -21.14 51.45 13.91 ULMN 3 1ax4_c06 TRYPTOPHANASE user 4 3 # 4 C 130 PHE A 30 PHE~? 14.44 O2 EDO A 88 C 223 ASP A 37 ASP~? 13.07 O1 EDO A 88 C 265 LYS A 85 LYS~? 4.81 O2 EDO A 88 coo -6.55 73.45 23.60 -6.77 71.48 21.66 -29.96 56.34 -1.22 -29.15 55.58 -3.78 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -25.14 65.39 3.92 -25.04 66.91 2.43 coo -4.44 67.20 42.32 -7.50 62.41 40.49 -19.67 57.49 14.47 -21.14 51.45 13.91 ULMN 3 1ax4_c06 TRYPTOPHANASE user 5 3 # 5 C 130 PHE B 23 PHE^? 19.87 C2 EDO A 88 C 223 ASP B 27 ASP.? 26.46 C2 EDO A 88 C 265 LYS B 85 LYS~? 25.46 C2 EDO A 88 coo -6.55 73.45 23.60 -6.77 71.48 21.66 -14.23 56.53 -8.52 -14.72 53.85 -9.16 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -4.76 50.56 -10.13 -3.07 50.63 -8.85 coo -4.44 67.20 42.32 -7.50 62.41 40.49 -1.24 41.95 -2.07 0.00 48.03 -2.24 ULMN 3 1ax4_c06 TRYPTOPHANASE user 6 3 # 6 C 130 PHE B 30 PHE~? 27.21 C2 EDO A 88 C 223 ASP B 27 ASP.? 26.46 C2 EDO A 88 C 265 LYS B 85 LYS~? 25.46 C2 EDO A 88 coo -6.55 73.45 23.60 -6.77 71.48 21.66 -12.94 47.02 -15.56 -15.52 48.08 -15.37 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -4.76 50.56 -10.13 -3.07 50.63 -8.85 coo -4.44 67.20 42.32 -7.50 62.41 40.49 -1.24 41.95 -2.07 0.00 48.03 -2.24 ULMN 3 1ax4_c06 TRYPTOPHANASE user 7 3 # 7 C 130 PHE B 30 PHE~? 27.21 C2 EDO A 88 C 223 ASP B 37 ASP~? 29.91 O2 EDO A 88 C 265 LYS B 85 LYS~? 25.46 C2 EDO A 88 coo -6.55 73.45 23.60 -6.77 71.48 21.66 -12.94 47.02 -15.56 -15.52 48.08 -15.37 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -11.14 36.80 -11.01 -12.56 35.32 -11.54 coo -4.44 67.20 42.32 -7.50 62.41 40.49 -1.24 41.95 -2.07 0.00 48.03 -2.24 ULMN 3 1ax4_c06 TRYPTOPHANASE user 8 3 # 8 C 130 PHE B 70 PHE~? 11.90 O1 EDO A 88 C 223 ASP A 41 ASP.? 14.91 O1 EDO A 88 C 265 LYS A 35 LYS~? 3.82 C1 EDO A 88 coo -6.55 73.45 23.60 -6.77 71.48 21.66 -8.93 59.39 6.56 -11.26 59.36 5.03 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -14.25 67.95 8.57 -13.10 69.71 8.75 coo -4.44 67.20 42.32 -7.50 62.41 40.49 -27.16 62.03 7.83 -24.89 58.41 11.08 1ax4_c06 source 1ax4 TRYPTOPHANASE : 8 hits 1ax4_c06 naa= 3 ULMN 3 1ax4_c07 TRYPTOPHANASE user 1 3 # 1 D 130 PHE A 23 PHE^? 14.66 O2 EDO A 88 D 223 ASP A 27 ASP.? 4.81 O2 EDO A 88 D 265 LYS A 35 LYS~? 3.82 C1 EDO A 88 coo -38.60 55.38 52.70 -40.06 57.72 53.04 -23.10 44.35 -2.13 -21.44 43.58 -0.03 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -26.65 50.87 6.95 -25.73 50.39 8.79 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -27.16 62.03 7.83 -24.89 58.41 11.08 ULMN 3 1ax4_c07 TRYPTOPHANASE user 2 3 # 2 D 130 PHE A 23 PHE^? 14.66 O2 EDO A 88 D 223 ASP A 27 ASP.? 4.81 O2 EDO A 88 D 265 LYS A 85 LYS~? 4.81 O2 EDO A 88 coo -38.60 55.38 52.70 -40.06 57.72 53.04 -23.10 44.35 -2.13 -21.44 43.58 -0.03 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -26.65 50.87 6.95 -25.73 50.39 8.79 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -19.67 57.49 14.47 -21.14 51.45 13.91 ULMN 3 1ax4_c07 TRYPTOPHANASE user 3 3 # 3 D 130 PHE A 30 PHE~? 14.44 O2 EDO A 88 D 223 ASP A 27 ASP.? 4.81 O2 EDO A 88 D 265 LYS A 85 LYS~? 4.81 O2 EDO A 88 coo -38.60 55.38 52.70 -40.06 57.72 53.04 -29.96 56.34 -1.22 -29.15 55.58 -3.78 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -26.65 50.87 6.95 -25.73 50.39 8.79 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -19.67 57.49 14.47 -21.14 51.45 13.91 ULMN 3 1ax4_c07 TRYPTOPHANASE user 4 3 # 4 D 130 PHE A 30 PHE~? 14.44 O2 EDO A 88 D 223 ASP A 37 ASP~? 13.07 O1 EDO A 88 D 265 LYS A 85 LYS~? 4.81 O2 EDO A 88 coo -38.60 55.38 52.70 -40.06 57.72 53.04 -29.96 56.34 -1.22 -29.15 55.58 -3.78 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -25.14 65.39 3.92 -25.04 66.91 2.43 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -19.67 57.49 14.47 -21.14 51.45 13.91 ULMN 3 1ax4_c07 TRYPTOPHANASE user 5 3 # 5 D 130 PHE B 23 PHE^? 19.87 C2 EDO A 88 D 223 ASP B 27 ASP.? 26.46 C2 EDO A 88 D 265 LYS B 85 LYS~? 25.46 C2 EDO A 88 coo -38.60 55.38 52.70 -40.06 57.72 53.04 -14.23 56.53 -8.52 -14.72 53.85 -9.16 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -4.76 50.56 -10.13 -3.07 50.63 -8.85 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -1.24 41.95 -2.07 0.00 48.03 -2.24 ULMN 3 1ax4_c07 TRYPTOPHANASE user 6 3 # 6 D 130 PHE B 30 PHE~? 27.21 C2 EDO A 88 D 223 ASP B 27 ASP.? 26.46 C2 EDO A 88 D 265 LYS B 85 LYS~? 25.46 C2 EDO A 88 coo -38.60 55.38 52.70 -40.06 57.72 53.04 -12.94 47.02 -15.56 -15.52 48.08 -15.37 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -4.76 50.56 -10.13 -3.07 50.63 -8.85 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -1.24 41.95 -2.07 0.00 48.03 -2.24 ULMN 3 1ax4_c07 TRYPTOPHANASE user 7 3 # 7 D 130 PHE B 30 PHE~? 27.21 C2 EDO A 88 D 223 ASP B 37 ASP~? 29.91 O2 EDO A 88 D 265 LYS B 85 LYS~? 25.46 C2 EDO A 88 coo -38.60 55.38 52.70 -40.06 57.72 53.04 -12.94 47.02 -15.56 -15.52 48.08 -15.37 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -11.14 36.80 -11.01 -12.56 35.32 -11.54 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -1.24 41.95 -2.07 0.00 48.03 -2.24 ULMN 3 1ax4_c07 TRYPTOPHANASE user 8 3 # 8 D 130 PHE B 70 PHE~? 11.90 O1 EDO A 88 D 223 ASP A 41 ASP.? 14.91 O1 EDO A 88 D 265 LYS A 35 LYS~? 3.82 C1 EDO A 88 coo -38.60 55.38 52.70 -40.06 57.72 53.04 -8.93 59.39 6.56 -11.26 59.36 5.03 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -14.25 67.95 8.57 -13.10 69.71 8.75 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -27.16 62.03 7.83 -24.89 58.41 11.08 1ax4_c07 source 1ax4 TRYPTOPHANASE : 8 hits 1ax4_c07 naa= 3 ULMN 3 1azw_c00 PROLINE IMINOPEPTIDASE user 1 3 # 1 A 110 SER A 24 SER^? 14.86 O2 EDO A 88 A 266 ASP A 27 ASP.? 4.81 O2 EDO A 88 A 294 HIS A 26 HIS.? 12.31 O2 EDO A 88 coo 32.07 25.76 77.83 34.46 26.05 77.46 -27.05 44.01 0.12 -28.54 42.91 1.70 coo 33.07 35.01 79.81 33.39 33.02 79.13 -26.65 50.87 6.95 -25.73 50.39 8.79 coo 35.53 30.26 79.89 34.62 28.71 78.80 -27.15 43.88 6.97 -27.62 42.01 6.19 1azw_c00 source 1azw PROLINE IMINOPEPTIDASE : 1 hits 1azw_c00 naa= 3 ULMN 3 1azw_c01 PROLINE IMINOPEPTIDASE user 1 3 # 1 B 110 SER A 24 SER^? 14.86 O2 EDO A 88 B 266 ASP A 27 ASP.? 4.81 O2 EDO A 88 B 294 HIS A 26 HIS.? 12.31 O2 EDO A 88 coo 51.18 33.22 36.61 49.29 31.79 37.02 -27.05 44.01 0.12 -28.54 42.91 1.70 coo 44.19 39.32 34.54 45.21 37.66 35.38 -26.65 50.87 6.95 -25.73 50.39 8.79 coo 45.79 34.26 34.63 47.54 33.80 35.70 -27.15 43.88 6.97 -27.62 42.01 6.19 1azw_c01 source 1azw PROLINE IMINOPEPTIDASE : 1 hits 1azw_c01 naa= 3 ULMN 3 1b57_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 1 3 # 1 A 109 ASP A 27 ASP.? 4.81 O2 EDO A 88 A 182 GLU A 59 GLU~? 11.45 O2 EDO A 88 A 286 ASN A 3 ASN^? 12.24 O2 EDO A 88 coo 26.03 44.66 108.90 25.67 42.61 108.82 -26.65 50.87 6.95 -25.73 50.39 8.79 coo 18.06 44.02 105.38 18.08 45.37 107.03 -22.28 43.98 3.30 -23.32 43.37 5.05 coo 25.47 38.28 112.06 27.26 39.30 111.54 -30.96 48.32 2.04 -31.97 49.04 3.78 ULMN 3 1b57_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 2 3 # 2 A 109 ASP B 27 ASP.? 26.46 C2 EDO A 88 A 182 GLU B 59 GLU~? 21.18 O1 EDO A 88 A 286 ASN B 3 ASN^? 29.42 C2 EDO A 88 coo 26.03 44.66 108.90 25.67 42.61 108.82 -4.76 50.56 -10.13 -3.07 50.63 -8.85 coo 18.06 44.02 105.38 18.08 45.37 107.03 -9.24 58.13 -5.40 -7.22 57.75 -6.04 coo 25.47 38.28 112.06 27.26 39.30 111.54 -8.54 54.49 -14.85 -6.79 53.63 -15.72 1b57_c00 source 1b57 FRUCTOSE-BISPHOSPHATE ALDOLASE II : 2 hits 1b57_c00 naa= 3 ULMN 3 1b57_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 1 3 # 1 B 109 ASP A 28 ASP~? 11.68 O2 EDO A 88 B 182 GLU A 34 GLU~? 13.90 C1 EDO A 88 B 286 ASN A 3 ASN^? 12.24 O2 EDO A 88 coo 13.82 69.26 132.27 11.87 70.14 132.51 -31.33 53.08 5.19 -32.37 54.22 3.74 coo 8.74 63.05 136.42 9.87 62.19 134.79 -30.48 62.02 2.95 -32.58 61.85 3.30 coo 8.26 72.60 129.22 10.14 73.45 129.80 -30.96 48.32 2.04 -31.97 49.04 3.78 ULMN 3 1b57_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 2 3 # 2 B 109 ASP B 27 ASP.? 26.46 C2 EDO A 88 B 182 GLU B 59 GLU~? 21.18 O1 EDO A 88 B 286 ASN B 3 ASN^? 29.42 C2 EDO A 88 coo 13.82 69.26 132.27 11.87 70.14 132.51 -4.76 50.56 -10.13 -3.07 50.63 -8.85 coo 8.74 63.05 136.42 9.87 62.19 134.79 -9.24 58.13 -5.40 -7.22 57.75 -6.04 coo 8.26 72.60 129.22 10.14 73.45 129.80 -8.54 54.49 -14.85 -6.79 53.63 -15.72 ULMN 3 1b57_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 3 3 # 3 B 109 ASP B 28 ASP~? 30.32 C2 EDO A 88 B 182 GLU B 34 GLU~? 32.51 C2 EDO A 88 B 286 ASN B 3 ASN^? 29.42 C2 EDO A 88 coo 13.82 69.26 132.27 11.87 70.14 132.51 -6.22 49.12 -15.05 -7.63 48.42 -16.47 coo 8.74 63.05 136.42 9.87 62.19 134.79 -10.00 40.79 -15.51 -9.28 41.58 -17.36 coo 8.26 72.60 129.22 10.14 73.45 129.80 -8.54 54.49 -14.85 -6.79 53.63 -15.72 1b57_c01 source 1b57 FRUCTOSE-BISPHOSPHATE ALDOLASE II : 3 hits 1b57_c01 naa= 3 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 1 3 # 1 A 145 TYR A 5 TYR^? 13.23 O2 EDO A 88 A 230 ASP A 28 ASP~? 11.68 O2 EDO A 88 A 273 LYS A 55 LYS~? -3.15 O2 EDO A 88s coo 9.23 21.44 106.88 10.18 19.34 105.31 -28.09 49.40 -2.46 -28.96 50.64 -0.10 coo 1.45 22.80 104.16 2.58 21.02 104.01 -31.33 53.08 5.19 -32.37 54.22 3.74 coo 2.97 11.64 107.87 6.59 15.13 107.03 -20.05 50.35 3.45 -22.02 51.39 7.78 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 2 3 # 2 A 145 TYR B 5 TYR^? 24.90 C2 EDO A 88 A 230 ASP B 28 ASP~? 30.32 C2 EDO A 88 A 273 LYS B 55 LYS~? 22.80 C2 EDO A 88 coo 9.23 21.44 106.88 10.18 19.34 105.31 -13.48 53.76 -13.02 -11.19 52.33 -13.67 coo 1.45 22.80 104.16 2.58 21.02 104.01 -6.22 49.12 -15.05 -7.63 48.42 -16.47 coo 2.97 11.64 107.87 6.59 15.13 107.03 -10.41 51.47 -4.09 -5.84 50.62 -6.36 1b8g_c04 source 1b8g 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYNTHASE : 2 hits 1b8g_c04 naa= 3 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 1 3 # 1 B 145 TYR A 5 TYR^? 13.23 O2 EDO A 88 B 230 ASP A 28 ASP~? 11.68 O2 EDO A 88 B 273 LYS A 55 LYS~? -3.15 O2 EDO A 88s coo 11.81 13.41 73.03 10.00 13.03 75.12 -28.09 49.40 -2.46 -28.96 50.64 -0.10 coo 19.17 11.01 76.14 17.26 10.42 76.77 -31.33 53.08 5.19 -32.37 54.22 3.74 coo 11.10 2.31 76.60 10.24 7.24 75.62 -20.05 50.35 3.45 -22.02 51.39 7.78 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 2 3 # 2 B 145 TYR B 5 TYR^? 24.90 C2 EDO A 88 B 230 ASP B 28 ASP~? 30.32 C2 EDO A 88 B 273 LYS B 55 LYS~? 22.80 C2 EDO A 88 coo 11.81 13.41 73.03 10.00 13.03 75.12 -13.48 53.76 -13.02 -11.19 52.33 -13.67 coo 19.17 11.01 76.14 17.26 10.42 76.77 -6.22 49.12 -15.05 -7.63 48.42 -16.47 coo 11.10 2.31 76.60 10.24 7.24 75.62 -10.41 51.47 -4.09 -5.84 50.62 -6.36 1b8g_c05 source 1b8g 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYNTHASE : 2 hits 1b8g_c05 naa= 3 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 1 3 # 1 A 88 PHE A 30 PHE~? 14.44 O2 EDO A 88 A 159 ASP A 27 ASP.? 4.81 O2 EDO A 88 A 188 LYS B 12 LYS.? 22.50 O2 EDO A 88 coo 13.91 34.58 14.67 12.95 36.00 12.47 -29.96 56.34 -1.22 -29.15 55.58 -3.78 coo 20.97 28.40 16.26 20.19 30.15 15.34 -26.65 50.87 6.95 -25.73 50.39 8.79 coo 22.55 41.65 15.60 18.92 37.20 14.63 -33.93 48.03 -5.83 -30.65 43.44 -8.38 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 2 3 # 2 A 88 PHE A 50 PHE~? 7.73 O1 EDO A 88 A 159 ASP A 41 ASP.? 14.91 O1 EDO A 88 A 188 LYS A 35 LYS~? 3.82 C1 EDO A 88 coo 13.91 34.58 14.67 12.95 36.00 12.47 -15.30 58.35 3.55 -15.30 57.87 6.26 coo 20.97 28.40 16.26 20.19 30.15 15.34 -14.25 67.95 8.57 -13.10 69.71 8.75 coo 22.55 41.65 15.60 18.92 37.20 14.63 -27.16 62.03 7.83 -24.89 58.41 11.08 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 3 3 # 3 A 88 PHE A 50 PHE~? 7.73 O1 EDO A 88 A 159 ASP A 41 ASP.? 14.91 O1 EDO A 88 A 188 LYS A 85 LYS~? 4.81 O2 EDO A 88 coo 13.91 34.58 14.67 12.95 36.00 12.47 -15.30 58.35 3.55 -15.30 57.87 6.26 coo 20.97 28.40 16.26 20.19 30.15 15.34 -14.25 67.95 8.57 -13.10 69.71 8.75 coo 22.55 41.65 15.60 18.92 37.20 14.63 -19.67 57.49 14.47 -21.14 51.45 13.91 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 4 3 # 4 A 88 PHE A 50 PHE~? 7.73 O1 EDO A 88 A 159 ASP A 41 ASP.? 14.91 O1 EDO A 88 A 188 LYS B 71 LYS~? 21.06 O1 EDO A 88 coo 13.91 34.58 14.67 12.95 36.00 12.47 -15.30 58.35 3.55 -15.30 57.87 6.26 coo 20.97 28.40 16.26 20.19 30.15 15.34 -14.25 67.95 8.57 -13.10 69.71 8.75 coo 22.55 41.65 15.60 18.92 37.20 14.63 -4.46 59.86 10.42 -1.71 65.47 11.76 1b9h_c02 source 1b9h 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHASE : 4 hits 1b9h_c02 naa= 3 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 1 3 # 1 14 ASP A 41 ASP.? 14.91 O1 EDO A 88 16 HIS B 67 HIS~? 12.87 O1 EDO A 88 67 GLY A 58 GLY~? 9.83 O2 EDO A 88 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -14.25 67.95 8.57 -13.10 69.71 8.75 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -9.98 64.51 7.37 -11.90 65.11 7.97 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -17.11 46.78 5.39 -17.45 46.41 4.77 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 2 3 # 2 14 ASP A 41 ASP.? 14.91 O1 EDO A 88 16 HIS B 67 HIS~? 12.87 O1 EDO A 88 67 GLY B 53 GLY~? 14.25 C2 EDO A 88 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -14.25 67.95 8.57 -13.10 69.71 8.75 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -9.98 64.51 7.37 -11.90 65.11 7.97 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -15.31 49.67 -2.05 -14.58 49.52 -2.41 1be1_c02 source 1be1 GLUTAMATE MUTASE : 2 hits 1be1_c02 naa= 3 ULMN 3 1bhg_c02 BETA-GLUCURONIDASE user 1 3 # 1 A 451 GLU B 22 GLU^? 25.61 O1 EDO A 88 A 504 TYR B 5 TYR^? 24.90 C2 EDO A 88 A 540 GLU A 10 GLU^? 27.07 C2 EDO A 88 coo 81.34 87.29 87.22 82.36 86.09 88.61 -17.79 60.61 -13.20 -17.15 61.81 -14.83 coo 80.85 81.34 94.77 81.70 80.16 92.41 -13.48 53.76 -13.02 -11.19 52.33 -13.67 coo 79.94 80.46 88.84 81.11 81.36 87.27 -20.28 53.65 -16.35 -22.20 53.78 -17.27 1bhg_c02 source 1bhg BETA-GLUCURONIDASE : 1 hits 1bhg_c02 naa= 3 ULMN 3 1bhg_c03 BETA-GLUCURONIDASE user 1 3 # 1 B 451 GLU A 10 GLU^? 27.07 C2 EDO A 88 B 504 TYR B 5 TYR^? 24.90 C2 EDO A 88 B 540 GLU B 22 GLU^? 25.61 O1 EDO A 88 coo 86.52 35.28 112.74 87.08 36.38 110.99 -20.28 53.65 -16.35 -22.20 53.78 -17.27 coo 84.93 40.21 105.31 85.72 41.45 107.72 -13.48 53.76 -13.02 -11.19 52.33 -13.67 coo 83.38 41.19 112.55 85.47 40.59 112.72 -17.79 60.61 -13.20 -17.15 61.81 -14.83 ULMN 3 1bhg_c03 BETA-GLUCURONIDASE user 2 3 # 2 B 451 GLU B 22 GLU^? 25.61 O1 EDO A 88 B 504 TYR B 5 TYR^? 24.90 C2 EDO A 88 B 540 GLU A 10 GLU^? 27.07 C2 EDO A 88 coo 86.52 35.28 112.74 87.08 36.38 110.99 -17.79 60.61 -13.20 -17.15 61.81 -14.83 coo 84.93 40.21 105.31 85.72 41.45 107.72 -13.48 53.76 -13.02 -11.19 52.33 -13.67 coo 83.38 41.19 112.55 85.47 40.59 112.72 -20.28 53.65 -16.35 -22.20 53.78 -17.27 1bhg_c03 source 1bhg BETA-GLUCURONIDASE : 2 hits 1bhg_c03 naa= 3 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 1 3 # 1 B 382 ARG A 17 ARG.? 31.93 C2 EDO A 88 B 451 GLU A 10 GLU^? 27.07 C2 EDO A 88 B 540 GLU A 11 GLU^? 30.56 C2 EDO A 88 coo 82.21 41.07 119.14 83.95 40.66 116.59 -12.86 46.28 -20.15 -10.06 46.57 -18.92 coo 86.52 35.28 112.74 87.08 36.38 110.99 -20.28 53.65 -16.35 -22.20 53.78 -17.27 coo 83.38 41.19 112.55 85.47 40.59 112.72 -13.41 51.24 -17.67 -12.24 50.07 -19.00 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 2 3 # 2 B 382 ARG B 17 ARG.? 14.88 O2 EDO A 88 B 451 GLU B 10 GLU^? 22.83 O2 EDO A 88 B 540 GLU B 11 GLU^? 16.09 O2 EDO A 88 coo 82.21 41.07 119.14 83.95 40.66 116.59 -34.10 57.90 -1.91 -33.96 56.91 1.01 coo 86.52 35.28 112.74 87.08 36.38 110.99 -29.59 50.76 -9.46 -29.70 50.98 -11.60 coo 83.38 41.19 112.55 85.47 40.59 112.72 -32.33 52.63 -2.59 -33.86 53.51 -1.46 1bhg_c05 source 1bhg BETA-GLUCURONIDASE : 2 hits 1bhg_c05 naa= 3 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 1 3 # 1 118 ARG A 78 ARG~? 12.59 O2 EDO A 88 183 LYS A 71 LYS~? 25.13 O2 EDO A 88 317 ARG B 78 ARG~? 23.79 O1 EDO A 88 coo 76.57 109.19 73.41 73.86 110.26 72.16 -15.79 46.53 17.00 -17.06 47.71 19.54 coo 82.09 117.51 66.37 80.60 114.32 71.44 -9.57 38.72 11.51 -8.72 32.82 12.46 coo 65.21 120.62 58.76 63.62 123.14 59.66 1.00 53.33 4.39 2.31 53.17 7.17 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 2 3 # 2 118 ARG B 78 ARG~? 23.79 O1 EDO A 88 183 LYS B 71 LYS~? 21.06 O1 EDO A 88 317 ARG A 78 ARG~? 12.59 O2 EDO A 88 coo 76.57 109.19 73.41 73.86 110.26 72.16 1.00 53.33 4.39 2.31 53.17 7.17 coo 82.09 117.51 66.37 80.60 114.32 71.44 -4.46 59.86 10.42 -1.71 65.47 11.76 coo 65.21 120.62 58.76 63.62 123.14 59.66 -15.79 46.53 17.00 -17.06 47.71 19.54 1bib_c00 source 1bib BIRA BIFUNCTIONAL PROTEIN (ACTS AS BIOTIN OPER: 2 hits 1bib_c00 naa= 3 ULMN 3 1bqc_c01 BETA-MANNANASE user 1 3 # 1 A 50 ARG A 17 ARG.? 31.93 C2 EDO A 88 A 128 GLU A 10 GLU^? 27.07 C2 EDO A 88 A 225 GLU A 11 GLU^? 30.56 C2 EDO A 88 coo 38.56 19.11 14.83 37.12 21.00 16.76 -12.86 46.28 -20.15 -10.06 46.57 -18.92 coo 36.48 24.43 22.02 36.86 26.34 21.13 -20.28 53.65 -16.35 -22.20 53.78 -17.27 coo 40.16 23.71 17.01 38.52 24.96 17.40 -13.41 51.24 -17.67 -12.24 50.07 -19.00 1bqc_c01 source 1bqc BETA-MANNANASE : 1 hits 1bqc_c01 naa= 3 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 1 3 # 1 A 109 PHE A 23 PHE^? 14.66 O2 EDO A 88 A 205 ASP A 28 ASP~? 11.68 O2 EDO A 88 A 236 LYS B 12 LYS.? 22.50 O2 EDO A 88 coo 4.14 2.10 36.34 6.69 3.08 36.92 -23.10 44.35 -2.13 -21.44 43.58 -0.03 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 -31.33 53.08 5.19 -32.37 54.22 3.74 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 -33.93 48.03 -5.83 -30.65 43.44 -8.38 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 2 3 # 2 A 109 PHE A 50 PHE~? 7.73 O1 EDO A 88 A 205 ASP A 27 ASP.? 4.81 O2 EDO A 88 A 236 LYS A 35 LYS~? 3.82 C1 EDO A 88 coo 4.14 2.10 36.34 6.69 3.08 36.92 -15.30 58.35 3.55 -15.30 57.87 6.26 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 -26.65 50.87 6.95 -25.73 50.39 8.79 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 -27.16 62.03 7.83 -24.89 58.41 11.08 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 3 3 # 3 A 109 PHE A 50 PHE~? 7.73 O1 EDO A 88 A 205 ASP A 28 ASP~? 11.68 O2 EDO A 88 A 236 LYS A 35 LYS~? 3.82 C1 EDO A 88 coo 4.14 2.10 36.34 6.69 3.08 36.92 -15.30 58.35 3.55 -15.30 57.87 6.26 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 -31.33 53.08 5.19 -32.37 54.22 3.74 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 -27.16 62.03 7.83 -24.89 58.41 11.08 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 4 3 # 4 A 109 PHE A 57 PHE~? 12.26 C2 EDO A 88 A 205 ASP B 27 ASP.? 26.46 C2 EDO A 88 A 236 LYS B 85 LYS~? 25.46 C2 EDO A 88 coo 4.14 2.10 36.34 6.69 3.08 36.92 -13.72 47.97 2.47 -12.13 49.16 4.44 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 -4.76 50.56 -10.13 -3.07 50.63 -8.85 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 -1.24 41.95 -2.07 0.00 48.03 -2.24 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 5 3 # 5 A 109 PHE A 77 PHE~? 9.83 C2 EDO A 88 A 205 ASP A 27 ASP.? 4.81 O2 EDO A 88 A 236 LYS A 85 LYS~? 4.81 O2 EDO A 88 coo 4.14 2.10 36.34 6.69 3.08 36.92 -12.84 48.09 9.66 -14.85 49.03 7.92 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 -26.65 50.87 6.95 -25.73 50.39 8.79 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 -19.67 57.49 14.47 -21.14 51.45 13.91 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 6 3 # 6 A 109 PHE B 21 PHE^? 16.25 O1 EDO A 88 A 205 ASP A 37 ASP~? 13.07 O1 EDO A 88 A 236 LYS A 31 LYS~? 12.16 C1 EDO A 88 coo 4.14 2.10 36.34 6.69 3.08 36.92 -19.99 59.28 -6.97 -19.33 57.17 -5.24 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 -25.14 65.39 3.92 -25.04 66.91 2.43 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 -30.40 57.71 4.72 -33.78 58.75 8.98 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 7 3 # 7 A 109 PHE B 57 PHE~? 11.47 C2 EDO A 88 A 205 ASP A 27 ASP.? 4.81 O2 EDO A 88 A 236 LYS A 85 LYS~? 4.81 O2 EDO A 88 coo 4.14 2.10 36.34 6.69 3.08 36.92 -12.21 53.70 2.45 -11.20 54.09 5.00 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 -26.65 50.87 6.95 -25.73 50.39 8.79 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 -19.67 57.49 14.47 -21.14 51.45 13.91 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 8 3 # 8 A 109 PHE B 57 PHE~? 11.47 C2 EDO A 88 A 205 ASP A 41 ASP.? 14.91 O1 EDO A 88 A 236 LYS A 85 LYS~? 4.81 O2 EDO A 88 coo 4.14 2.10 36.34 6.69 3.08 36.92 -12.21 53.70 2.45 -11.20 54.09 5.00 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 -14.25 67.95 8.57 -13.10 69.71 8.75 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 -19.67 57.49 14.47 -21.14 51.45 13.91 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 9 3 # 9 A 109 PHE B 57 PHE~? 11.47 C2 EDO A 88 A 205 ASP A 41 ASP.? 14.91 O1 EDO A 88 A 236 LYS B 71 LYS~? 21.06 O1 EDO A 88 coo 4.14 2.10 36.34 6.69 3.08 36.92 -12.21 53.70 2.45 -11.20 54.09 5.00 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 -14.25 67.95 8.57 -13.10 69.71 8.75 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 -4.46 59.86 10.42 -1.71 65.47 11.76 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 10 3 # 10 A 109 PHE B 73 PHE~? 13.06 C2 EDO A 88 A 205 ASP A 41 ASP.? 14.91 O1 EDO A 88 A 236 LYS A 85 LYS~? 4.81 O2 EDO A 88 coo 4.14 2.10 36.34 6.69 3.08 36.92 -7.98 53.56 9.40 -9.22 51.34 8.27 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 -14.25 67.95 8.57 -13.10 69.71 8.75 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 -19.67 57.49 14.47 -21.14 51.45 13.91 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 11 3 # 11 A 109 PHE B 73 PHE~? 13.06 C2 EDO A 88 A 205 ASP A 41 ASP.? 14.91 O1 EDO A 88 A 236 LYS A 86 LYS~? 13.64 O1 EDO A 88 coo 4.14 2.10 36.34 6.69 3.08 36.92 -7.98 53.56 9.40 -9.22 51.34 8.27 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 -14.25 67.95 8.57 -13.10 69.71 8.75 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 -18.60 60.01 17.15 -15.10 59.96 22.04 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 12 3 # 12 A 109 PHE B 77 PHE~? 16.10 C2 EDO A 88 A 205 ASP B 27 ASP.? 26.46 C2 EDO A 88 A 236 LYS B 85 LYS~? 25.46 C2 EDO A 88 coo 4.14 2.10 36.34 6.69 3.08 36.92 -6.20 51.56 4.90 -7.58 51.30 2.49 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 -4.76 50.56 -10.13 -3.07 50.63 -8.85 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 -1.24 41.95 -2.07 0.00 48.03 -2.24 1bs0_c01 source 1bs0 8-AMINO-7-OXONANOATE SYNTHASE : 12 hits 1bs0_c01 naa= 3 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 1 3 # 1 A 50 GLN B 48 GLN~? 23.89 O2 EDO A 88 A 91 LEU A 19 LEU^? 24.09 O2 EDO A 88 A 133 GLU B 34 GLU~? 32.51 C2 EDO A 88 coo 43.58 43.67 66.73 42.32 42.78 68.15 -17.10 41.91 -8.85 -18.61 40.74 -9.82 coo 38.58 45.09 70.44 38.28 45.21 72.59 -18.28 45.53 -13.40 -17.54 46.15 -11.48 coo 44.05 36.87 70.65 43.15 38.64 69.97 -10.00 40.79 -15.51 -9.28 41.58 -17.36 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 2 3 # 2 A 50 GLN B 48 GLN~? 23.89 O2 EDO A 88 A 91 LEU A 19 LEU^? 24.09 O2 EDO A 88 A 133 GLU B 45 GLU~? 23.69 O2 EDO A 88 coo 43.58 43.67 66.73 42.32 42.78 68.15 -17.10 41.91 -8.85 -18.61 40.74 -9.82 coo 38.58 45.09 70.44 38.28 45.21 72.59 -18.28 45.53 -13.40 -17.54 46.15 -11.48 coo 44.05 36.87 70.65 43.15 38.64 69.97 -22.69 38.92 -6.32 -22.61 36.80 -6.71 1bs4_c00 source 1bs4 PEPTIDE DEFORMYLASE : 2 hits 1bs4_c00 naa= 3 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 1 3 # 1 B 550 GLN B 48 GLN~? 23.89 O2 EDO A 88 B 591 LEU A 19 LEU^? 24.09 O2 EDO A 88 B 633 GLU B 34 GLU~? 32.51 C2 EDO A 88 coo 88.06 44.34 57.19 89.06 45.53 55.74 -17.10 41.91 -8.85 -18.61 40.74 -9.82 coo 86.70 48.66 52.61 87.15 48.69 50.51 -18.28 45.53 -13.40 -17.54 46.15 -11.48 coo 95.42 44.52 54.43 93.46 45.31 54.70 -10.00 40.79 -15.51 -9.28 41.58 -17.36 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 2 3 # 2 B 550 GLN B 48 GLN~? 23.89 O2 EDO A 88 B 591 LEU A 19 LEU^? 24.09 O2 EDO A 88 B 633 GLU B 45 GLU~? 23.69 O2 EDO A 88 coo 88.06 44.34 57.19 89.06 45.53 55.74 -17.10 41.91 -8.85 -18.61 40.74 -9.82 coo 86.70 48.66 52.61 87.15 48.69 50.51 -18.28 45.53 -13.40 -17.54 46.15 -11.48 coo 95.42 44.52 54.43 93.46 45.31 54.70 -22.69 38.92 -6.32 -22.61 36.80 -6.71 1bs4_c01 source 1bs4 PEPTIDE DEFORMYLASE : 2 hits 1bs4_c01 naa= 3 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 1 3 # 1 C1050 GLN B 48 GLN~? 23.89 O2 EDO A 88 C1091 LEU A 19 LEU^? 24.09 O2 EDO A 88 C1133 GLU B 34 GLU~? 32.51 C2 EDO A 88 coo 68.29 34.44 43.03 66.67 34.74 44.37 -17.10 41.91 -8.85 -18.61 40.74 -9.82 coo 65.83 38.95 47.05 65.46 38.90 49.20 -18.28 45.53 -13.40 -17.54 46.15 -11.48 coo 63.14 29.39 46.25 63.84 31.31 45.74 -10.00 40.79 -15.51 -9.28 41.58 -17.36 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 2 3 # 2 C1050 GLN B 48 GLN~? 23.89 O2 EDO A 88 C1091 LEU A 19 LEU^? 24.09 O2 EDO A 88 C1133 GLU B 45 GLU~? 23.69 O2 EDO A 88 coo 68.29 34.44 43.03 66.67 34.74 44.37 -17.10 41.91 -8.85 -18.61 40.74 -9.82 coo 65.83 38.95 47.05 65.46 38.90 49.20 -18.28 45.53 -13.40 -17.54 46.15 -11.48 coo 63.14 29.39 46.25 63.84 31.31 45.74 -22.69 38.92 -6.32 -22.61 36.80 -6.71 1bs4_c02 source 1bs4 PEPTIDE DEFORMYLASE : 2 hits 1bs4_c02 naa= 3 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 1 3 # 1 A 50 GLN B 48 GLN~? 23.89 O2 EDO A 88 A 91 LEU A 19 LEU^? 24.09 O2 EDO A 88 A 133 GLU B 34 GLU~? 32.51 C2 EDO A 88 coo 38.23 53.34 67.59 38.84 53.87 69.56 -17.10 41.91 -8.85 -18.61 40.74 -9.82 coo 35.40 53.22 73.30 35.37 54.87 74.74 -18.28 45.53 -13.40 -17.54 46.15 -11.48 coo 45.08 56.04 70.60 43.15 55.19 70.77 -10.00 40.79 -15.51 -9.28 41.58 -17.36 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 2 3 # 2 A 50 GLN B 48 GLN~? 23.89 O2 EDO A 88 A 91 LEU A 19 LEU^? 24.09 O2 EDO A 88 A 133 GLU B 45 GLU~? 23.69 O2 EDO A 88 coo 38.23 53.34 67.59 38.84 53.87 69.56 -17.10 41.91 -8.85 -18.61 40.74 -9.82 coo 35.40 53.22 73.30 35.37 54.87 74.74 -18.28 45.53 -13.40 -17.54 46.15 -11.48 coo 45.08 56.04 70.60 43.15 55.19 70.77 -22.69 38.92 -6.32 -22.61 36.80 -6.71 1bsj_c00 source 1bsj PEPTIDE DEFORMYLASE : 2 hits 1bsj_c00 naa= 3 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 1 3 # 1 A 325 ASP A 37 ASP~? 13.07 O1 EDO A 88 A 354 GLU A 34 GLU~? 13.90 C1 EDO A 88 A 421 ASP A 28 ASP~? 11.68 O2 EDO A 88 coo 31.05 49.37 64.51 31.97 51.11 63.85 -25.14 65.39 3.92 -25.04 66.91 2.43 coo 29.07 50.42 58.36 29.02 52.18 59.49 -30.48 62.02 2.95 -32.58 61.85 3.30 coo 30.82 59.76 58.47 31.12 59.02 60.40 -31.33 53.08 5.19 -32.37 54.22 3.74 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 2 3 # 2 A 325 ASP B 37 ASP~? 29.91 O2 EDO A 88 A 354 GLU B 34 GLU~? 32.51 C2 EDO A 88 A 421 ASP B 28 ASP~? 30.32 C2 EDO A 88 coo 31.05 49.37 64.51 31.97 51.11 63.85 -11.14 36.80 -11.01 -12.56 35.32 -11.54 coo 29.07 50.42 58.36 29.02 52.18 59.49 -10.00 40.79 -15.51 -9.28 41.58 -17.36 coo 30.82 59.76 58.47 31.12 59.02 60.40 -6.22 49.12 -15.05 -7.63 48.42 -16.47 1bvz_c08 source 1bvz ALPHA-AMYLASE II : 2 hits 1bvz_c08 naa= 3 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 1 3 # 1 B 325 ASP A 37 ASP~? 13.07 O1 EDO A 88 B 354 GLU A 34 GLU~? 13.90 C1 EDO A 88 B 421 ASP A 28 ASP~? 11.68 O2 EDO A 88 coo 25.90 8.19 53.87 25.36 6.97 52.29 -25.14 65.39 3.92 -25.04 66.91 2.43 coo 27.87 10.66 47.95 27.82 8.60 48.27 -30.48 62.02 2.95 -32.58 61.85 3.30 coo 26.02 1.87 43.38 25.90 1.97 45.49 -31.33 53.08 5.19 -32.37 54.22 3.74 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 2 3 # 2 B 325 ASP B 37 ASP~? 29.91 O2 EDO A 88 B 354 GLU B 34 GLU~? 32.51 C2 EDO A 88 B 421 ASP B 28 ASP~? 30.32 C2 EDO A 88 coo 25.90 8.19 53.87 25.36 6.97 52.29 -11.14 36.80 -11.01 -12.56 35.32 -11.54 coo 27.87 10.66 47.95 27.82 8.60 48.27 -10.00 40.79 -15.51 -9.28 41.58 -17.36 coo 26.02 1.87 43.38 25.90 1.97 45.49 -6.22 49.12 -15.05 -7.63 48.42 -16.47 1bvz_c09 source 1bvz ALPHA-AMYLASE II : 2 hits 1bvz_c09 naa= 3 ULMN 3 1bwp_c01 PLATELET-ACTIVATING FACTOR ACETYLHYDuser 1 3 # 1 104 ASN A 83 ASN~? 10.47 O1 EDO A 88 192 ASP A 41 ASP.? 14.91 O1 EDO A 88 195 HIS B 67 HIS~? 12.87 O1 EDO A 88 coo 48.26 -8.64 25.32 50.17 -7.72 25.52 -12.86 57.40 15.39 -12.23 59.42 15.35 coo 56.18 0.19 32.76 56.16 -1.23 31.19 -14.25 67.95 8.57 -13.10 69.71 8.75 coo 56.71 -3.36 28.21 54.80 -3.08 27.37 -9.98 64.51 7.37 -11.90 65.11 7.97 1bwp_c01 source 1bwp PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE : 1 hits 1bwp_c01 naa= 3 ULMN 3 1c2t_c02 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 1 3 # 1 A 106 ASN B 3 ASN^? 29.42 C2 EDO A 88 A 108 HIS B 26 HIS.? 29.20 O1 EDO A 88 A 144 ASP B 27 ASP.? 26.46 C2 EDO A 88 coo 16.88 2.43 18.09 16.20 3.65 19.72 -8.54 54.49 -14.85 -6.79 53.63 -15.72 coo 16.00 9.54 19.61 16.53 10.80 21.20 -1.78 55.32 -10.54 -0.01 54.91 -11.57 coo 20.15 8.89 19.42 18.82 8.12 20.82 -4.76 50.56 -10.13 -3.07 50.63 -8.85 1c2t_c02 source 1c2t GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMYLASE : 1 hits 1c2t_c02 naa= 3 ULMN 3 1c2t_c03 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 1 3 # 1 B 106 ASN B 3 ASN^? 29.42 C2 EDO A 88 B 108 HIS B 26 HIS.? 29.20 O1 EDO A 88 B 144 ASP B 27 ASP.? 26.46 C2 EDO A 88 coo 35.24 22.62 -1.00 36.98 21.40 -1.03 -8.54 54.49 -14.85 -6.79 53.63 -15.72 coo 37.11 15.55 -1.20 38.41 14.30 -0.14 -1.78 55.32 -10.54 -0.01 54.91 -11.57 coo 35.12 16.22 2.69 37.05 17.04 2.40 -4.76 50.56 -10.13 -3.07 50.63 -8.85 1c2t_c03 source 1c2t GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMYLASE : 1 hits 1c2t_c03 naa= 3 ULMN 3 1c4x_c00 2-HYDROXY-6-OXO-6-PHENYLHEXA-2,4-DIEuser 1 3 # 1 A 110 SER A 24 SER^? 14.86 O2 EDO A 88 A 235 ASP A 27 ASP.? 4.81 O2 EDO A 88 A 263 HIS A 26 HIS.? 12.31 O2 EDO A 88 coo 30.32 56.27 16.76 31.62 57.99 17.94 -27.05 44.01 0.12 -28.54 42.91 1.70 coo 31.33 62.80 9.68 31.68 62.04 11.62 -26.65 50.87 6.95 -25.73 50.39 8.79 coo 30.23 62.32 14.77 30.86 60.47 15.53 -27.15 43.88 6.97 -27.62 42.01 6.19 1c4x_c00 source 1c4x 2-HYDROXY-6-OXO-6-PHENYLHEXA-2,4-DIENOATE HYDR: 1 hits 1c4x_c00 naa= 3 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 1 3 # 1 A 14 ASP A 41 ASP.? 14.91 O1 EDO A 88 A 16 HIS B 67 HIS~? 12.87 O1 EDO A 88 A 67 GLY A 38 GLY.? 11.75 O1 EDO A 88 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 -14.25 67.95 8.57 -13.10 69.71 8.75 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 -9.98 64.51 7.37 -11.90 65.11 7.97 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 -21.62 68.05 5.82 -21.64 67.37 6.20 1cb7_c06 source 1cb7 GLUTAMATE MUTASE : 1 hits 1cb7_c06 naa= 3 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 1 3 # 1 C 14 ASP A 41 ASP.? 14.91 O1 EDO A 88 C 16 HIS B 67 HIS~? 12.87 O1 EDO A 88 C 67 GLY A 38 GLY.? 11.75 O1 EDO A 88 coo 10.04 44.27 88.44 9.47 42.32 89.03 -14.25 67.95 8.57 -13.10 69.71 8.75 coo 6.38 39.80 88.71 6.88 38.89 86.87 -9.98 64.51 7.37 -11.90 65.11 7.97 coo 17.63 42.50 89.25 18.11 42.29 88.64 -21.62 68.05 5.82 -21.64 67.37 6.20 1cb7_c07 source 1cb7 GLUTAMATE MUTASE : 1 hits 1cb7_c07 naa= 3 ULMN 3 1cde_c04 PHOSPHORIBOSYLGLYCINAMIDE FORMYLTRANuser 1 3 # 1 106 ASN B 3 ASN^? 29.42 C2 EDO A 88 108 HIS B 26 HIS.? 29.20 O1 EDO A 88 144 ASP B 27 ASP.? 26.46 C2 EDO A 88 coo -1.10 -5.24 -0.75 -0.59 -6.18 1.17 -8.54 54.49 -14.85 -6.79 53.63 -15.72 coo 2.74 -10.94 1.41 2.75 -12.60 2.56 -1.78 55.32 -10.54 -0.01 54.91 -11.57 coo -0.94 -12.96 0.04 -1.03 -11.72 1.73 -4.76 50.56 -10.13 -3.07 50.63 -8.85 1cde_c04 source 1cde PHOSPHORIBOSYLGLYCINAMIDE FORMYLTRANSFERASE : 1 hits 1cde_c04 naa= 3 ULMN 3 1cde_c05 PHOSPHORIBOSYLGLYCINAMIDE FORMYLTRANuser 1 3 # 1 106 ASN B 3 ASN^? 29.42 C2 EDO A 88 108 HIS B 26 HIS.? 29.20 O1 EDO A 88 144 ASP B 27 ASP.? 26.46 C2 EDO A 88 coo -1.10 -5.24 -0.75 -0.59 -6.18 1.17 -8.54 54.49 -14.85 -6.79 53.63 -15.72 coo 2.74 -10.94 1.41 2.75 -12.60 2.56 -1.78 55.32 -10.54 -0.01 54.91 -11.57 coo -0.94 -12.96 0.04 -1.03 -11.72 1.73 -4.76 50.56 -10.13 -3.07 50.63 -8.85 1cde_c05 source 1cde PHOSPHORIBOSYLGLYCINAMIDE FORMYLTRANSFERASE : 1 hits 1cde_c05 naa= 3 ULMN 3 1cde_c06 PHOSPHORIBOSYLGLYCINAMIDE FORMYLTRANuser 1 3 # 1 106 ASN B 3 ASN^? 29.42 C2 EDO A 88 108 HIS B 26 HIS.? 29.20 O1 EDO A 88 144 ASP B 27 ASP.? 26.46 C2 EDO A 88 coo -1.10 -5.24 -0.75 -0.59 -6.18 1.17 -8.54 54.49 -14.85 -6.79 53.63 -15.72 coo 2.74 -10.94 1.41 2.75 -12.60 2.56 -1.78 55.32 -10.54 -0.01 54.91 -11.57 coo -0.94 -12.96 0.04 -1.03 -11.72 1.73 -4.76 50.56 -10.13 -3.07 50.63 -8.85 1cde_c06 source 1cde PHOSPHORIBOSYLGLYCINAMIDE FORMYLTRANSFERASE : 1 hits 1cde_c06 naa= 3 ULMN 3 1cde_c07 PHOSPHORIBOSYLGLYCINAMIDE FORMYLTRANuser 1 3 # 1 106 ASN B 3 ASN^? 29.42 C2 EDO A 88 108 HIS B 26 HIS.? 29.20 O1 EDO A 88 144 ASP B 27 ASP.? 26.46 C2 EDO A 88 coo -1.10 -5.24 -0.75 -0.59 -6.18 1.17 -8.54 54.49 -14.85 -6.79 53.63 -15.72 coo 2.74 -10.94 1.41 2.75 -12.60 2.56 -1.78 55.32 -10.54 -0.01 54.91 -11.57 coo -0.94 -12.96 0.04 -1.03 -11.72 1.73 -4.76 50.56 -10.13 -3.07 50.63 -8.85 1cde_c07 source 1cde PHOSPHORIBOSYLGLYCINAMIDE FORMYLTRANSFERASE : 1 hits 1cde_c07 naa= 3 ULMN 3 1cns_c00 CHITINASE user 1 3 # 1 A 67 GLU A 10 GLU^? 27.07 C2 EDO A 88 A 89 GLU B 10 GLU^? 22.83 O2 EDO A 88 A 120 SER A 20 SER^? 23.95 O2 EDO A 88 coo -24.35 9.53 67.64 -25.07 11.29 68.60 -20.28 53.65 -16.35 -22.20 53.78 -17.27 coo -31.18 6.91 75.60 -32.39 8.51 74.91 -29.59 50.76 -9.46 -29.70 50.98 -11.60 coo -34.73 8.57 68.21 -33.63 9.08 70.28 -22.75 45.49 -12.51 -25.02 46.25 -12.74 ULMN 3 1cns_c00 CHITINASE user 2 3 # 2 A 67 GLU A 10 GLU^? 27.07 C2 EDO A 88 A 89 GLU B 10 GLU^? 22.83 O2 EDO A 88 A 120 SER B 20 SER^? 21.95 C2 EDO A 88 coo -24.35 9.53 67.64 -25.07 11.29 68.60 -20.28 53.65 -16.35 -22.20 53.78 -17.27 coo -31.18 6.91 75.60 -32.39 8.51 74.91 -29.59 50.76 -9.46 -29.70 50.98 -11.60 coo -34.73 8.57 68.21 -33.63 9.08 70.28 -24.09 58.44 -9.47 -23.94 57.89 -11.81 ULMN 3 1cns_c00 CHITINASE user 3 3 # 3 A 67 GLU A 11 GLU^? 30.56 C2 EDO A 88 A 89 GLU B 22 GLU^? 25.61 O1 EDO A 88 A 120 SER B 24 SER^? 25.27 O1 EDO A 88 coo -24.35 9.53 67.64 -25.07 11.29 68.60 -13.41 51.24 -17.67 -12.24 50.07 -19.00 coo -31.18 6.91 75.60 -32.39 8.51 74.91 -17.79 60.61 -13.20 -17.15 61.81 -14.83 coo -34.73 8.57 68.21 -33.63 9.08 70.28 -10.38 58.47 -10.73 -8.49 59.58 -11.78 ULMN 3 1cns_c00 CHITINASE user 4 3 # 4 A 67 GLU A 22 GLU^? 21.42 O2 EDO A 88 A 89 GLU B 10 GLU^? 22.83 O2 EDO A 88 A 120 SER A 20 SER^? 23.95 O2 EDO A 88 coo -24.35 9.53 67.64 -25.07 11.29 68.60 -28.40 42.45 -5.63 -29.98 41.10 -5.71 coo -31.18 6.91 75.60 -32.39 8.51 74.91 -29.59 50.76 -9.46 -29.70 50.98 -11.60 coo -34.73 8.57 68.21 -33.63 9.08 70.28 -22.75 45.49 -12.51 -25.02 46.25 -12.74 ULMN 3 1cns_c00 CHITINASE user 5 3 # 5 A 67 GLU B 10 GLU^? 22.83 O2 EDO A 88 A 89 GLU A 10 GLU^? 27.07 C2 EDO A 88 A 120 SER A 20 SER^? 23.95 O2 EDO A 88 coo -24.35 9.53 67.64 -25.07 11.29 68.60 -29.59 50.76 -9.46 -29.70 50.98 -11.60 coo -31.18 6.91 75.60 -32.39 8.51 74.91 -20.28 53.65 -16.35 -22.20 53.78 -17.27 coo -34.73 8.57 68.21 -33.63 9.08 70.28 -22.75 45.49 -12.51 -25.02 46.25 -12.74 ULMN 3 1cns_c00 CHITINASE user 6 3 # 6 A 67 GLU B 10 GLU^? 22.83 O2 EDO A 88 A 89 GLU A 10 GLU^? 27.07 C2 EDO A 88 A 120 SER B 20 SER^? 21.95 C2 EDO A 88 coo -24.35 9.53 67.64 -25.07 11.29 68.60 -29.59 50.76 -9.46 -29.70 50.98 -11.60 coo -31.18 6.91 75.60 -32.39 8.51 74.91 -20.28 53.65 -16.35 -22.20 53.78 -17.27 coo -34.73 8.57 68.21 -33.63 9.08 70.28 -24.09 58.44 -9.47 -23.94 57.89 -11.81 ULMN 3 1cns_c00 CHITINASE user 7 3 # 7 A 67 GLU B 10 GLU^? 22.83 O2 EDO A 88 A 89 GLU A 22 GLU^? 21.42 O2 EDO A 88 A 120 SER A 20 SER^? 23.95 O2 EDO A 88 coo -24.35 9.53 67.64 -25.07 11.29 68.60 -29.59 50.76 -9.46 -29.70 50.98 -11.60 coo -31.18 6.91 75.60 -32.39 8.51 74.91 -28.40 42.45 -5.63 -29.98 41.10 -5.71 coo -34.73 8.57 68.21 -33.63 9.08 70.28 -22.75 45.49 -12.51 -25.02 46.25 -12.74 1cns_c00 source 1cns CHITINASE : 7 hits 1cns_c00 naa= 3 ULMN 3 1cns_c01 CHITINASE user 1 3 # 1 B 67 GLU A 10 GLU^? 27.07 C2 EDO A 88 B 89 GLU B 10 GLU^? 22.83 O2 EDO A 88 B 120 SER A 20 SER^? 23.95 O2 EDO A 88 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 -20.28 53.65 -16.35 -22.20 53.78 -17.27 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 -29.59 50.76 -9.46 -29.70 50.98 -11.60 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 -22.75 45.49 -12.51 -25.02 46.25 -12.74 ULMN 3 1cns_c01 CHITINASE user 2 3 # 2 B 67 GLU A 10 GLU^? 27.07 C2 EDO A 88 B 89 GLU B 10 GLU^? 22.83 O2 EDO A 88 B 120 SER B 20 SER^? 21.95 C2 EDO A 88 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 -20.28 53.65 -16.35 -22.20 53.78 -17.27 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 -29.59 50.76 -9.46 -29.70 50.98 -11.60 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 -24.09 58.44 -9.47 -23.94 57.89 -11.81 ULMN 3 1cns_c01 CHITINASE user 3 3 # 3 B 67 GLU A 11 GLU^? 30.56 C2 EDO A 88 B 89 GLU B 22 GLU^? 25.61 O1 EDO A 88 B 120 SER B 24 SER^? 25.27 O1 EDO A 88 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 -13.41 51.24 -17.67 -12.24 50.07 -19.00 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 -17.79 60.61 -13.20 -17.15 61.81 -14.83 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 -10.38 58.47 -10.73 -8.49 59.58 -11.78 ULMN 3 1cns_c01 CHITINASE user 4 3 # 4 B 67 GLU B 10 GLU^? 22.83 O2 EDO A 88 B 89 GLU A 10 GLU^? 27.07 C2 EDO A 88 B 120 SER A 20 SER^? 23.95 O2 EDO A 88 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 -29.59 50.76 -9.46 -29.70 50.98 -11.60 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 -20.28 53.65 -16.35 -22.20 53.78 -17.27 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 -22.75 45.49 -12.51 -25.02 46.25 -12.74 ULMN 3 1cns_c01 CHITINASE user 5 3 # 5 B 67 GLU B 10 GLU^? 22.83 O2 EDO A 88 B 89 GLU A 10 GLU^? 27.07 C2 EDO A 88 B 120 SER B 20 SER^? 21.95 C2 EDO A 88 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 -29.59 50.76 -9.46 -29.70 50.98 -11.60 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 -20.28 53.65 -16.35 -22.20 53.78 -17.27 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 -24.09 58.44 -9.47 -23.94 57.89 -11.81 1cns_c01 source 1cns CHITINASE : 5 hits 1cns_c01 naa= 3 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 1 3 # 1 A 37 ASP A 27 ASP.? 4.81 O2 EDO A 88 A 56 ILE A 4 ILE^? 18.41 O2 EDO A 88 A 82 TYR A 5 TYR^? 13.23 O2 EDO A 88 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 -26.65 50.87 6.95 -25.73 50.39 8.79 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 -31.53 44.54 -2.45 -31.93 43.21 -2.77 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 -28.09 49.40 -2.46 -28.96 50.64 -0.10 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 2 3 # 2 A 37 ASP A 28 ASP~? 11.68 O2 EDO A 88 A 56 ILE A 4 ILE^? 18.41 O2 EDO A 88 A 82 TYR A 5 TYR^? 13.23 O2 EDO A 88 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 -31.33 53.08 5.19 -32.37 54.22 3.74 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 -31.53 44.54 -2.45 -31.93 43.21 -2.77 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 -28.09 49.40 -2.46 -28.96 50.64 -0.10 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 3 3 # 3 A 37 ASP B 27 ASP.? 26.46 C2 EDO A 88 A 56 ILE B 4 ILE^? 27.00 O1 EDO A 88 A 82 TYR B 5 TYR^? 24.90 C2 EDO A 88 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 -4.76 50.56 -10.13 -3.07 50.63 -8.85 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 -12.27 59.04 -15.35 -12.36 60.44 -15.41 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 -13.48 53.76 -13.02 -11.19 52.33 -13.67 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 4 3 # 4 A 37 ASP B 28 ASP~? 30.32 C2 EDO A 88 A 56 ILE B 4 ILE^? 27.00 O1 EDO A 88 A 82 TYR B 5 TYR^? 24.90 C2 EDO A 88 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 -6.22 49.12 -15.05 -7.63 48.42 -16.47 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 -12.27 59.04 -15.35 -12.36 60.44 -15.41 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 -13.48 53.76 -13.02 -11.19 52.33 -13.67 1d6o_c00 source 1d6o FK506-BINDING PROTEIN : 4 hits 1d6o_c00 naa= 3 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 1 3 # 1 B 37 ASP A 27 ASP.? 4.81 O2 EDO A 88 B 56 ILE A 4 ILE^? 18.41 O2 EDO A 88 B 82 TYR A 5 TYR^? 13.23 O2 EDO A 88 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 -26.65 50.87 6.95 -25.73 50.39 8.79 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 -31.53 44.54 -2.45 -31.93 43.21 -2.77 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 -28.09 49.40 -2.46 -28.96 50.64 -0.10 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 2 3 # 2 B 37 ASP A 28 ASP~? 11.68 O2 EDO A 88 B 56 ILE A 4 ILE^? 18.41 O2 EDO A 88 B 82 TYR A 5 TYR^? 13.23 O2 EDO A 88 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 -31.33 53.08 5.19 -32.37 54.22 3.74 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 -31.53 44.54 -2.45 -31.93 43.21 -2.77 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 -28.09 49.40 -2.46 -28.96 50.64 -0.10 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 3 3 # 3 B 37 ASP B 27 ASP.? 26.46 C2 EDO A 88 B 56 ILE B 4 ILE^? 27.00 O1 EDO A 88 B 82 TYR B 5 TYR^? 24.90 C2 EDO A 88 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 -4.76 50.56 -10.13 -3.07 50.63 -8.85 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 -12.27 59.04 -15.35 -12.36 60.44 -15.41 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 -13.48 53.76 -13.02 -11.19 52.33 -13.67 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 4 3 # 4 B 37 ASP B 28 ASP~? 30.32 C2 EDO A 88 B 56 ILE B 4 ILE^? 27.00 O1 EDO A 88 B 82 TYR B 5 TYR^? 24.90 C2 EDO A 88 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 -6.22 49.12 -15.05 -7.63 48.42 -16.47 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 -12.27 59.04 -15.35 -12.36 60.44 -15.41 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 -13.48 53.76 -13.02 -11.19 52.33 -13.67 1d6o_c01 source 1d6o FK506-BINDING PROTEIN : 4 hits 1d6o_c01 naa= 3 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 1 3 # 1 A 173 TYR A 5 TYR^? 13.23 O2 EDO A 88 A 243 ASP B 27 ASP.? 26.46 C2 EDO A 88 A 272 LYS B 85 LYS~? 25.46 C2 EDO A 88 coo 2.03 68.31 21.46 0.66 68.36 23.90 -28.09 49.40 -2.46 -28.96 50.64 -0.10 coo 16.93 55.67 9.65 17.16 54.23 11.19 -4.76 50.56 -10.13 -3.07 50.63 -8.85 coo 14.13 45.79 13.40 14.25 49.41 18.30 -1.24 41.95 -2.07 0.00 48.03 -2.24 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 2 3 # 2 A 173 TYR B 5 TYR^? 24.90 C2 EDO A 88 A 243 ASP A 27 ASP.? 4.81 O2 EDO A 88 A 272 LYS A 35 LYS~? 3.82 C1 EDO A 88 coo 2.03 68.31 21.46 0.66 68.36 23.90 -13.48 53.76 -13.02 -11.19 52.33 -13.67 coo 16.93 55.67 9.65 17.16 54.23 11.19 -26.65 50.87 6.95 -25.73 50.39 8.79 coo 14.13 45.79 13.40 14.25 49.41 18.30 -27.16 62.03 7.83 -24.89 58.41 11.08 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 3 3 # 3 A 173 TYR B 5 TYR^? 24.90 C2 EDO A 88 A 243 ASP A 27 ASP.? 4.81 O2 EDO A 88 A 272 LYS A 85 LYS~? 4.81 O2 EDO A 88 coo 2.03 68.31 21.46 0.66 68.36 23.90 -13.48 53.76 -13.02 -11.19 52.33 -13.67 coo 16.93 55.67 9.65 17.16 54.23 11.19 -26.65 50.87 6.95 -25.73 50.39 8.79 coo 14.13 45.79 13.40 14.25 49.41 18.30 -19.67 57.49 14.47 -21.14 51.45 13.91 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 4 3 # 4 A 173 TYR B 5 TYR^? 24.90 C2 EDO A 88 A 243 ASP A 37 ASP~? 13.07 O1 EDO A 88 A 272 LYS A 31 LYS~? 12.16 C1 EDO A 88 coo 2.03 68.31 21.46 0.66 68.36 23.90 -13.48 53.76 -13.02 -11.19 52.33 -13.67 coo 16.93 55.67 9.65 17.16 54.23 11.19 -25.14 65.39 3.92 -25.04 66.91 2.43 coo 14.13 45.79 13.40 14.25 49.41 18.30 -30.40 57.71 4.72 -33.78 58.75 8.98 1d7r_c02 source 1d7r 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYRUVATE) : 4 hits 1d7r_c02 naa= 3 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 1 3 # 1 A 145 LYS A 31 LYS~? 12.16 C1 EDO A 88 A 177 GLU B 11 GLU^? 16.09 O2 EDO A 88 A 201 LEU A 29 LEU~? 9.59 O2 EDO A 88 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 -30.40 57.71 4.72 -33.78 58.75 8.98 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 -32.33 52.63 -2.59 -33.86 53.51 -1.46 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 -26.64 53.17 1.28 -24.69 53.55 0.41 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 2 3 # 2 A 145 LYS B 31 LYS~? 34.04 C2 EDO A 88 A 177 GLU A 11 GLU^? 30.56 C2 EDO A 88 A 201 LEU B 29 LEU~? 23.21 C2 EDO A 88 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 -7.49 44.50 -14.70 -1.79 44.49 -16.08 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 -13.41 51.24 -17.67 -12.24 50.07 -19.00 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 -11.06 49.55 -11.46 -12.52 49.36 -9.88 1daa_c00 source 1daa D-AMINO ACID AMINOTRANSFERASE : 2 hits 1daa_c00 naa= 3 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 1 3 # 1 B 145 LYS A 31 LYS~? 12.16 C1 EDO A 88 B 177 GLU B 11 GLU^? 16.09 O2 EDO A 88 B 201 LEU A 29 LEU~? 9.59 O2 EDO A 88 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 -30.40 57.71 4.72 -33.78 58.75 8.98 coo 27.00 6.35 51.01 26.30 4.53 50.18 -32.33 52.63 -2.59 -33.86 53.51 -1.46 coo 23.74 1.68 49.50 22.87 -0.24 49.97 -26.64 53.17 1.28 -24.69 53.55 0.41 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 2 3 # 2 B 145 LYS B 31 LYS~? 34.04 C2 EDO A 88 B 177 GLU A 11 GLU^? 30.56 C2 EDO A 88 B 201 LEU B 29 LEU~? 23.21 C2 EDO A 88 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 -7.49 44.50 -14.70 -1.79 44.49 -16.08 coo 27.00 6.35 51.01 26.30 4.53 50.18 -13.41 51.24 -17.67 -12.24 50.07 -19.00 coo 23.74 1.68 49.50 22.87 -0.24 49.97 -11.06 49.55 -11.46 -12.52 49.36 -9.88 1daa_c01 source 1daa D-AMINO ACID AMINOTRANSFERASE : 2 hits 1daa_c01 naa= 3 ULMN 3 1db3_c01 GDP-MANNOSE 4,6-DEHYDRATASE user 1 3 # 1 A 132 THR B 18 THR^? 21.02 O2 EDO A 88 A 156 TYR A 5 TYR^? 13.23 O2 EDO A 88 A 160 LYS B 12 LYS.? 22.50 O2 EDO A 88 coo 10.50 56.87 17.73 11.24 57.93 19.43 -30.25 56.49 -7.39 -30.39 55.85 -9.47 coo 11.64 63.07 23.95 11.76 62.47 21.20 -28.09 49.40 -2.46 -28.96 50.64 -0.10 coo 5.78 61.30 21.65 8.04 62.89 17.54 -33.93 48.03 -5.83 -30.65 43.44 -8.38 1db3_c01 source 1db3 GDP-MANNOSE 4,6-DEHYDRATASE : 1 hits 1db3_c01 naa= 3 ULMN 3 1ddj_c15 PLASMINOGEN user 1 3 # 1 D 603 HIS A 26 HIS.? 12.31 O2 EDO A 88 D 646 ASP A 27 ASP.? 4.81 O2 EDO A 88 D 739 GLY A 53 GLY~? 11.45 C2 EDO A 88 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -27.15 43.88 6.97 -27.62 42.01 6.19 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -26.65 50.87 6.95 -25.73 50.39 8.79 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -16.69 52.63 -0.43 -17.18 52.70 0.21 ULMN 3 1ddj_c15 PLASMINOGEN user 2 3 # 2 D 603 HIS A 26 HIS.? 12.31 O2 EDO A 88 D 646 ASP A 27 ASP.? 4.81 O2 EDO A 88 D 739 GLY B 53 GLY~? 14.25 C2 EDO A 88 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -27.15 43.88 6.97 -27.62 42.01 6.19 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -26.65 50.87 6.95 -25.73 50.39 8.79 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -15.31 49.67 -2.05 -14.58 49.52 -2.41 1ddj_c15 source 1ddj PLASMINOGEN : 2 hits 1ddj_c15 naa= 3 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 A 57 GLU A 10 GLU^? 27.07 C2 EDO A 88 A 226 THR A 47 THR~? 9.56 O1 EDO A 88 A 229 LYS A 39 LYS.? 9.97 O1 EDO A 88 coo 9.66 102.78 70.07 9.79 101.18 71.42 -20.28 53.65 -16.35 -22.20 53.78 -17.27 coo 7.24 97.46 49.60 8.11 95.69 48.80 -18.11 62.28 1.75 -19.10 63.54 3.24 coo 10.53 97.56 43.71 9.33 93.71 47.17 -20.54 66.31 9.07 -25.61 65.89 11.03 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 A 57 GLU B 10 GLU^? 22.83 O2 EDO A 88 A 226 THR A 47 THR~? 9.56 O1 EDO A 88 A 229 LYS A 39 LYS.? 9.97 O1 EDO A 88 coo 9.66 102.78 70.07 9.79 101.18 71.42 -29.59 50.76 -9.46 -29.70 50.98 -11.60 coo 7.24 97.46 49.60 8.11 95.69 48.80 -18.11 62.28 1.75 -19.10 63.54 3.24 coo 10.53 97.56 43.71 9.33 93.71 47.17 -20.54 66.31 9.07 -25.61 65.89 11.03 1dfo_c04 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 2 hits 1dfo_c04 naa= 3 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 1 3 # 1 A 44 THR A 8 THR^? 23.58 O2 EDO A 88 A 45 THR B 8 THR^? 21.75 O2 EDO A 88 A 161 LYS B 12 LYS.? 22.50 O2 EDO A 88 coo 26.16 88.25 79.16 25.22 89.47 80.71 -22.63 49.63 -11.64 -24.06 49.62 -13.30 coo 27.73 89.90 76.08 29.24 91.46 75.95 -24.11 54.23 -9.95 -25.46 54.68 -11.65 coo 33.83 91.15 88.62 31.07 91.06 83.02 -33.93 48.03 -5.83 -30.65 43.44 -8.38 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 2 3 # 2 A 44 THR A 8 THR^? 23.58 O2 EDO A 88 A 45 THR B 8 THR^? 21.75 O2 EDO A 88 A 161 LYS B 55 LYS~? 22.80 C2 EDO A 88 coo 26.16 88.25 79.16 25.22 89.47 80.71 -22.63 49.63 -11.64 -24.06 49.62 -13.30 coo 27.73 89.90 76.08 29.24 91.46 75.95 -24.11 54.23 -9.95 -25.46 54.68 -11.65 coo 33.83 91.15 88.62 31.07 91.06 83.02 -10.41 51.47 -4.09 -5.84 50.62 -6.36 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 3 3 # 3 A 44 THR B 8 THR^? 21.75 O2 EDO A 88 A 45 THR A 8 THR^? 23.58 O2 EDO A 88 A 161 LYS B 12 LYS.? 22.50 O2 EDO A 88 coo 26.16 88.25 79.16 25.22 89.47 80.71 -24.11 54.23 -9.95 -25.46 54.68 -11.65 coo 27.73 89.90 76.08 29.24 91.46 75.95 -22.63 49.63 -11.64 -24.06 49.62 -13.30 coo 33.83 91.15 88.62 31.07 91.06 83.02 -33.93 48.03 -5.83 -30.65 43.44 -8.38 1dhp_c02 source 1dhp DIHYDRODIPICOLINATE SYNTHASE : 3 hits 1dhp_c02 naa= 3 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 1 3 # 1 B 44 THR A 8 THR^? 23.58 O2 EDO A 88 B 45 THR B 8 THR^? 21.75 O2 EDO A 88 B 161 LYS B 12 LYS.? 22.50 O2 EDO A 88 coo 7.39 128.28 94.56 8.34 126.36 94.79 -22.63 49.63 -11.64 -24.06 49.62 -13.30 coo 5.75 129.25 91.25 4.29 128.16 90.07 -24.11 54.23 -9.95 -25.46 54.68 -11.65 coo -0.17 119.75 99.65 2.51 123.83 95.70 -33.93 48.03 -5.83 -30.65 43.44 -8.38 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 2 3 # 2 B 44 THR A 8 THR^? 23.58 O2 EDO A 88 B 45 THR B 8 THR^? 21.75 O2 EDO A 88 B 161 LYS B 55 LYS~? 22.80 C2 EDO A 88 coo 7.39 128.28 94.56 8.34 126.36 94.79 -22.63 49.63 -11.64 -24.06 49.62 -13.30 coo 5.75 129.25 91.25 4.29 128.16 90.07 -24.11 54.23 -9.95 -25.46 54.68 -11.65 coo -0.17 119.75 99.65 2.51 123.83 95.70 -10.41 51.47 -4.09 -5.84 50.62 -6.36 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 3 3 # 3 B 44 THR B 8 THR^? 21.75 O2 EDO A 88 B 45 THR A 8 THR^? 23.58 O2 EDO A 88 B 161 LYS B 12 LYS.? 22.50 O2 EDO A 88 coo 7.39 128.28 94.56 8.34 126.36 94.79 -24.11 54.23 -9.95 -25.46 54.68 -11.65 coo 5.75 129.25 91.25 4.29 128.16 90.07 -22.63 49.63 -11.64 -24.06 49.62 -13.30 coo -0.17 119.75 99.65 2.51 123.83 95.70 -33.93 48.03 -5.83 -30.65 43.44 -8.38 1dhp_c03 source 1dhp DIHYDRODIPICOLINATE SYNTHASE : 3 hits 1dhp_c03 naa= 3 ULMN 3 1dwo_c00 HYDROXYNITRILE LYASE user 1 3 # 1 A 80 SER A 24 SER^? 14.86 O2 EDO A 88 A 208 ASP A 27 ASP.? 4.81 O2 EDO A 88 A 236 HIS A 26 HIS.? 12.31 O2 EDO A 88 coo 49.19 42.85 125.39 50.92 43.54 123.63 -27.05 44.01 0.12 -28.54 42.91 1.70 coo 57.80 42.94 129.59 56.47 43.28 127.93 -26.65 50.87 6.95 -25.73 50.39 8.79 coo 55.54 41.70 125.00 53.71 42.50 124.53 -27.15 43.88 6.97 -27.62 42.01 6.19 1dwo_c00 source 1dwo HYDROXYNITRILE LYASE : 1 hits 1dwo_c00 naa= 3 ULMN 3 1dwo_c01 HYDROXYNITRILE LYASE user 1 3 # 1 B 80 SER A 24 SER^? 14.86 O2 EDO A 88 B 208 ASP A 27 ASP.? 4.81 O2 EDO A 88 B 236 HIS A 26 HIS.? 12.31 O2 EDO A 88 coo 55.25 19.46 97.60 53.04 19.32 98.76 -27.05 44.01 0.12 -28.54 42.91 1.70 coo 57.34 11.46 102.30 56.11 13.10 101.70 -26.65 50.87 6.95 -25.73 50.39 8.79 coo 55.03 16.17 103.08 54.39 17.23 101.45 -27.15 43.88 6.97 -27.62 42.01 6.19 1dwo_c01 source 1dwo HYDROXYNITRILE LYASE : 1 hits 1dwo_c01 naa= 3 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 1 3 # 1 A 131 LYS A 31 LYS~? 12.16 C1 EDO A 88 A 215 LYS A 39 LYS.? 9.97 O1 EDO A 88 A 277 LYS A 86 LYS~? 13.64 O1 EDO A 88 coo 0.50 24.09 51.68 1.51 29.34 52.35 -30.40 57.71 4.72 -33.78 58.75 8.98 coo 13.06 30.79 51.73 11.40 35.76 53.48 -20.54 66.31 9.07 -25.61 65.89 11.03 coo 13.04 31.88 60.72 10.57 35.34 57.49 -18.60 60.01 17.15 -15.10 59.96 22.04 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 2 3 # 2 A 131 LYS A 55 LYS~? -3.15 O2 EDO A 88s A 215 LYS A 35 LYS~? 3.82 C1 EDO A 88 A 277 LYS A 39 LYS.? 9.97 O1 EDO A 88 coo 0.50 24.09 51.68 1.51 29.34 52.35 -20.05 50.35 3.45 -22.02 51.39 7.78 coo 13.06 30.79 51.73 11.40 35.76 53.48 -27.16 62.03 7.83 -24.89 58.41 11.08 coo 13.04 31.88 60.72 10.57 35.34 57.49 -20.54 66.31 9.07 -25.61 65.89 11.03 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 3 3 # 3 A 131 LYS A 55 LYS~? -3.15 O2 EDO A 88s A 215 LYS A 85 LYS~? 4.81 O2 EDO A 88 A 277 LYS A 39 LYS.? 9.97 O1 EDO A 88 coo 0.50 24.09 51.68 1.51 29.34 52.35 -20.05 50.35 3.45 -22.02 51.39 7.78 coo 13.06 30.79 51.73 11.40 35.76 53.48 -19.67 57.49 14.47 -21.14 51.45 13.91 coo 13.04 31.88 60.72 10.57 35.34 57.49 -20.54 66.31 9.07 -25.61 65.89 11.03 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 4 3 # 4 A 131 LYS B 71 LYS~? 21.06 O1 EDO A 88 A 215 LYS A 85 LYS~? 4.81 O2 EDO A 88 A 277 LYS A 39 LYS.? 9.97 O1 EDO A 88 coo 0.50 24.09 51.68 1.51 29.34 52.35 -4.46 59.86 10.42 -1.71 65.47 11.76 coo 13.06 30.79 51.73 11.40 35.76 53.48 -19.67 57.49 14.47 -21.14 51.45 13.91 coo 13.04 31.88 60.72 10.57 35.34 57.49 -20.54 66.31 9.07 -25.61 65.89 11.03 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 5 3 # 5 A 131 LYS B 71 LYS~? 21.06 O1 EDO A 88 A 215 LYS A 86 LYS~? 13.64 O1 EDO A 88 A 277 LYS A 39 LYS.? 9.97 O1 EDO A 88 coo 0.50 24.09 51.68 1.51 29.34 52.35 -4.46 59.86 10.42 -1.71 65.47 11.76 coo 13.06 30.79 51.73 11.40 35.76 53.48 -18.60 60.01 17.15 -15.10 59.96 22.04 coo 13.04 31.88 60.72 10.57 35.34 57.49 -20.54 66.31 9.07 -25.61 65.89 11.03 1e19_c00 source 1e19 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPHATE SYNTH: 5 hits 1e19_c00 naa= 3 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 1 3 # 1 B 131 LYS A 31 LYS~? 12.16 C1 EDO A 88 B 215 LYS A 39 LYS.? 9.97 O1 EDO A 88 B 277 LYS A 86 LYS~? 13.64 O1 EDO A 88 coo 6.78 45.91 16.15 7.82 40.81 15.84 -30.40 57.71 4.72 -33.78 58.75 8.98 coo 17.88 38.77 19.81 16.38 34.23 17.24 -20.54 66.31 9.07 -25.61 65.89 11.03 coo 20.33 37.78 11.20 16.77 34.53 13.47 -18.60 60.01 17.15 -15.10 59.96 22.04 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 2 3 # 2 B 131 LYS A 55 LYS~? -3.15 O2 EDO A 88s B 215 LYS A 35 LYS~? 3.82 C1 EDO A 88 B 277 LYS A 39 LYS.? 9.97 O1 EDO A 88 coo 6.78 45.91 16.15 7.82 40.81 15.84 -20.05 50.35 3.45 -22.02 51.39 7.78 coo 17.88 38.77 19.81 16.38 34.23 17.24 -27.16 62.03 7.83 -24.89 58.41 11.08 coo 20.33 37.78 11.20 16.77 34.53 13.47 -20.54 66.31 9.07 -25.61 65.89 11.03 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 3 3 # 3 B 131 LYS A 55 LYS~? -3.15 O2 EDO A 88s B 215 LYS A 85 LYS~? 4.81 O2 EDO A 88 B 277 LYS A 39 LYS.? 9.97 O1 EDO A 88 coo 6.78 45.91 16.15 7.82 40.81 15.84 -20.05 50.35 3.45 -22.02 51.39 7.78 coo 17.88 38.77 19.81 16.38 34.23 17.24 -19.67 57.49 14.47 -21.14 51.45 13.91 coo 20.33 37.78 11.20 16.77 34.53 13.47 -20.54 66.31 9.07 -25.61 65.89 11.03 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 4 3 # 4 B 131 LYS B 71 LYS~? 21.06 O1 EDO A 88 B 215 LYS A 86 LYS~? 13.64 O1 EDO A 88 B 277 LYS A 39 LYS.? 9.97 O1 EDO A 88 coo 6.78 45.91 16.15 7.82 40.81 15.84 -4.46 59.86 10.42 -1.71 65.47 11.76 coo 17.88 38.77 19.81 16.38 34.23 17.24 -18.60 60.01 17.15 -15.10 59.96 22.04 coo 20.33 37.78 11.20 16.77 34.53 13.47 -20.54 66.31 9.07 -25.61 65.89 11.03 1e19_c01 source 1e19 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPHATE SYNTH: 4 hits 1e19_c01 naa= 3 ULMN 3 1ec9_c04 GLUCARATE DEHYDRATASE user 1 3 # 1 A 205 LYS A 31 LYS~? 12.16 C1 EDO A 88 A 207 LYS A 35 LYS~? 3.82 C1 EDO A 88 A 366 ASP A 27 ASP.? 4.81 O2 EDO A 88 coo -15.19 -26.42 1.17 -15.94 -21.72 -3.01 -30.40 57.71 4.72 -33.78 58.75 8.98 coo -20.91 -23.36 1.14 -20.26 -20.07 -2.33 -27.16 62.03 7.83 -24.89 58.41 11.08 coo -13.66 -24.10 -6.32 -13.27 -22.99 -4.55 -26.65 50.87 6.95 -25.73 50.39 8.79 1ec9_c04 source 1ec9 GLUCARATE DEHYDRATASE : 1 hits 1ec9_c04 naa= 3 ULMN 3 1ec9_c05 GLUCARATE DEHYDRATASE user 1 3 # 1 B 205 LYS A 31 LYS~? 12.16 C1 EDO A 88 B 207 LYS A 35 LYS~? 3.82 C1 EDO A 88 B 366 ASP A 27 ASP.? 4.81 O2 EDO A 88 coo -11.45 28.09 -2.93 -13.20 23.63 1.17 -30.40 57.71 4.72 -33.78 58.75 8.98 coo -17.50 25.66 -3.58 -17.49 22.55 -0.15 -27.16 62.03 7.83 -24.89 58.41 11.08 coo -11.13 25.71 4.86 -10.82 24.43 3.24 -26.65 50.87 6.95 -25.73 50.39 8.79 1ec9_c05 source 1ec9 GLUCARATE DEHYDRATASE : 1 hits 1ec9_c05 naa= 3 ULMN 3 1ec9_c06 GLUCARATE DEHYDRATASE user 1 3 # 1 C 205 LYS A 31 LYS~? 12.16 C1 EDO A 88 C 207 LYS A 35 LYS~? 3.82 C1 EDO A 88 C 366 ASP A 27 ASP.? 4.81 O2 EDO A 88 coo 15.57 11.65 -23.50 16.31 5.98 -20.68 -30.40 57.71 4.72 -33.78 58.75 8.98 coo 21.27 10.43 -20.58 20.77 6.00 -18.91 -27.16 62.03 7.83 -24.89 58.41 11.08 coo 14.28 3.88 -24.50 13.85 4.89 -22.78 -26.65 50.87 6.95 -25.73 50.39 8.79 1ec9_c06 source 1ec9 GLUCARATE DEHYDRATASE : 1 hits 1ec9_c06 naa= 3 ULMN 3 1ec9_c07 GLUCARATE DEHYDRATASE user 1 3 # 1 D 205 LYS A 31 LYS~? 12.16 C1 EDO A 88 D 207 LYS A 35 LYS~? 3.82 C1 EDO A 88 D 366 ASP A 27 ASP.? 4.81 O2 EDO A 88 coo 11.00 -13.38 25.10 13.14 -7.87 22.68 -30.40 57.71 4.72 -33.78 58.75 8.98 coo 17.14 -12.99 22.96 17.50 -8.64 21.08 -27.16 62.03 7.83 -24.89 58.41 11.08 coo 10.74 -5.36 25.95 10.35 -6.43 24.20 -26.65 50.87 6.95 -25.73 50.39 8.79 1ec9_c07 source 1ec9 GLUCARATE DEHYDRATASE : 1 hits 1ec9_c07 naa= 3 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 1 3 # 1 A 99 HIS B 26 HIS.? 29.20 O1 EDO A 88 A 177 ASP B 28 ASP~? 30.32 C2 EDO A 88 A 203 LYS B 55 LYS~? 22.80 C2 EDO A 88 coo 8.74 45.76 47.19 9.33 46.93 45.56 -1.78 55.32 -10.54 -0.01 54.91 -11.57 coo 11.68 42.31 52.96 12.05 43.92 51.65 -6.22 49.12 -15.05 -7.63 48.42 -16.47 coo 18.07 52.81 49.62 14.17 49.99 48.07 -10.41 51.47 -4.09 -5.84 50.62 -6.36 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 2 3 # 2 A 99 HIS B 67 HIS~? 12.87 O1 EDO A 88 A 177 ASP A 41 ASP.? 14.91 O1 EDO A 88 A 203 LYS A 86 LYS~? 13.64 O1 EDO A 88 coo 8.74 45.76 47.19 9.33 46.93 45.56 -9.98 64.51 7.37 -11.90 65.11 7.97 coo 11.68 42.31 52.96 12.05 43.92 51.65 -14.25 67.95 8.57 -13.10 69.71 8.75 coo 18.07 52.81 49.62 14.17 49.99 48.07 -18.60 60.01 17.15 -15.10 59.96 22.04 1ecx_c02 source 1ecx AMINOTRANSFERASE : 2 hits 1ecx_c02 naa= 3 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 1 3 # 1 B 99 HIS B 26 HIS.? 29.20 O1 EDO A 88 B 177 ASP B 28 ASP~? 30.32 C2 EDO A 88 B 203 LYS B 55 LYS~? 22.80 C2 EDO A 88 coo 14.87 88.04 21.51 13.64 87.90 19.81 -1.78 55.32 -10.54 -0.01 54.91 -11.57 coo 15.87 92.46 27.37 14.46 91.76 25.94 -6.22 49.12 -15.05 -7.63 48.42 -16.47 coo 3.60 91.42 23.52 8.20 89.55 22.63 -10.41 51.47 -4.09 -5.84 50.62 -6.36 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 2 3 # 2 B 99 HIS B 67 HIS~? 12.87 O1 EDO A 88 B 177 ASP A 41 ASP.? 14.91 O1 EDO A 88 B 203 LYS A 86 LYS~? 13.64 O1 EDO A 88 coo 14.87 88.04 21.51 13.64 87.90 19.81 -9.98 64.51 7.37 -11.90 65.11 7.97 coo 15.87 92.46 27.37 14.46 91.76 25.94 -14.25 67.95 8.57 -13.10 69.71 8.75 coo 3.60 91.42 23.52 8.20 89.55 22.63 -18.60 60.01 17.15 -15.10 59.96 22.04 1ecx_c03 source 1ecx AMINOTRANSFERASE : 2 hits 1ecx_c03 naa= 3 ULMN 3 1ef8_c01 METHYLMALONYL COA DECARBOXYLASE user 1 3 # 1 B 66 HIS A 26 HIS.? 12.31 O2 EDO A 88 B 110 GLY A 2 GLY.? 13.70 O2 EDO A 88 B 140 TYR A 5 TYR^? 13.23 O2 EDO A 88 coo 15.25 42.02 9.50 15.08 40.17 8.54 -27.15 43.88 6.97 -27.62 42.01 6.19 coo 16.54 37.86 10.86 17.07 37.78 11.48 -30.86 44.31 4.56 -31.56 44.77 4.67 coo 8.70 35.97 10.91 11.44 36.02 10.35 -28.09 49.40 -2.46 -28.96 50.64 -0.10 1ef8_c01 source 1ef8 METHYLMALONYL COA DECARBOXYLASE : 1 hits 1ef8_c01 naa= 3 ULMN 3 1ef8_c02 METHYLMALONYL COA DECARBOXYLASE user 1 3 # 1 C 66 HIS A 26 HIS.? 12.31 O2 EDO A 88 C 110 GLY A 2 GLY.? 13.70 O2 EDO A 88 C 140 TYR A 5 TYR^? 13.23 O2 EDO A 88 coo -9.82 10.01 28.41 -9.17 11.02 26.71 -27.15 43.88 6.97 -27.62 42.01 6.19 coo -5.73 12.49 27.77 -5.15 12.61 28.37 -30.86 44.31 4.56 -31.56 44.77 4.67 coo -4.68 8.05 21.05 -4.91 10.19 22.84 -28.09 49.40 -2.46 -28.96 50.64 -0.10 1ef8_c02 source 1ef8 METHYLMALONYL COA DECARBOXYLASE : 1 hits 1ef8_c02 naa= 3 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 1 3 # 1 A 114 HIS B 26 HIS.? 29.20 O1 EDO A 88 A 197 ASP B 28 ASP~? 30.32 C2 EDO A 88 A 223 LYS B 55 LYS~? 22.80 C2 EDO A 88 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 -1.78 55.32 -10.54 -0.01 54.91 -11.57 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 -6.22 49.12 -15.05 -7.63 48.42 -16.47 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 -10.41 51.47 -4.09 -5.84 50.62 -6.36 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 2 3 # 2 A 114 HIS B 67 HIS~? 12.87 O1 EDO A 88 A 197 ASP A 41 ASP.? 14.91 O1 EDO A 88 A 223 LYS A 85 LYS~? 4.81 O2 EDO A 88 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 -9.98 64.51 7.37 -11.90 65.11 7.97 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 -14.25 67.95 8.57 -13.10 69.71 8.75 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 -19.67 57.49 14.47 -21.14 51.45 13.91 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 3 3 # 3 A 114 HIS B 67 HIS~? 12.87 O1 EDO A 88 A 197 ASP A 41 ASP.? 14.91 O1 EDO A 88 A 223 LYS A 86 LYS~? 13.64 O1 EDO A 88 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 -9.98 64.51 7.37 -11.90 65.11 7.97 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 -14.25 67.95 8.57 -13.10 69.71 8.75 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 -18.60 60.01 17.15 -15.10 59.96 22.04 1elq_c02 source 1elq L-CYSTEINE/L-CYSTINE C-S LYASE : 3 hits 1elq_c02 naa= 3 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 1 3 # 1 B 114 HIS B 26 HIS.? 29.20 O1 EDO A 88 B 197 ASP B 28 ASP~? 30.32 C2 EDO A 88 B 223 LYS B 55 LYS~? 22.80 C2 EDO A 88 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 -1.78 55.32 -10.54 -0.01 54.91 -11.57 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 -6.22 49.12 -15.05 -7.63 48.42 -16.47 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 -10.41 51.47 -4.09 -5.84 50.62 -6.36 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 2 3 # 2 B 114 HIS B 67 HIS~? 12.87 O1 EDO A 88 B 197 ASP A 41 ASP.? 14.91 O1 EDO A 88 B 223 LYS A 85 LYS~? 4.81 O2 EDO A 88 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 -9.98 64.51 7.37 -11.90 65.11 7.97 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 -14.25 67.95 8.57 -13.10 69.71 8.75 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 -19.67 57.49 14.47 -21.14 51.45 13.91 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 3 3 # 3 B 114 HIS B 67 HIS~? 12.87 O1 EDO A 88 B 197 ASP A 41 ASP.? 14.91 O1 EDO A 88 B 223 LYS A 86 LYS~? 13.64 O1 EDO A 88 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 -9.98 64.51 7.37 -11.90 65.11 7.97 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 -14.25 67.95 8.57 -13.10 69.71 8.75 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 -18.60 60.01 17.15 -15.10 59.96 22.04 1elq_c03 source 1elq L-CYSTEINE/L-CYSTINE C-S LYASE : 3 hits 1elq_c03 naa= 3 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 1 3 # 1 A 38 THR A 43 THR~? 16.85 O1 EDO A 88 A 159 LYS A 39 LYS.? 9.97 O1 EDO A 88 A 193 GLU A 34 GLU~? 13.90 C1 EDO A 88 coo -2.58 16.31 54.79 -4.02 14.93 55.64 -16.43 67.99 0.38 -14.88 68.16 -1.11 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -20.54 66.31 9.07 -25.61 65.89 11.03 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -30.48 62.02 2.95 -32.58 61.85 3.30 1et0_c02 source 1et0 4-AMINO-4-DEOXYCHORISMATE LYASE : 1 hits 1et0_c02 naa= 3 ULMN 3 1euu_c00 SIALIDASE user 1 3 # 1 92 ASP A 27 ASP.? 4.81 O2 EDO A 88 260 GLU B 11 GLU^? 16.09 O2 EDO A 88 370 TYR A 5 TYR^? 13.23 O2 EDO A 88 coo 8.60 -17.93 28.38 7.67 -19.04 26.88 -26.65 50.87 6.95 -25.73 50.39 8.79 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 -32.33 52.63 -2.59 -33.86 53.51 -1.46 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 -28.09 49.40 -2.46 -28.96 50.64 -0.10 1euu_c00 source 1euu SIALIDASE : 1 hits 1euu_c00 naa= 3 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 1 3 # 1 A 105 HIS A 26 HIS.? 12.31 O2 EDO A 88 C 62 LYS B 12 LYS.? 22.50 O2 EDO A 88 F 35 ASP A 27 ASP.? 4.81 O2 EDO A 88 coo 15.40 22.79 16.66 13.93 24.10 15.98 -27.15 43.88 6.97 -27.62 42.01 6.19 coo 19.95 18.98 4.81 18.82 20.94 10.49 -33.93 48.03 -5.83 -30.65 43.44 -8.38 coo 16.32 15.30 17.19 17.71 14.73 18.69 -26.65 50.87 6.95 -25.73 50.39 8.79 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 2 3 # 2 A 105 HIS B 26 HIS.? 29.20 O1 EDO A 88 C 62 LYS B 55 LYS~? 22.80 C2 EDO A 88 F 35 ASP B 28 ASP~? 30.32 C2 EDO A 88 coo 15.40 22.79 16.66 13.93 24.10 15.98 -1.78 55.32 -10.54 -0.01 54.91 -11.57 coo 19.95 18.98 4.81 18.82 20.94 10.49 -10.41 51.47 -4.09 -5.84 50.62 -6.36 coo 16.32 15.30 17.19 17.71 14.73 18.69 -6.22 49.12 -15.05 -7.63 48.42 -16.47 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 3 3 # 3 A 105 HIS B 67 HIS~? 12.87 O1 EDO A 88 C 62 LYS A 85 LYS~? 4.81 O2 EDO A 88 F 35 ASP A 41 ASP.? 14.91 O1 EDO A 88 coo 15.40 22.79 16.66 13.93 24.10 15.98 -9.98 64.51 7.37 -11.90 65.11 7.97 coo 19.95 18.98 4.81 18.82 20.94 10.49 -19.67 57.49 14.47 -21.14 51.45 13.91 coo 16.32 15.30 17.19 17.71 14.73 18.69 -14.25 67.95 8.57 -13.10 69.71 8.75 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 4 3 # 4 A 105 HIS B 67 HIS~? 12.87 O1 EDO A 88 C 62 LYS A 86 LYS~? 13.64 O1 EDO A 88 F 35 ASP A 41 ASP.? 14.91 O1 EDO A 88 coo 15.40 22.79 16.66 13.93 24.10 15.98 -9.98 64.51 7.37 -11.90 65.11 7.97 coo 19.95 18.98 4.81 18.82 20.94 10.49 -18.60 60.01 17.15 -15.10 59.96 22.04 coo 16.32 15.30 17.19 17.71 14.73 18.69 -14.25 67.95 8.57 -13.10 69.71 8.75 1f80_c03 source 1f80 ACYL CARRIER PROTEIN : 4 hits 1f80_c03 naa= 3 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 1 3 # 1 B 62 LYS B 12 LYS.? 22.50 O2 EDO A 88 C 105 HIS A 26 HIS.? 12.31 O2 EDO A 88 D 35 ASP A 27 ASP.? 4.81 O2 EDO A 88 coo 38.76 28.25 7.87 36.33 26.41 13.58 -33.93 48.03 -5.83 -30.65 43.44 -8.38 coo 34.93 19.72 17.37 34.72 18.17 15.98 -27.15 43.88 6.97 -27.62 42.01 6.19 coo 41.01 23.02 20.83 40.65 24.26 22.55 -26.65 50.87 6.95 -25.73 50.39 8.79 1f80_c04 source 1f80 ACYL CARRIER PROTEIN : 1 hits 1f80_c04 naa= 3 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 1 3 # 1 A 62 LYS B 12 LYS.? 22.50 O2 EDO A 88 B 105 HIS A 26 HIS.? 12.31 O2 EDO A 88 E 35 ASP A 27 ASP.? 4.81 O2 EDO A 88 coo 20.51 39.76 8.83 21.23 37.38 14.18 -33.93 48.03 -5.83 -30.65 43.44 -8.38 coo 27.18 37.56 20.68 29.07 38.28 20.13 -27.15 43.88 6.97 -27.62 42.01 6.19 coo 19.97 40.39 22.03 18.53 39.30 23.18 -26.65 50.87 6.95 -25.73 50.39 8.79 1f80_c05 source 1f80 ACYL CARRIER PROTEIN : 1 hits 1f80_c05 naa= 3 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 1 3 # 1 A 112 PHE A 50 PHE~? 7.73 O1 EDO A 88 A 210 ASP A 37 ASP~? 13.07 O1 EDO A 88 A 244 LYS A 85 LYS~? 4.81 O2 EDO A 88 coo 9.23 46.77 25.11 11.48 48.39 24.76 -15.30 58.35 3.55 -15.30 57.87 6.26 coo 10.51 37.86 19.71 9.07 39.38 20.04 -25.14 65.39 3.92 -25.04 66.91 2.43 coo -1.20 42.34 17.67 3.19 45.13 19.06 -19.67 57.49 14.47 -21.14 51.45 13.91 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 2 3 # 2 A 112 PHE A 50 PHE~? 7.73 O1 EDO A 88 A 210 ASP A 41 ASP.? 14.91 O1 EDO A 88 A 244 LYS A 35 LYS~? 3.82 C1 EDO A 88 coo 9.23 46.77 25.11 11.48 48.39 24.76 -15.30 58.35 3.55 -15.30 57.87 6.26 coo 10.51 37.86 19.71 9.07 39.38 20.04 -14.25 67.95 8.57 -13.10 69.71 8.75 coo -1.20 42.34 17.67 3.19 45.13 19.06 -27.16 62.03 7.83 -24.89 58.41 11.08 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 3 3 # 3 A 112 PHE A 50 PHE~? 7.73 O1 EDO A 88 A 210 ASP A 41 ASP.? 14.91 O1 EDO A 88 A 244 LYS A 85 LYS~? 4.81 O2 EDO A 88 coo 9.23 46.77 25.11 11.48 48.39 24.76 -15.30 58.35 3.55 -15.30 57.87 6.26 coo 10.51 37.86 19.71 9.07 39.38 20.04 -14.25 67.95 8.57 -13.10 69.71 8.75 coo -1.20 42.34 17.67 3.19 45.13 19.06 -19.67 57.49 14.47 -21.14 51.45 13.91 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 4 3 # 4 A 112 PHE A 50 PHE~? 7.73 O1 EDO A 88 A 210 ASP A 41 ASP.? 14.91 O1 EDO A 88 A 244 LYS A 86 LYS~? 13.64 O1 EDO A 88 coo 9.23 46.77 25.11 11.48 48.39 24.76 -15.30 58.35 3.55 -15.30 57.87 6.26 coo 10.51 37.86 19.71 9.07 39.38 20.04 -14.25 67.95 8.57 -13.10 69.71 8.75 coo -1.20 42.34 17.67 3.19 45.13 19.06 -18.60 60.01 17.15 -15.10 59.96 22.04 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 5 3 # 5 A 112 PHE A 50 PHE~? 7.73 O1 EDO A 88 A 210 ASP A 41 ASP.? 14.91 O1 EDO A 88 A 244 LYS B 71 LYS~? 21.06 O1 EDO A 88 coo 9.23 46.77 25.11 11.48 48.39 24.76 -15.30 58.35 3.55 -15.30 57.87 6.26 coo 10.51 37.86 19.71 9.07 39.38 20.04 -14.25 67.95 8.57 -13.10 69.71 8.75 coo -1.20 42.34 17.67 3.19 45.13 19.06 -4.46 59.86 10.42 -1.71 65.47 11.76 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 6 3 # 6 A 112 PHE B 50 PHE~? 17.81 C2 EDO A 88 A 210 ASP B 37 ASP~? 29.91 O2 EDO A 88 A 244 LYS B 85 LYS~? 25.46 C2 EDO A 88 coo 9.23 46.77 25.11 11.48 48.39 24.76 -12.81 43.27 -0.64 -10.49 43.54 0.89 coo 10.51 37.86 19.71 9.07 39.38 20.04 -11.14 36.80 -11.01 -12.56 35.32 -11.54 coo -1.20 42.34 17.67 3.19 45.13 19.06 -1.24 41.95 -2.07 0.00 48.03 -2.24 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 7 3 # 7 A 112 PHE B 70 PHE~? 11.90 O1 EDO A 88 A 210 ASP A 41 ASP.? 14.91 O1 EDO A 88 A 244 LYS A 85 LYS~? 4.81 O2 EDO A 88 coo 9.23 46.77 25.11 11.48 48.39 24.76 -8.93 59.39 6.56 -11.26 59.36 5.03 coo 10.51 37.86 19.71 9.07 39.38 20.04 -14.25 67.95 8.57 -13.10 69.71 8.75 coo -1.20 42.34 17.67 3.19 45.13 19.06 -19.67 57.49 14.47 -21.14 51.45 13.91 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 8 3 # 8 A 112 PHE B 70 PHE~? 11.90 O1 EDO A 88 A 210 ASP A 41 ASP.? 14.91 O1 EDO A 88 A 244 LYS A 86 LYS~? 13.64 O1 EDO A 88 coo 9.23 46.77 25.11 11.48 48.39 24.76 -8.93 59.39 6.56 -11.26 59.36 5.03 coo 10.51 37.86 19.71 9.07 39.38 20.04 -14.25 67.95 8.57 -13.10 69.71 8.75 coo -1.20 42.34 17.67 3.19 45.13 19.06 -18.60 60.01 17.15 -15.10 59.96 22.04 1fc4_c02 source 1fc4 2-AMINO-3-KETOBUTYRATE CONENZYME A LIGASE : 8 hits 1fc4_c02 naa= 3 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 1 3 # 1 B 112 PHE A 50 PHE~? 7.73 O1 EDO A 88 B 210 ASP A 37 ASP~? 13.07 O1 EDO A 88 B 244 LYS A 85 LYS~? 4.81 O2 EDO A 88 coo 8.76 47.85 34.91 11.08 46.36 35.41 -15.30 58.35 3.55 -15.30 57.87 6.26 coo 9.06 56.85 40.30 7.71 55.27 39.90 -25.14 65.39 3.92 -25.04 66.91 2.43 coo -2.38 51.82 41.62 2.07 49.19 40.42 -19.67 57.49 14.47 -21.14 51.45 13.91 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 2 3 # 2 B 112 PHE A 50 PHE~? 7.73 O1 EDO A 88 B 210 ASP A 41 ASP.? 14.91 O1 EDO A 88 B 244 LYS A 35 LYS~? 3.82 C1 EDO A 88 coo 8.76 47.85 34.91 11.08 46.36 35.41 -15.30 58.35 3.55 -15.30 57.87 6.26 coo 9.06 56.85 40.30 7.71 55.27 39.90 -14.25 67.95 8.57 -13.10 69.71 8.75 coo -2.38 51.82 41.62 2.07 49.19 40.42 -27.16 62.03 7.83 -24.89 58.41 11.08 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 3 3 # 3 B 112 PHE A 50 PHE~? 7.73 O1 EDO A 88 B 210 ASP A 41 ASP.? 14.91 O1 EDO A 88 B 244 LYS A 85 LYS~? 4.81 O2 EDO A 88 coo 8.76 47.85 34.91 11.08 46.36 35.41 -15.30 58.35 3.55 -15.30 57.87 6.26 coo 9.06 56.85 40.30 7.71 55.27 39.90 -14.25 67.95 8.57 -13.10 69.71 8.75 coo -2.38 51.82 41.62 2.07 49.19 40.42 -19.67 57.49 14.47 -21.14 51.45 13.91 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 4 3 # 4 B 112 PHE A 50 PHE~? 7.73 O1 EDO A 88 B 210 ASP A 41 ASP.? 14.91 O1 EDO A 88 B 244 LYS A 86 LYS~? 13.64 O1 EDO A 88 coo 8.76 47.85 34.91 11.08 46.36 35.41 -15.30 58.35 3.55 -15.30 57.87 6.26 coo 9.06 56.85 40.30 7.71 55.27 39.90 -14.25 67.95 8.57 -13.10 69.71 8.75 coo -2.38 51.82 41.62 2.07 49.19 40.42 -18.60 60.01 17.15 -15.10 59.96 22.04 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 5 3 # 5 B 112 PHE A 50 PHE~? 7.73 O1 EDO A 88 B 210 ASP A 41 ASP.? 14.91 O1 EDO A 88 B 244 LYS B 71 LYS~? 21.06 O1 EDO A 88 coo 8.76 47.85 34.91 11.08 46.36 35.41 -15.30 58.35 3.55 -15.30 57.87 6.26 coo 9.06 56.85 40.30 7.71 55.27 39.90 -14.25 67.95 8.57 -13.10 69.71 8.75 coo -2.38 51.82 41.62 2.07 49.19 40.42 -4.46 59.86 10.42 -1.71 65.47 11.76 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 6 3 # 6 B 112 PHE B 50 PHE~? 17.81 C2 EDO A 88 B 210 ASP B 37 ASP~? 29.91 O2 EDO A 88 B 244 LYS B 85 LYS~? 25.46 C2 EDO A 88 coo 8.76 47.85 34.91 11.08 46.36 35.41 -12.81 43.27 -0.64 -10.49 43.54 0.89 coo 9.06 56.85 40.30 7.71 55.27 39.90 -11.14 36.80 -11.01 -12.56 35.32 -11.54 coo -2.38 51.82 41.62 2.07 49.19 40.42 -1.24 41.95 -2.07 0.00 48.03 -2.24 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 7 3 # 7 B 112 PHE B 70 PHE~? 11.90 O1 EDO A 88 B 210 ASP A 41 ASP.? 14.91 O1 EDO A 88 B 244 LYS A 85 LYS~? 4.81 O2 EDO A 88 coo 8.76 47.85 34.91 11.08 46.36 35.41 -8.93 59.39 6.56 -11.26 59.36 5.03 coo 9.06 56.85 40.30 7.71 55.27 39.90 -14.25 67.95 8.57 -13.10 69.71 8.75 coo -2.38 51.82 41.62 2.07 49.19 40.42 -19.67 57.49 14.47 -21.14 51.45 13.91 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 8 3 # 8 B 112 PHE B 70 PHE~? 11.90 O1 EDO A 88 B 210 ASP A 41 ASP.? 14.91 O1 EDO A 88 B 244 LYS A 86 LYS~? 13.64 O1 EDO A 88 coo 8.76 47.85 34.91 11.08 46.36 35.41 -8.93 59.39 6.56 -11.26 59.36 5.03 coo 9.06 56.85 40.30 7.71 55.27 39.90 -14.25 67.95 8.57 -13.10 69.71 8.75 coo -2.38 51.82 41.62 2.07 49.19 40.42 -18.60 60.01 17.15 -15.10 59.96 22.04 1fc4_c03 source 1fc4 2-AMINO-3-KETOBUTYRATE CONENZYME A LIGASE : 8 hits 1fc4_c03 naa= 3 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 1 3 # 1 A 136 HIS B 67 HIS~? 12.87 O1 EDO A 88 A 210 ASP A 41 ASP.? 14.91 O1 EDO A 88 A 244 LYS A 85 LYS~? 4.81 O2 EDO A 88 coo 11.28 44.53 18.60 9.91 46.00 19.20 -9.98 64.51 7.37 -11.90 65.11 7.97 coo 10.51 37.86 19.71 9.07 39.38 20.04 -14.25 67.95 8.57 -13.10 69.71 8.75 coo -1.20 42.34 17.67 3.19 45.13 19.06 -19.67 57.49 14.47 -21.14 51.45 13.91 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 2 3 # 2 A 136 HIS B 67 HIS~? 12.87 O1 EDO A 88 A 210 ASP A 41 ASP.? 14.91 O1 EDO A 88 A 244 LYS A 86 LYS~? 13.64 O1 EDO A 88 coo 11.28 44.53 18.60 9.91 46.00 19.20 -9.98 64.51 7.37 -11.90 65.11 7.97 coo 10.51 37.86 19.71 9.07 39.38 20.04 -14.25 67.95 8.57 -13.10 69.71 8.75 coo -1.20 42.34 17.67 3.19 45.13 19.06 -18.60 60.01 17.15 -15.10 59.96 22.04 1fc4_c04 source 1fc4 2-AMINO-3-KETOBUTYRATE CONENZYME A LIGASE : 2 hits 1fc4_c04 naa= 3 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 1 3 # 1 B 136 HIS B 26 HIS.? 29.20 O1 EDO A 88 B 210 ASP B 28 ASP~? 30.32 C2 EDO A 88 B 244 LYS B 55 LYS~? 22.80 C2 EDO A 88 coo 10.08 50.18 41.78 8.91 48.61 41.04 -1.78 55.32 -10.54 -0.01 54.91 -11.57 coo 9.06 56.85 40.30 7.71 55.27 39.90 -6.22 49.12 -15.05 -7.63 48.42 -16.47 coo -2.38 51.82 41.62 2.07 49.19 40.42 -10.41 51.47 -4.09 -5.84 50.62 -6.36 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 2 3 # 2 B 136 HIS B 67 HIS~? 12.87 O1 EDO A 88 B 210 ASP A 41 ASP.? 14.91 O1 EDO A 88 B 244 LYS A 85 LYS~? 4.81 O2 EDO A 88 coo 10.08 50.18 41.78 8.91 48.61 41.04 -9.98 64.51 7.37 -11.90 65.11 7.97 coo 9.06 56.85 40.30 7.71 55.27 39.90 -14.25 67.95 8.57 -13.10 69.71 8.75 coo -2.38 51.82 41.62 2.07 49.19 40.42 -19.67 57.49 14.47 -21.14 51.45 13.91 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 3 3 # 3 B 136 HIS B 67 HIS~? 12.87 O1 EDO A 88 B 210 ASP A 41 ASP.? 14.91 O1 EDO A 88 B 244 LYS A 86 LYS~? 13.64 O1 EDO A 88 coo 10.08 50.18 41.78 8.91 48.61 41.04 -9.98 64.51 7.37 -11.90 65.11 7.97 coo 9.06 56.85 40.30 7.71 55.27 39.90 -14.25 67.95 8.57 -13.10 69.71 8.75 coo -2.38 51.82 41.62 2.07 49.19 40.42 -18.60 60.01 17.15 -15.10 59.96 22.04 1fc4_c05 source 1fc4 2-AMINO-3-KETOBUTYRATE CONENZYME A LIGASE : 3 hits 1fc4_c05 naa= 3 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 A 137 TYR A 5 TYR^? 13.23 O2 EDO A 88 A 142 LEU B 19 LEU^? 15.59 C2 EDO A 88 A 165 LYS B 12 LYS.? 22.50 O2 EDO A 88 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 -28.09 49.40 -2.46 -28.96 50.64 -0.10 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 -26.30 58.32 -5.53 -24.78 57.28 -4.36 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 -33.93 48.03 -5.83 -30.65 43.44 -8.38 1fdy_c00 source 1fdy N-ACETYLNEURAMINATE LYASE : 1 hits 1fdy_c00 naa= 3 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 B 137 TYR A 5 TYR^? 13.23 O2 EDO A 88 B 142 LEU B 19 LEU^? 15.59 C2 EDO A 88 B 165 LYS B 12 LYS.? 22.50 O2 EDO A 88 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 -28.09 49.40 -2.46 -28.96 50.64 -0.10 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 -26.30 58.32 -5.53 -24.78 57.28 -4.36 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 -33.93 48.03 -5.83 -30.65 43.44 -8.38 1fdy_c01 source 1fdy N-ACETYLNEURAMINATE LYASE : 1 hits 1fdy_c01 naa= 3 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 C 137 TYR A 5 TYR^? 13.23 O2 EDO A 88 C 142 LEU B 19 LEU^? 15.59 C2 EDO A 88 C 165 LYS B 12 LYS.? 22.50 O2 EDO A 88 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 -28.09 49.40 -2.46 -28.96 50.64 -0.10 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 -26.30 58.32 -5.53 -24.78 57.28 -4.36 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 -33.93 48.03 -5.83 -30.65 43.44 -8.38 1fdy_c02 source 1fdy N-ACETYLNEURAMINATE LYASE : 1 hits 1fdy_c02 naa= 3 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 D 137 TYR A 5 TYR^? 13.23 O2 EDO A 88 D 142 LEU B 19 LEU^? 15.59 C2 EDO A 88 D 165 LYS B 12 LYS.? 22.50 O2 EDO A 88 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 -28.09 49.40 -2.46 -28.96 50.64 -0.10 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 -26.30 58.32 -5.53 -24.78 57.28 -4.36 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 -33.93 48.03 -5.83 -30.65 43.44 -8.38 1fdy_c03 source 1fdy N-ACETYLNEURAMINATE LYASE : 1 hits 1fdy_c03 naa= 3 ULMN 3 1fdy_c04 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 A 47 SER A 20 SER^? 23.95 O2 EDO A 88 A 48 THR A 8 THR^? 23.58 O2 EDO A 88 A 165 LYS B 12 LYS.? 22.50 O2 EDO A 88 coo -39.09 -83.21 -19.79 -37.33 -83.94 -21.38 -22.75 45.49 -12.51 -25.02 46.25 -12.74 coo -41.85 -80.60 -20.11 -42.94 -79.78 -21.77 -22.63 49.63 -11.64 -24.06 49.62 -13.30 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 -33.93 48.03 -5.83 -30.65 43.44 -8.38 1fdy_c04 source 1fdy N-ACETYLNEURAMINATE LYASE : 1 hits 1fdy_c04 naa= 3 ULMN 3 1fdy_c05 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 B 47 SER A 20 SER^? 23.95 O2 EDO A 88 B 48 THR A 8 THR^? 23.58 O2 EDO A 88 B 165 LYS B 12 LYS.? 22.50 O2 EDO A 88 coo 0.74 -71.26 -35.87 -0.36 -73.34 -35.30 -22.75 45.49 -12.51 -25.02 46.25 -12.74 coo 2.65 -68.72 -33.78 3.66 -68.93 -31.87 -22.63 49.63 -11.64 -24.06 49.62 -13.30 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 -33.93 48.03 -5.83 -30.65 43.44 -8.38 1fdy_c05 source 1fdy N-ACETYLNEURAMINATE LYASE : 1 hits 1fdy_c05 naa= 3 ULMN 3 1fdy_c06 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 C 47 SER A 20 SER^? 23.95 O2 EDO A 88 C 48 THR A 8 THR^? 23.58 O2 EDO A 88 C 165 LYS B 12 LYS.? 22.50 O2 EDO A 88 coo -15.18 -75.37 -50.42 -16.12 -74.55 -48.34 -22.75 45.49 -12.51 -25.02 46.25 -12.74 coo -16.57 -77.65 -53.15 -18.61 -78.18 -53.63 -22.63 49.63 -11.64 -24.06 49.62 -13.30 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 -33.93 48.03 -5.83 -30.65 43.44 -8.38 1fdy_c06 source 1fdy N-ACETYLNEURAMINATE LYASE : 1 hits 1fdy_c06 naa= 3 ULMN 3 1fdy_c07 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 D 47 SER A 20 SER^? 23.95 O2 EDO A 88 D 48 THR A 8 THR^? 23.58 O2 EDO A 88 D 165 LYS B 12 LYS.? 22.50 O2 EDO A 88 coo -21.69 -90.39 -8.89 -21.07 -88.29 -10.03 -22.75 45.49 -12.51 -25.02 46.25 -12.74 coo -19.38 -93.32 -7.98 -17.24 -93.31 -7.67 -22.63 49.63 -11.64 -24.06 49.62 -13.30 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 -33.93 48.03 -5.83 -30.65 43.44 -8.38 1fdy_c07 source 1fdy N-ACETYLNEURAMINATE LYASE : 1 hits 1fdy_c07 naa= 3 ULMN 3 1fhl_c00 BETA-1,4-GALACTANASE user 1 3 # 1 A 45 ARG A 17 ARG.? 31.93 C2 EDO A 88 A 136 GLU A 10 GLU^? 27.07 C2 EDO A 88 A 246 GLU A 11 GLU^? 30.56 C2 EDO A 88 coo 13.48 30.30 107.06 11.75 30.99 109.44 -12.86 46.28 -20.15 -10.06 46.57 -18.92 coo 9.46 32.37 115.82 8.50 34.20 115.47 -20.28 53.65 -16.35 -22.20 53.78 -17.27 coo 11.99 34.33 109.92 10.08 34.19 110.77 -13.41 51.24 -17.67 -12.24 50.07 -19.00 ULMN 3 1fhl_c00 BETA-1,4-GALACTANASE user 2 3 # 2 A 45 ARG B 17 ARG.? 14.88 O2 EDO A 88 A 136 GLU B 10 GLU^? 22.83 O2 EDO A 88 A 246 GLU B 11 GLU^? 16.09 O2 EDO A 88 coo 13.48 30.30 107.06 11.75 30.99 109.44 -34.10 57.90 -1.91 -33.96 56.91 1.01 coo 9.46 32.37 115.82 8.50 34.20 115.47 -29.59 50.76 -9.46 -29.70 50.98 -11.60 coo 11.99 34.33 109.92 10.08 34.19 110.77 -32.33 52.63 -2.59 -33.86 53.51 -1.46 1fhl_c00 source 1fhl BETA-1,4-GALACTANASE : 2 hits 1fhl_c00 naa= 3 ULMN 3 1fob_c00 BETA-1,4-GALACTANASE user 1 3 # 1 A 45 ARG A 17 ARG.? 31.93 C2 EDO A 88 A 136 GLU A 10 GLU^? 27.07 C2 EDO A 88 A 246 GLU A 11 GLU^? 30.56 C2 EDO A 88 coo 13.94 29.84 106.80 11.67 30.40 108.79 -12.86 46.28 -20.15 -10.06 46.57 -18.92 coo 9.52 31.97 115.23 8.45 33.74 114.72 -20.28 53.65 -16.35 -22.20 53.78 -17.27 coo 11.92 33.82 109.35 10.10 33.50 110.39 -13.41 51.24 -17.67 -12.24 50.07 -19.00 ULMN 3 1fob_c00 BETA-1,4-GALACTANASE user 2 3 # 2 A 45 ARG B 17 ARG.? 14.88 O2 EDO A 88 A 136 GLU B 10 GLU^? 22.83 O2 EDO A 88 A 246 GLU B 11 GLU^? 16.09 O2 EDO A 88 coo 13.94 29.84 106.80 11.67 30.40 108.79 -34.10 57.90 -1.91 -33.96 56.91 1.01 coo 9.52 31.97 115.23 8.45 33.74 114.72 -29.59 50.76 -9.46 -29.70 50.98 -11.60 coo 11.92 33.82 109.35 10.10 33.50 110.39 -32.33 52.63 -2.59 -33.86 53.51 -1.46 1fob_c00 source 1fob BETA-1,4-GALACTANASE : 2 hits 1fob_c00 naa= 3 ULMN 3 1grc_c02 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 1 3 # 1 A 106 ASN A 3 ASN^? 12.24 O2 EDO A 88 A 108 HIS A 26 HIS.? 12.31 O2 EDO A 88 A 144 ASP A 27 ASP.? 4.81 O2 EDO A 88 coo 51.28 61.14 17.85 51.16 61.61 19.96 -30.96 48.32 2.04 -31.97 49.04 3.78 coo 52.62 57.63 23.12 50.77 57.51 22.26 -27.15 43.88 6.97 -27.62 42.01 6.19 coo 46.65 56.95 20.09 48.42 58.17 20.01 -26.65 50.87 6.95 -25.73 50.39 8.79 ULMN 3 1grc_c02 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 2 3 # 2 A 106 ASN B 3 ASN^? 29.42 C2 EDO A 88 A 108 HIS B 26 HIS.? 29.20 O1 EDO A 88 A 144 ASP B 27 ASP.? 26.46 C2 EDO A 88 coo 51.28 61.14 17.85 51.16 61.61 19.96 -8.54 54.49 -14.85 -6.79 53.63 -15.72 coo 52.62 57.63 23.12 50.77 57.51 22.26 -1.78 55.32 -10.54 -0.01 54.91 -11.57 coo 46.65 56.95 20.09 48.42 58.17 20.01 -4.76 50.56 -10.13 -3.07 50.63 -8.85 1grc_c02 source 1grc GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMYLASE (E.C: 2 hits 1grc_c02 naa= 3 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 A 189 PHE A 30 PHE~? 14.44 O2 EDO A 88 A 298 ASP A 27 ASP.? 4.81 O2 EDO A 88 A 329 LYS A 35 LYS~? 3.82 C1 EDO A 88 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 -29.96 56.34 -1.22 -29.15 55.58 -3.78 coo 2.59 0.29 25.55 4.65 0.18 25.07 -26.65 50.87 6.95 -25.73 50.39 8.79 coo 12.42 6.10 23.27 9.95 1.57 20.16 -27.16 62.03 7.83 -24.89 58.41 11.08 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 2 3 # 2 A 189 PHE A 30 PHE~? 14.44 O2 EDO A 88 A 298 ASP A 28 ASP~? 11.68 O2 EDO A 88 A 329 LYS A 35 LYS~? 3.82 C1 EDO A 88 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 -29.96 56.34 -1.22 -29.15 55.58 -3.78 coo 2.59 0.29 25.55 4.65 0.18 25.07 -31.33 53.08 5.19 -32.37 54.22 3.74 coo 12.42 6.10 23.27 9.95 1.57 20.16 -27.16 62.03 7.83 -24.89 58.41 11.08 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 3 3 # 3 A 189 PHE A 30 PHE~? 14.44 O2 EDO A 88 A 298 ASP A 28 ASP~? 11.68 O2 EDO A 88 A 329 LYS A 55 LYS~? -3.15 O2 EDO A 88s coo 6.56 -4.17 18.88 9.26 -4.62 19.48 -29.96 56.34 -1.22 -29.15 55.58 -3.78 coo 2.59 0.29 25.55 4.65 0.18 25.07 -31.33 53.08 5.19 -32.37 54.22 3.74 coo 12.42 6.10 23.27 9.95 1.57 20.16 -20.05 50.35 3.45 -22.02 51.39 7.78 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 4 3 # 4 A 189 PHE A 50 PHE~? 7.73 O1 EDO A 88 A 298 ASP A 41 ASP.? 14.91 O1 EDO A 88 A 329 LYS A 85 LYS~? 4.81 O2 EDO A 88 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 -15.30 58.35 3.55 -15.30 57.87 6.26 coo 2.59 0.29 25.55 4.65 0.18 25.07 -14.25 67.95 8.57 -13.10 69.71 8.75 coo 12.42 6.10 23.27 9.95 1.57 20.16 -19.67 57.49 14.47 -21.14 51.45 13.91 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 5 3 # 5 A 189 PHE A 50 PHE~? 7.73 O1 EDO A 88 A 298 ASP A 41 ASP.? 14.91 O1 EDO A 88 A 329 LYS A 86 LYS~? 13.64 O1 EDO A 88 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 -15.30 58.35 3.55 -15.30 57.87 6.26 coo 2.59 0.29 25.55 4.65 0.18 25.07 -14.25 67.95 8.57 -13.10 69.71 8.75 coo 12.42 6.10 23.27 9.95 1.57 20.16 -18.60 60.01 17.15 -15.10 59.96 22.04 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 6 3 # 6 A 189 PHE A 50 PHE~? 7.73 O1 EDO A 88 A 298 ASP A 41 ASP.? 14.91 O1 EDO A 88 A 329 LYS B 71 LYS~? 21.06 O1 EDO A 88 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 -15.30 58.35 3.55 -15.30 57.87 6.26 coo 2.59 0.29 25.55 4.65 0.18 25.07 -14.25 67.95 8.57 -13.10 69.71 8.75 coo 12.42 6.10 23.27 9.95 1.57 20.16 -4.46 59.86 10.42 -1.71 65.47 11.76 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 7 3 # 7 A 189 PHE B 30 PHE~? 27.21 C2 EDO A 88 A 298 ASP B 28 ASP~? 30.32 C2 EDO A 88 A 329 LYS B 55 LYS~? 22.80 C2 EDO A 88 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 -12.94 47.02 -15.56 -15.52 48.08 -15.37 coo 2.59 0.29 25.55 4.65 0.18 25.07 -6.22 49.12 -15.05 -7.63 48.42 -16.47 coo 12.42 6.10 23.27 9.95 1.57 20.16 -10.41 51.47 -4.09 -5.84 50.62 -6.36 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 8 3 # 8 A 189 PHE B 70 PHE~? 11.90 O1 EDO A 88 A 298 ASP A 41 ASP.? 14.91 O1 EDO A 88 A 329 LYS A 85 LYS~? 4.81 O2 EDO A 88 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 -8.93 59.39 6.56 -11.26 59.36 5.03 coo 2.59 0.29 25.55 4.65 0.18 25.07 -14.25 67.95 8.57 -13.10 69.71 8.75 coo 12.42 6.10 23.27 9.95 1.57 20.16 -19.67 57.49 14.47 -21.14 51.45 13.91 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 9 3 # 9 A 189 PHE B 70 PHE~? 11.90 O1 EDO A 88 A 298 ASP A 41 ASP.? 14.91 O1 EDO A 88 A 329 LYS A 86 LYS~? 13.64 O1 EDO A 88 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 -8.93 59.39 6.56 -11.26 59.36 5.03 coo 2.59 0.29 25.55 4.65 0.18 25.07 -14.25 67.95 8.57 -13.10 69.71 8.75 coo 12.42 6.10 23.27 9.95 1.57 20.16 -18.60 60.01 17.15 -15.10 59.96 22.04 1gtx_c00 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 9 hits 1gtx_c00 naa= 3 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 B 189 PHE A 30 PHE~? 14.44 O2 EDO A 88 B 298 ASP A 27 ASP.? 4.81 O2 EDO A 88 B 329 LYS A 35 LYS~? 3.82 C1 EDO A 88 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 -29.96 56.34 -1.22 -29.15 55.58 -3.78 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 -26.65 50.87 6.95 -25.73 50.39 8.79 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 -27.16 62.03 7.83 -24.89 58.41 11.08 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 2 3 # 2 B 189 PHE A 30 PHE~? 14.44 O2 EDO A 88 B 298 ASP A 28 ASP~? 11.68 O2 EDO A 88 B 329 LYS A 35 LYS~? 3.82 C1 EDO A 88 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 -29.96 56.34 -1.22 -29.15 55.58 -3.78 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 -31.33 53.08 5.19 -32.37 54.22 3.74 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 -27.16 62.03 7.83 -24.89 58.41 11.08 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 3 3 # 3 B 189 PHE A 30 PHE~? 14.44 O2 EDO A 88 B 298 ASP A 28 ASP~? 11.68 O2 EDO A 88 B 329 LYS A 55 LYS~? -3.15 O2 EDO A 88s coo 20.14 -12.51 41.29 18.81 -10.14 40.57 -29.96 56.34 -1.22 -29.15 55.58 -3.78 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 -31.33 53.08 5.19 -32.37 54.22 3.74 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 -20.05 50.35 3.45 -22.02 51.39 7.78 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 4 3 # 4 B 189 PHE A 50 PHE~? 7.73 O1 EDO A 88 B 298 ASP A 41 ASP.? 14.91 O1 EDO A 88 B 329 LYS A 85 LYS~? 4.81 O2 EDO A 88 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 -15.30 58.35 3.55 -15.30 57.87 6.26 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 -14.25 67.95 8.57 -13.10 69.71 8.75 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 -19.67 57.49 14.47 -21.14 51.45 13.91 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 5 3 # 5 B 189 PHE A 50 PHE~? 7.73 O1 EDO A 88 B 298 ASP A 41 ASP.? 14.91 O1 EDO A 88 B 329 LYS A 86 LYS~? 13.64 O1 EDO A 88 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 -15.30 58.35 3.55 -15.30 57.87 6.26 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 -14.25 67.95 8.57 -13.10 69.71 8.75 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 -18.60 60.01 17.15 -15.10 59.96 22.04 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 6 3 # 6 B 189 PHE A 50 PHE~? 7.73 O1 EDO A 88 B 298 ASP A 41 ASP.? 14.91 O1 EDO A 88 B 329 LYS B 71 LYS~? 21.06 O1 EDO A 88 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 -15.30 58.35 3.55 -15.30 57.87 6.26 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 -14.25 67.95 8.57 -13.10 69.71 8.75 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 -4.46 59.86 10.42 -1.71 65.47 11.76 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 7 3 # 7 B 189 PHE B 30 PHE~? 27.21 C2 EDO A 88 B 298 ASP B 28 ASP~? 30.32 C2 EDO A 88 B 329 LYS B 55 LYS~? 22.80 C2 EDO A 88 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 -12.94 47.02 -15.56 -15.52 48.08 -15.37 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 -6.22 49.12 -15.05 -7.63 48.42 -16.47 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 -10.41 51.47 -4.09 -5.84 50.62 -6.36 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 8 3 # 8 B 189 PHE B 70 PHE~? 11.90 O1 EDO A 88 B 298 ASP A 41 ASP.? 14.91 O1 EDO A 88 B 329 LYS A 85 LYS~? 4.81 O2 EDO A 88 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 -8.93 59.39 6.56 -11.26 59.36 5.03 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 -14.25 67.95 8.57 -13.10 69.71 8.75 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 -19.67 57.49 14.47 -21.14 51.45 13.91 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 9 3 # 9 B 189 PHE B 70 PHE~? 11.90 O1 EDO A 88 B 298 ASP A 41 ASP.? 14.91 O1 EDO A 88 B 329 LYS A 86 LYS~? 13.64 O1 EDO A 88 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 -8.93 59.39 6.56 -11.26 59.36 5.03 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 -14.25 67.95 8.57 -13.10 69.71 8.75 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 -18.60 60.01 17.15 -15.10 59.96 22.04 1gtx_c01 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 9 hits 1gtx_c01 naa= 3 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 C 189 PHE A 30 PHE~? 14.44 O2 EDO A 88 C 298 ASP A 27 ASP.? 4.81 O2 EDO A 88 C 329 LYS A 35 LYS~? 3.82 C1 EDO A 88 coo 17.41 60.57 64.39 18.40 58.12 65.34 -29.96 56.34 -1.22 -29.15 55.58 -3.78 coo 24.10 66.43 63.33 24.18 64.30 63.40 -26.65 50.87 6.95 -25.73 50.39 8.79 coo 27.64 56.61 58.17 22.18 57.92 60.36 -27.16 62.03 7.83 -24.89 58.41 11.08 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 2 3 # 2 C 189 PHE A 30 PHE~? 14.44 O2 EDO A 88 C 298 ASP A 28 ASP~? 11.68 O2 EDO A 88 C 329 LYS A 35 LYS~? 3.82 C1 EDO A 88 coo 17.41 60.57 64.39 18.40 58.12 65.34 -29.96 56.34 -1.22 -29.15 55.58 -3.78 coo 24.10 66.43 63.33 24.18 64.30 63.40 -31.33 53.08 5.19 -32.37 54.22 3.74 coo 27.64 56.61 58.17 22.18 57.92 60.36 -27.16 62.03 7.83 -24.89 58.41 11.08 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 3 3 # 3 C 189 PHE A 30 PHE~? 14.44 O2 EDO A 88 C 298 ASP A 28 ASP~? 11.68 O2 EDO A 88 C 329 LYS A 55 LYS~? -3.15 O2 EDO A 88s coo 17.41 60.57 64.39 18.40 58.12 65.34 -29.96 56.34 -1.22 -29.15 55.58 -3.78 coo 24.10 66.43 63.33 24.18 64.30 63.40 -31.33 53.08 5.19 -32.37 54.22 3.74 coo 27.64 56.61 58.17 22.18 57.92 60.36 -20.05 50.35 3.45 -22.02 51.39 7.78 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 4 3 # 4 C 189 PHE A 50 PHE~? 7.73 O1 EDO A 88 C 298 ASP A 41 ASP.? 14.91 O1 EDO A 88 C 329 LYS A 85 LYS~? 4.81 O2 EDO A 88 coo 17.41 60.57 64.39 18.40 58.12 65.34 -15.30 58.35 3.55 -15.30 57.87 6.26 coo 24.10 66.43 63.33 24.18 64.30 63.40 -14.25 67.95 8.57 -13.10 69.71 8.75 coo 27.64 56.61 58.17 22.18 57.92 60.36 -19.67 57.49 14.47 -21.14 51.45 13.91 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 5 3 # 5 C 189 PHE A 50 PHE~? 7.73 O1 EDO A 88 C 298 ASP A 41 ASP.? 14.91 O1 EDO A 88 C 329 LYS A 86 LYS~? 13.64 O1 EDO A 88 coo 17.41 60.57 64.39 18.40 58.12 65.34 -15.30 58.35 3.55 -15.30 57.87 6.26 coo 24.10 66.43 63.33 24.18 64.30 63.40 -14.25 67.95 8.57 -13.10 69.71 8.75 coo 27.64 56.61 58.17 22.18 57.92 60.36 -18.60 60.01 17.15 -15.10 59.96 22.04 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 6 3 # 6 C 189 PHE A 50 PHE~? 7.73 O1 EDO A 88 C 298 ASP A 41 ASP.? 14.91 O1 EDO A 88 C 329 LYS B 71 LYS~? 21.06 O1 EDO A 88 coo 17.41 60.57 64.39 18.40 58.12 65.34 -15.30 58.35 3.55 -15.30 57.87 6.26 coo 24.10 66.43 63.33 24.18 64.30 63.40 -14.25 67.95 8.57 -13.10 69.71 8.75 coo 27.64 56.61 58.17 22.18 57.92 60.36 -4.46 59.86 10.42 -1.71 65.47 11.76 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 7 3 # 7 C 189 PHE B 30 PHE~? 27.21 C2 EDO A 88 C 298 ASP B 28 ASP~? 30.32 C2 EDO A 88 C 329 LYS B 55 LYS~? 22.80 C2 EDO A 88 coo 17.41 60.57 64.39 18.40 58.12 65.34 -12.94 47.02 -15.56 -15.52 48.08 -15.37 coo 24.10 66.43 63.33 24.18 64.30 63.40 -6.22 49.12 -15.05 -7.63 48.42 -16.47 coo 27.64 56.61 58.17 22.18 57.92 60.36 -10.41 51.47 -4.09 -5.84 50.62 -6.36 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 8 3 # 8 C 189 PHE B 70 PHE~? 11.90 O1 EDO A 88 C 298 ASP A 41 ASP.? 14.91 O1 EDO A 88 C 329 LYS A 85 LYS~? 4.81 O2 EDO A 88 coo 17.41 60.57 64.39 18.40 58.12 65.34 -8.93 59.39 6.56 -11.26 59.36 5.03 coo 24.10 66.43 63.33 24.18 64.30 63.40 -14.25 67.95 8.57 -13.10 69.71 8.75 coo 27.64 56.61 58.17 22.18 57.92 60.36 -19.67 57.49 14.47 -21.14 51.45 13.91 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 9 3 # 9 C 189 PHE B 70 PHE~? 11.90 O1 EDO A 88 C 298 ASP A 41 ASP.? 14.91 O1 EDO A 88 C 329 LYS A 86 LYS~? 13.64 O1 EDO A 88 coo 17.41 60.57 64.39 18.40 58.12 65.34 -8.93 59.39 6.56 -11.26 59.36 5.03 coo 24.10 66.43 63.33 24.18 64.30 63.40 -14.25 67.95 8.57 -13.10 69.71 8.75 coo 27.64 56.61 58.17 22.18 57.92 60.36 -18.60 60.01 17.15 -15.10 59.96 22.04 1gtx_c02 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 9 hits 1gtx_c02 naa= 3 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 D 189 PHE A 30 PHE~? 14.44 O2 EDO A 88 D 298 ASP A 27 ASP.? 4.81 O2 EDO A 88 D 329 LYS A 35 LYS~? 3.82 C1 EDO A 88 coo 35.44 53.35 83.81 35.65 54.53 81.28 -29.96 56.34 -1.22 -29.15 55.58 -3.78 coo 29.72 46.46 83.60 30.79 47.36 81.99 -26.65 50.87 6.95 -25.73 50.39 8.79 coo 36.89 44.91 74.55 37.33 48.94 79.01 -27.16 62.03 7.83 -24.89 58.41 11.08 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 2 3 # 2 D 189 PHE A 30 PHE~? 14.44 O2 EDO A 88 D 298 ASP A 28 ASP~? 11.68 O2 EDO A 88 D 329 LYS A 35 LYS~? 3.82 C1 EDO A 88 coo 35.44 53.35 83.81 35.65 54.53 81.28 -29.96 56.34 -1.22 -29.15 55.58 -3.78 coo 29.72 46.46 83.60 30.79 47.36 81.99 -31.33 53.08 5.19 -32.37 54.22 3.74 coo 36.89 44.91 74.55 37.33 48.94 79.01 -27.16 62.03 7.83 -24.89 58.41 11.08 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 3 3 # 3 D 189 PHE A 30 PHE~? 14.44 O2 EDO A 88 D 298 ASP A 28 ASP~? 11.68 O2 EDO A 88 D 329 LYS A 55 LYS~? -3.15 O2 EDO A 88s coo 35.44 53.35 83.81 35.65 54.53 81.28 -29.96 56.34 -1.22 -29.15 55.58 -3.78 coo 29.72 46.46 83.60 30.79 47.36 81.99 -31.33 53.08 5.19 -32.37 54.22 3.74 coo 36.89 44.91 74.55 37.33 48.94 79.01 -20.05 50.35 3.45 -22.02 51.39 7.78 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 4 3 # 4 D 189 PHE A 50 PHE~? 7.73 O1 EDO A 88 D 298 ASP A 41 ASP.? 14.91 O1 EDO A 88 D 329 LYS A 85 LYS~? 4.81 O2 EDO A 88 coo 35.44 53.35 83.81 35.65 54.53 81.28 -15.30 58.35 3.55 -15.30 57.87 6.26 coo 29.72 46.46 83.60 30.79 47.36 81.99 -14.25 67.95 8.57 -13.10 69.71 8.75 coo 36.89 44.91 74.55 37.33 48.94 79.01 -19.67 57.49 14.47 -21.14 51.45 13.91 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 5 3 # 5 D 189 PHE A 50 PHE~? 7.73 O1 EDO A 88 D 298 ASP A 41 ASP.? 14.91 O1 EDO A 88 D 329 LYS A 86 LYS~? 13.64 O1 EDO A 88 coo 35.44 53.35 83.81 35.65 54.53 81.28 -15.30 58.35 3.55 -15.30 57.87 6.26 coo 29.72 46.46 83.60 30.79 47.36 81.99 -14.25 67.95 8.57 -13.10 69.71 8.75 coo 36.89 44.91 74.55 37.33 48.94 79.01 -18.60 60.01 17.15 -15.10 59.96 22.04 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 6 3 # 6 D 189 PHE A 50 PHE~? 7.73 O1 EDO A 88 D 298 ASP A 41 ASP.? 14.91 O1 EDO A 88 D 329 LYS B 71 LYS~? 21.06 O1 EDO A 88 coo 35.44 53.35 83.81 35.65 54.53 81.28 -15.30 58.35 3.55 -15.30 57.87 6.26 coo 29.72 46.46 83.60 30.79 47.36 81.99 -14.25 67.95 8.57 -13.10 69.71 8.75 coo 36.89 44.91 74.55 37.33 48.94 79.01 -4.46 59.86 10.42 -1.71 65.47 11.76 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 7 3 # 7 D 189 PHE B 30 PHE~? 27.21 C2 EDO A 88 D 298 ASP B 28 ASP~? 30.32 C2 EDO A 88 D 329 LYS B 55 LYS~? 22.80 C2 EDO A 88 coo 35.44 53.35 83.81 35.65 54.53 81.28 -12.94 47.02 -15.56 -15.52 48.08 -15.37 coo 29.72 46.46 83.60 30.79 47.36 81.99 -6.22 49.12 -15.05 -7.63 48.42 -16.47 coo 36.89 44.91 74.55 37.33 48.94 79.01 -10.41 51.47 -4.09 -5.84 50.62 -6.36 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 8 3 # 8 D 189 PHE B 70 PHE~? 11.90 O1 EDO A 88 D 298 ASP A 41 ASP.? 14.91 O1 EDO A 88 D 329 LYS A 85 LYS~? 4.81 O2 EDO A 88 coo 35.44 53.35 83.81 35.65 54.53 81.28 -8.93 59.39 6.56 -11.26 59.36 5.03 coo 29.72 46.46 83.60 30.79 47.36 81.99 -14.25 67.95 8.57 -13.10 69.71 8.75 coo 36.89 44.91 74.55 37.33 48.94 79.01 -19.67 57.49 14.47 -21.14 51.45 13.91 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 9 3 # 9 D 189 PHE B 70 PHE~? 11.90 O1 EDO A 88 D 298 ASP A 41 ASP.? 14.91 O1 EDO A 88 D 329 LYS A 86 LYS~? 13.64 O1 EDO A 88 coo 35.44 53.35 83.81 35.65 54.53 81.28 -8.93 59.39 6.56 -11.26 59.36 5.03 coo 29.72 46.46 83.60 30.79 47.36 81.99 -14.25 67.95 8.57 -13.10 69.71 8.75 coo 36.89 44.91 74.55 37.33 48.94 79.01 -18.60 60.01 17.15 -15.10 59.96 22.04 1gtx_c03 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 9 hits 1gtx_c03 naa= 3 ULMN 3 1hy3_c00 ESTROGEN SULFOTRANSFERASE user 1 3 # 1 A 47 LYS A 71 LYS~? 25.13 O2 EDO A 88 A 107 HIS A 67 HIS~? 22.73 O2 EDO A 88 A 137 SER A 74 SER~? 16.95 O2 EDO A 88 coo 5.11 -0.55 31.43 1.36 1.90 33.24 -9.57 38.72 11.51 -8.72 32.82 12.46 coo 6.14 -0.73 24.01 6.05 0.83 25.40 -10.81 35.78 4.36 -9.61 35.51 2.67 coo 1.06 -1.40 35.67 2.72 0.28 35.10 -11.23 43.70 12.54 -11.15 41.78 13.99 ULMN 3 1hy3_c00 ESTROGEN SULFOTRANSFERASE user 2 3 # 2 A 47 LYS B 71 LYS~? 21.06 O1 EDO A 88 A 107 HIS B 67 HIS~? 12.87 O1 EDO A 88 A 137 SER B 74 SER~? 19.22 O1 EDO A 88 coo 5.11 -0.55 31.43 1.36 1.90 33.24 -4.46 59.86 10.42 -1.71 65.47 11.76 coo 6.14 -0.73 24.01 6.05 0.83 25.40 -9.98 64.51 7.37 -11.90 65.11 7.97 coo 1.06 -1.40 35.67 2.72 0.28 35.10 -3.17 54.89 8.06 -1.80 56.73 8.77 1hy3_c00 source 1hy3 ESTROGEN SULFOTRANSFERASE : 2 hits 1hy3_c00 naa= 3 ULMN 3 1hy3_c01 ESTROGEN SULFOTRANSFERASE user 1 3 # 1 B 47 LYS A 71 LYS~? 25.13 O2 EDO A 88 B 107 HIS A 67 HIS~? 22.73 O2 EDO A 88 B 137 SER A 74 SER~? 16.95 O2 EDO A 88 coo -20.15 -16.49 60.11 -21.92 -14.52 56.18 -9.57 38.72 11.51 -8.72 32.82 12.46 coo -23.43 -14.78 66.71 -24.10 -15.65 64.93 -10.81 35.78 4.36 -9.61 35.51 2.67 coo -17.90 -14.30 55.11 -19.49 -15.96 55.90 -11.23 43.70 12.54 -11.15 41.78 13.99 ULMN 3 1hy3_c01 ESTROGEN SULFOTRANSFERASE user 2 3 # 2 B 47 LYS B 71 LYS~? 21.06 O1 EDO A 88 B 107 HIS B 67 HIS~? 12.87 O1 EDO A 88 B 137 SER B 74 SER~? 19.22 O1 EDO A 88 coo -20.15 -16.49 60.11 -21.92 -14.52 56.18 -4.46 59.86 10.42 -1.71 65.47 11.76 coo -23.43 -14.78 66.71 -24.10 -15.65 64.93 -9.98 64.51 7.37 -11.90 65.11 7.97 coo -17.90 -14.30 55.11 -19.49 -15.96 55.90 -3.17 54.89 8.06 -1.80 56.73 8.77 1hy3_c01 source 1hy3 ESTROGEN SULFOTRANSFERASE : 2 hits 1hy3_c01 naa= 3 ULMN 3 1i29_c01 CSDB user 1 3 # 1 A 123 HIS B 26 HIS.? 29.20 O1 EDO A 88 A 200 ASP B 28 ASP~? 30.32 C2 EDO A 88 A 226 LYS B 55 LYS~? 22.80 C2 EDO A 88 coo 23.24 46.58 4.39 24.43 46.59 2.66 -1.78 55.32 -10.54 -0.01 54.91 -11.57 coo 24.51 43.28 11.18 25.17 44.50 9.58 -6.22 49.12 -15.05 -7.63 48.42 -16.47 coo 34.47 51.09 7.19 28.58 51.18 7.53 -10.41 51.47 -4.09 -5.84 50.62 -6.36 1i29_c01 source 1i29 CSDB : 1 hits 1i29_c01 naa= 3 ULMN 3 1i29_c03 CSDB user 1 3 # 1 A 128 VAL A 36 VAL~? 5.66 O1 EDO A 88 A 200 ASP A 27 ASP.? 4.81 O2 EDO A 88 A 226 LYS B 12 LYS.? 22.50 O2 EDO A 88 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -23.35 62.42 7.35 -22.50 60.52 6.70 coo 24.51 43.28 11.18 25.17 44.50 9.58 -26.65 50.87 6.95 -25.73 50.39 8.79 coo 34.47 51.09 7.19 28.58 51.18 7.53 -33.93 48.03 -5.83 -30.65 43.44 -8.38 ULMN 3 1i29_c03 CSDB user 2 3 # 2 A 128 VAL A 36 VAL~? 5.66 O1 EDO A 88 A 200 ASP A 28 ASP~? 11.68 O2 EDO A 88 A 226 LYS B 12 LYS.? 22.50 O2 EDO A 88 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -23.35 62.42 7.35 -22.50 60.52 6.70 coo 24.51 43.28 11.18 25.17 44.50 9.58 -31.33 53.08 5.19 -32.37 54.22 3.74 coo 34.47 51.09 7.19 28.58 51.18 7.53 -33.93 48.03 -5.83 -30.65 43.44 -8.38 ULMN 3 1i29_c03 CSDB user 3 3 # 3 A 128 VAL A 36 VAL~? 5.66 O1 EDO A 88 A 200 ASP A 41 ASP.? 14.91 O1 EDO A 88 A 226 LYS B 71 LYS~? 21.06 O1 EDO A 88 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -23.35 62.42 7.35 -22.50 60.52 6.70 coo 24.51 43.28 11.18 25.17 44.50 9.58 -14.25 67.95 8.57 -13.10 69.71 8.75 coo 34.47 51.09 7.19 28.58 51.18 7.53 -4.46 59.86 10.42 -1.71 65.47 11.76 ULMN 3 1i29_c03 CSDB user 4 3 # 4 A 128 VAL A 60 VAL~? 15.14 O2 EDO A 88 A 200 ASP A 27 ASP.? 4.81 O2 EDO A 88 A 226 LYS A 85 LYS~? 4.81 O2 EDO A 88 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -17.87 42.04 2.81 -17.00 41.79 0.82 coo 24.51 43.28 11.18 25.17 44.50 9.58 -26.65 50.87 6.95 -25.73 50.39 8.79 coo 34.47 51.09 7.19 28.58 51.18 7.53 -19.67 57.49 14.47 -21.14 51.45 13.91 ULMN 3 1i29_c03 CSDB user 5 3 # 5 A 128 VAL A 60 VAL~? 15.14 O2 EDO A 88 A 200 ASP A 27 ASP.? 4.81 O2 EDO A 88 A 226 LYS B 12 LYS.? 22.50 O2 EDO A 88 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -17.87 42.04 2.81 -17.00 41.79 0.82 coo 24.51 43.28 11.18 25.17 44.50 9.58 -26.65 50.87 6.95 -25.73 50.39 8.79 coo 34.47 51.09 7.19 28.58 51.18 7.53 -33.93 48.03 -5.83 -30.65 43.44 -8.38 ULMN 3 1i29_c03 CSDB user 6 3 # 6 A 128 VAL B 9 VAL^? 16.04 O2 EDO A 88 A 200 ASP A 27 ASP.? 4.81 O2 EDO A 88 A 226 LYS A 85 LYS~? 4.81 O2 EDO A 88 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -25.88 52.88 -6.87 -24.98 52.76 -4.87 coo 24.51 43.28 11.18 25.17 44.50 9.58 -26.65 50.87 6.95 -25.73 50.39 8.79 coo 34.47 51.09 7.19 28.58 51.18 7.53 -19.67 57.49 14.47 -21.14 51.45 13.91 ULMN 3 1i29_c03 CSDB user 7 3 # 7 A 128 VAL B 60 VAL~? 14.20 O1 EDO A 88 A 200 ASP A 41 ASP.? 14.91 O1 EDO A 88 A 226 LYS A 86 LYS~? 13.64 O1 EDO A 88 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -10.66 59.60 -0.63 -12.74 59.98 -0.10 coo 24.51 43.28 11.18 25.17 44.50 9.58 -14.25 67.95 8.57 -13.10 69.71 8.75 coo 34.47 51.09 7.19 28.58 51.18 7.53 -18.60 60.01 17.15 -15.10 59.96 22.04 1i29_c03 source 1i29 CSDB : 7 hits 1i29_c03 naa= 3 ULMN 3 1j53_c00 DNA POLYMERASE III, EPSILON CHAIN user 1 3 # 1 A 14 GLU A 11 GLU^? 30.56 C2 EDO A 88 A 61 GLU B 34 GLU~? 32.51 C2 EDO A 88 A 162 HIS A 15 HIS.? 36.41 C2 EDO A 88 coo -1.50 25.58 -6.20 -2.54 26.76 -4.79 -13.41 51.24 -17.67 -12.24 50.07 -19.00 coo -4.89 20.85 5.22 -3.95 21.69 6.91 -10.00 40.79 -15.51 -9.28 41.58 -17.36 coo -7.53 27.82 -3.33 -8.58 28.59 -1.68 -10.83 48.67 -23.74 -8.99 48.18 -24.64 ULMN 3 1j53_c00 DNA POLYMERASE III, EPSILON CHAIN user 2 3 # 2 A 14 GLU A 59 GLU~? 11.45 O2 EDO A 88 A 61 GLU A 22 GLU^? 21.42 O2 EDO A 88 A 162 HIS A 26 HIS.? 12.31 O2 EDO A 88 coo -1.50 25.58 -6.20 -2.54 26.76 -4.79 -22.28 43.98 3.30 -23.32 43.37 5.05 coo -4.89 20.85 5.22 -3.95 21.69 6.91 -28.40 42.45 -5.63 -29.98 41.10 -5.71 coo -7.53 27.82 -3.33 -8.58 28.59 -1.68 -27.15 43.88 6.97 -27.62 42.01 6.19 1j53_c00 source 1j53 DNA POLYMERASE III, EPSILON CHAIN : 2 hits 1j53_c00 naa= 3 ULMN 3 1j7g_c00 D-TYROSYL-TRNA(TYR) DEACYLASE user 1 3 # 1 A 78 GLN A 6 GLN^? 22.61 O2 EDO A 88 A 79 PHE A 21 PHE^? 19.25 O2 EDO A 88 A 80 THR A 8 THR^? 23.58 O2 EDO A 88 coo 18.18 6.97 -1.14 17.20 5.70 -2.56 -27.52 46.68 -10.32 -27.37 44.56 -10.20 coo 24.87 4.39 -2.11 26.74 2.89 -0.67 -21.57 44.01 -7.94 -20.18 45.93 -6.48 coo 21.26 8.65 -4.24 19.54 7.67 -5.04 -22.63 49.63 -11.64 -24.06 49.62 -13.30 ULMN 3 1j7g_c00 D-TYROSYL-TRNA(TYR) DEACYLASE user 2 3 # 2 A 78 GLN A 46 GLN~? 16.10 O1 EDO A 88 A 79 PHE A 50 PHE~? 7.73 O1 EDO A 88 A 80 THR A 47 THR~? 9.56 O1 EDO A 88 coo 18.18 6.97 -1.14 17.20 5.70 -2.56 -13.35 64.39 -1.14 -11.98 65.68 -0.18 coo 24.87 4.39 -2.11 26.74 2.89 -0.67 -15.30 58.35 3.55 -15.30 57.87 6.26 coo 21.26 8.65 -4.24 19.54 7.67 -5.04 -18.11 62.28 1.75 -19.10 63.54 3.24 ULMN 3 1j7g_c00 D-TYROSYL-TRNA(TYR) DEACYLASE user 3 3 # 3 A 78 GLN B 6 GLN^? 24.72 C2 EDO A 88 A 79 PHE B 21 PHE^? 16.25 O1 EDO A 88 A 80 THR B 8 THR^? 21.75 O2 EDO A 88 coo 18.18 6.97 -1.14 17.20 5.70 -2.56 -20.97 56.95 -13.68 -22.14 58.34 -14.67 coo 24.87 4.39 -2.11 26.74 2.89 -0.67 -19.99 59.28 -6.97 -19.33 57.17 -5.24 coo 21.26 8.65 -4.24 19.54 7.67 -5.04 -24.11 54.23 -9.95 -25.46 54.68 -11.65 ULMN 3 1j7g_c00 D-TYROSYL-TRNA(TYR) DEACYLASE user 4 3 # 4 A 78 GLN B 46 GLN~? 19.81 O2 EDO A 88 A 79 PHE B 50 PHE~? 17.81 C2 EDO A 88 A 80 THR B 47 THR~? 23.16 O2 EDO A 88 coo 18.18 6.97 -1.14 17.20 5.70 -2.56 -19.03 38.33 -0.80 -18.69 36.68 0.49 coo 24.87 4.39 -2.11 26.74 2.89 -0.67 -12.81 43.27 -0.64 -10.49 43.54 0.89 coo 21.26 8.65 -4.24 19.54 7.67 -5.04 -14.91 40.27 -4.55 -13.65 38.90 -5.60 1j7g_c00 source 1j7g D-TYROSYL-TRNA(TYR) DEACYLASE : 4 hits 1j7g_c00 naa= 3 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 1 3 # 1 A 55 ASP A 27 ASP.? 4.81 O2 EDO A 88 A 58 ASP A 28 ASP~? 11.68 O2 EDO A 88 A 424 GLU B 11 GLU^? 16.09 O2 EDO A 88 coo 58.42 47.76 20.67 58.01 49.10 19.12 -26.65 50.87 6.95 -25.73 50.39 8.79 coo 58.59 41.80 18.81 58.94 43.89 18.94 -31.33 53.08 5.19 -32.37 54.22 3.74 coo 52.85 46.34 13.34 54.09 44.97 14.42 -32.33 52.63 -2.59 -33.86 53.51 -1.46 1js4_c00 source 1js4 ENDO-EXOCELLULASE E4 : 1 hits 1js4_c00 naa= 3 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 1 3 # 1 A 2 GLU A 59 GLU~? 11.45 O2 EDO A 88 A 56 LYS A 55 LYS~? -3.15 O2 EDO A 88s A 258 ARG A 65 ARG.? 13.82 O2 EDO A 88 coo 42.33 1.56 26.99 42.38 2.91 28.66 -22.28 43.98 3.30 -23.32 43.37 5.05 coo 38.45 -0.44 19.89 37.36 0.90 25.90 -20.05 50.35 3.45 -22.02 51.39 7.78 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 -16.89 38.09 13.12 -17.69 41.06 12.74 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 2 3 # 2 A 2 GLU B 59 GLU~? 21.18 O1 EDO A 88 A 56 LYS B 55 LYS~? 22.80 C2 EDO A 88 A 258 ARG B 65 ARG.? 22.04 O1 EDO A 88 coo 42.33 1.56 26.99 42.38 2.91 28.66 -9.24 58.13 -5.40 -7.22 57.75 -6.04 coo 38.45 -0.44 19.89 37.36 0.90 25.90 -10.41 51.47 -4.09 -5.84 50.62 -6.36 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 -0.70 61.13 2.94 -0.98 58.78 0.92 1k82_c00 source 1k82 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE : 2 hits 1k82_c00 naa= 3 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 1 3 # 1 B 2 GLU A 59 GLU~? 11.45 O2 EDO A 88 B 56 LYS A 55 LYS~? -3.15 O2 EDO A 88s B 258 ARG A 65 ARG.? 13.82 O2 EDO A 88 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 -22.28 43.98 3.30 -23.32 43.37 5.05 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 -20.05 50.35 3.45 -22.02 51.39 7.78 coo 2.64 1.83 34.81 1.56 1.13 32.02 -16.89 38.09 13.12 -17.69 41.06 12.74 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 2 3 # 2 B 2 GLU B 59 GLU~? 21.18 O1 EDO A 88 B 56 LYS B 55 LYS~? 22.80 C2 EDO A 88 B 258 ARG B 65 ARG.? 22.04 O1 EDO A 88 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 -9.24 58.13 -5.40 -7.22 57.75 -6.04 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 -10.41 51.47 -4.09 -5.84 50.62 -6.36 coo 2.64 1.83 34.81 1.56 1.13 32.02 -0.70 61.13 2.94 -0.98 58.78 0.92 1k82_c01 source 1k82 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE : 2 hits 1k82_c01 naa= 3 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 1 3 # 1 C 2 GLU A 59 GLU~? 11.45 O2 EDO A 88 C 56 LYS A 55 LYS~? -3.15 O2 EDO A 88s C 258 ARG A 65 ARG.? 13.82 O2 EDO A 88 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 -22.28 43.98 3.30 -23.32 43.37 5.05 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 -20.05 50.35 3.45 -22.02 51.39 7.78 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 -16.89 38.09 13.12 -17.69 41.06 12.74 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 2 3 # 2 C 2 GLU B 59 GLU~? 21.18 O1 EDO A 88 C 56 LYS B 55 LYS~? 22.80 C2 EDO A 88 C 258 ARG B 65 ARG.? 22.04 O1 EDO A 88 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 -9.24 58.13 -5.40 -7.22 57.75 -6.04 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 -10.41 51.47 -4.09 -5.84 50.62 -6.36 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 -0.70 61.13 2.94 -0.98 58.78 0.92 1k82_c02 source 1k82 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE : 2 hits 1k82_c02 naa= 3 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 1 3 # 1 D 2 GLU A 59 GLU~? 11.45 O2 EDO A 88 D 56 LYS A 55 LYS~? -3.15 O2 EDO A 88s D 258 ARG A 65 ARG.? 13.82 O2 EDO A 88 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 -22.28 43.98 3.30 -23.32 43.37 5.05 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 -20.05 50.35 3.45 -22.02 51.39 7.78 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 -16.89 38.09 13.12 -17.69 41.06 12.74 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 2 3 # 2 D 2 GLU B 59 GLU~? 21.18 O1 EDO A 88 D 56 LYS B 55 LYS~? 22.80 C2 EDO A 88 D 258 ARG B 65 ARG.? 22.04 O1 EDO A 88 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 -9.24 58.13 -5.40 -7.22 57.75 -6.04 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 -10.41 51.47 -4.09 -5.84 50.62 -6.36 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 -0.70 61.13 2.94 -0.98 58.78 0.92 1k82_c03 source 1k82 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE : 2 hits 1k82_c03 naa= 3 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 1 3 # 1 255 ASP A 27 ASP.? 4.81 O2 EDO A 88 262 LYS A 55 LYS~? -3.15 O2 EDO A 88s 336 ARG B 17 ARG.? 14.88 O2 EDO A 88 coo 61.88 50.78 12.96 63.84 50.60 13.71 -26.65 50.87 6.95 -25.73 50.39 8.79 coo 63.59 44.40 18.32 63.20 49.74 17.95 -20.05 50.35 3.45 -22.02 51.39 7.78 coo 72.60 57.42 15.86 71.61 56.68 18.70 -34.10 57.90 -1.91 -33.96 56.91 1.01 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 2 3 # 2 255 ASP B 27 ASP.? 26.46 C2 EDO A 88 262 LYS B 55 LYS~? 22.80 C2 EDO A 88 336 ARG A 17 ARG.? 31.93 C2 EDO A 88 coo 61.88 50.78 12.96 63.84 50.60 13.71 -4.76 50.56 -10.13 -3.07 50.63 -8.85 coo 63.59 44.40 18.32 63.20 49.74 17.95 -10.41 51.47 -4.09 -5.84 50.62 -6.36 coo 72.60 57.42 15.86 71.61 56.68 18.70 -12.86 46.28 -20.15 -10.06 46.57 -18.92 1lam_c00 source 1lam LEUCINE AMINOPEPTIDASE : 2 hits 1lam_c00 naa= 3 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 1 3 # 1 164 LYS A 39 LYS.? 9.97 O1 EDO A 88 166 LYS A 35 LYS~? 3.82 C1 EDO A 88 324 SER B 24 SER^? 25.27 O1 EDO A 88 coo 25.93 8.11 25.51 26.40 7.80 19.66 -20.54 66.31 9.07 -25.61 65.89 11.03 coo 27.27 1.43 25.09 29.18 5.25 22.89 -27.16 62.03 7.83 -24.89 58.41 11.08 coo 46.32 14.55 19.93 45.95 12.72 21.27 -10.38 58.47 -10.73 -8.49 59.58 -11.78 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 2 3 # 2 164 LYS A 39 LYS.? 9.97 O1 EDO A 88 166 LYS A 35 LYS~? 3.82 C1 EDO A 88 324 SER B 74 SER~? 19.22 O1 EDO A 88 coo 25.93 8.11 25.51 26.40 7.80 19.66 -20.54 66.31 9.07 -25.61 65.89 11.03 coo 27.27 1.43 25.09 29.18 5.25 22.89 -27.16 62.03 7.83 -24.89 58.41 11.08 coo 46.32 14.55 19.93 45.95 12.72 21.27 -3.17 54.89 8.06 -1.80 56.73 8.77 1mdr_c01 source 1mdr MANDELATE RACEMASE (E.C.5.1.2.2) : 2 hits 1mdr_c01 naa= 3 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 1 3 # 1 A 50 ASP A 27 ASP.? 4.81 O2 EDO A 88 A 55 TYR A 5 TYR^? 13.23 O2 EDO A 88 A 84 LYS A 55 LYS~? -3.15 O2 EDO A 88s coo 11.09 42.89 24.44 11.32 42.06 22.49 -26.65 50.87 6.95 -25.73 50.39 8.79 coo 4.60 40.33 20.42 7.25 39.50 20.05 -28.09 49.40 -2.46 -28.96 50.64 -0.10 coo 9.71 44.83 15.47 10.13 41.43 19.93 -20.05 50.35 3.45 -22.02 51.39 7.78 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 2 3 # 2 A 50 ASP B 27 ASP.? 26.46 C2 EDO A 88 A 55 TYR B 5 TYR^? 24.90 C2 EDO A 88 A 84 LYS B 55 LYS~? 22.80 C2 EDO A 88 coo 11.09 42.89 24.44 11.32 42.06 22.49 -4.76 50.56 -10.13 -3.07 50.63 -8.85 coo 4.60 40.33 20.42 7.25 39.50 20.05 -13.48 53.76 -13.02 -11.19 52.33 -13.67 coo 9.71 44.83 15.47 10.13 41.43 19.93 -10.41 51.47 -4.09 -5.84 50.62 -6.36 1mrq_c02 source 1mrq ALDO-KETO REDUCTASE FAMILY 1 MEMBER C1 : 2 hits 1mrq_c02 naa= 3 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 1 3 # 1 A 114 HIS A 26 HIS.? 12.31 O2 EDO A 88 A 197 ASP A 27 ASP.? 4.81 O2 EDO A 88 A 223 ALA B 13 ALA.? 19.84 O2 EDO A 88 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 -27.15 43.88 6.97 -27.62 42.01 6.19 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -26.65 50.87 6.95 -25.73 50.39 8.79 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -36.90 48.51 -3.47 -36.97 47.66 -2.20 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 2 3 # 2 A 114 HIS A 26 HIS.? 12.31 O2 EDO A 88 A 197 ASP A 27 ASP.? 4.81 O2 EDO A 88 A 223 ALA B 49 ALA~? 16.10 O2 EDO A 88 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 -27.15 43.88 6.97 -27.62 42.01 6.19 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -26.65 50.87 6.95 -25.73 50.39 8.79 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -17.98 44.88 -3.70 -19.05 44.33 -2.76 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 3 3 # 3 A 114 HIS B 67 HIS~? 12.87 O1 EDO A 88 A 197 ASP A 41 ASP.? 14.91 O1 EDO A 88 A 223 ALA A 49 ALA~? 14.07 O1 EDO A 88 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 -9.98 64.51 7.37 -11.90 65.11 7.97 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -14.25 67.95 8.57 -13.10 69.71 8.75 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -17.36 58.24 -2.24 -16.18 58.83 -3.07 1n2t_c02 source 1n2t L-CYSTEINE-CYSTINE LYASE C-DES : 3 hits 1n2t_c02 naa= 3 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 1 3 # 1 B 114 HIS A 26 HIS.? 12.31 O2 EDO A 88 B 197 ASP A 27 ASP.? 4.81 O2 EDO A 88 B 223 ALA B 13 ALA.? 19.84 O2 EDO A 88 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 -27.15 43.88 6.97 -27.62 42.01 6.19 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -26.65 50.87 6.95 -25.73 50.39 8.79 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -36.90 48.51 -3.47 -36.97 47.66 -2.20 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 2 3 # 2 B 114 HIS A 26 HIS.? 12.31 O2 EDO A 88 B 197 ASP A 27 ASP.? 4.81 O2 EDO A 88 B 223 ALA B 49 ALA~? 16.10 O2 EDO A 88 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 -27.15 43.88 6.97 -27.62 42.01 6.19 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -26.65 50.87 6.95 -25.73 50.39 8.79 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -17.98 44.88 -3.70 -19.05 44.33 -2.76 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 3 3 # 3 B 114 HIS B 67 HIS~? 12.87 O1 EDO A 88 B 197 ASP A 41 ASP.? 14.91 O1 EDO A 88 B 223 ALA A 49 ALA~? 14.07 O1 EDO A 88 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 -9.98 64.51 7.37 -11.90 65.11 7.97 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -14.25 67.95 8.57 -13.10 69.71 8.75 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -17.36 58.24 -2.24 -16.18 58.83 -3.07 1n2t_c03 source 1n2t L-CYSTEINE-CYSTINE LYASE C-DES : 3 hits 1n2t_c03 naa= 3 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 1 3 # 1 549 LYS A 85 LYS~? 4.81 O2 EDO A 88 631 LYS A 71 LYS~? 25.13 O2 EDO A 88 708 LYS A 39 LYS.? 9.97 O1 EDO A 88 coo 8.61 33.06 11.15 10.12 29.19 8.82 -19.67 57.49 14.47 -21.14 51.45 13.91 coo -11.99 27.40 17.14 -13.60 24.52 11.71 -9.57 38.72 11.51 -8.72 32.82 12.46 coo 18.16 32.86 9.85 16.06 28.20 13.56 -20.54 66.31 9.07 -25.61 65.89 11.03 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 2 3 # 2 549 LYS A 86 LYS~? 13.64 O1 EDO A 88 631 LYS A 71 LYS~? 25.13 O2 EDO A 88 708 LYS A 39 LYS.? 9.97 O1 EDO A 88 coo 8.61 33.06 11.15 10.12 29.19 8.82 -18.60 60.01 17.15 -15.10 59.96 22.04 coo -11.99 27.40 17.14 -13.60 24.52 11.71 -9.57 38.72 11.51 -8.72 32.82 12.46 coo 18.16 32.86 9.85 16.06 28.20 13.56 -20.54 66.31 9.07 -25.61 65.89 11.03 1nsf_c00 source 1nsf N-ETHYLMALEIMIDE SENSITIVE FACTOR : 2 hits 1nsf_c00 naa= 3 ULMN 3 1ohh_c06 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 1 3 # 1 A 175 LYS B 71 LYS~? 21.06 O1 EDO A 88 A 208 GLN A 87 GLN.? 9.05 O1 EDO A 88 A 209 LYS A 39 LYS.? 9.97 O1 EDO A 88 coo 98.39 14.31 -19.34 101.13 12.36 -14.91 -4.46 59.86 10.42 -1.71 65.47 11.76 coo 107.44 7.66 -20.60 106.37 8.45 -22.25 -16.80 62.11 12.87 -15.55 62.93 14.38 coo 109.03 2.06 -20.49 104.00 -1.36 -18.88 -20.54 66.31 9.07 -25.61 65.89 11.03 ULMN 3 1ohh_c06 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 2 3 # 2 A 175 LYS B 71 LYS~? 21.06 O1 EDO A 88 A 208 GLN A 87 GLN.? 9.05 O1 EDO A 88 A 209 LYS A 85 LYS~? 4.81 O2 EDO A 88 coo 98.39 14.31 -19.34 101.13 12.36 -14.91 -4.46 59.86 10.42 -1.71 65.47 11.76 coo 107.44 7.66 -20.60 106.37 8.45 -22.25 -16.80 62.11 12.87 -15.55 62.93 14.38 coo 109.03 2.06 -20.49 104.00 -1.36 -18.88 -19.67 57.49 14.47 -21.14 51.45 13.91 ULMN 3 1ohh_c06 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 3 3 # 3 A 175 LYS B 71 LYS~? 21.06 O1 EDO A 88 A 208 GLN A 87 GLN.? 9.05 O1 EDO A 88 A 209 LYS A 86 LYS~? 13.64 O1 EDO A 88 coo 98.39 14.31 -19.34 101.13 12.36 -14.91 -4.46 59.86 10.42 -1.71 65.47 11.76 coo 107.44 7.66 -20.60 106.37 8.45 -22.25 -16.80 62.11 12.87 -15.55 62.93 14.38 coo 109.03 2.06 -20.49 104.00 -1.36 -18.88 -18.60 60.01 17.15 -15.10 59.96 22.04 1ohh_c06 source 1ohh ATP SYNTHASE ALPHA CHAIN HEART ISOFORM, MITOCH: 3 hits 1ohh_c06 naa= 3 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 1 3 # 1 B 175 LYS B 71 LYS~? 21.06 O1 EDO A 88 B 208 GLN A 87 GLN.? 9.05 O1 EDO A 88 B 209 LYS A 39 LYS.? 9.97 O1 EDO A 88 coo 105.03 46.01 19.55 106.59 42.35 15.55 -4.46 59.86 10.42 -1.71 65.47 11.76 coo 113.93 46.99 13.56 113.37 48.52 14.95 -16.80 62.11 12.87 -15.55 62.93 14.38 coo 115.66 49.12 8.60 111.19 49.52 4.73 -20.54 66.31 9.07 -25.61 65.89 11.03 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 2 3 # 2 B 175 LYS B 71 LYS~? 21.06 O1 EDO A 88 B 208 GLN A 87 GLN.? 9.05 O1 EDO A 88 B 209 LYS A 85 LYS~? 4.81 O2 EDO A 88 coo 105.03 46.01 19.55 106.59 42.35 15.55 -4.46 59.86 10.42 -1.71 65.47 11.76 coo 113.93 46.99 13.56 113.37 48.52 14.95 -16.80 62.11 12.87 -15.55 62.93 14.38 coo 115.66 49.12 8.60 111.19 49.52 4.73 -19.67 57.49 14.47 -21.14 51.45 13.91 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 3 3 # 3 B 175 LYS B 71 LYS~? 21.06 O1 EDO A 88 B 208 GLN A 87 GLN.? 9.05 O1 EDO A 88 B 209 LYS A 86 LYS~? 13.64 O1 EDO A 88 coo 105.03 46.01 19.55 106.59 42.35 15.55 -4.46 59.86 10.42 -1.71 65.47 11.76 coo 113.93 46.99 13.56 113.37 48.52 14.95 -16.80 62.11 12.87 -15.55 62.93 14.38 coo 115.66 49.12 8.60 111.19 49.52 4.73 -18.60 60.01 17.15 -15.10 59.96 22.04 1ohh_c07 source 1ohh ATP SYNTHASE ALPHA CHAIN HEART ISOFORM, MITOCH: 3 hits 1ohh_c07 naa= 3 ULMN 3 1ohh_c08 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 1 3 # 1 C 175 LYS B 71 LYS~? 21.06 O1 EDO A 88 C 208 GLN A 87 GLN.? 9.05 O1 EDO A 88 C 209 LYS A 85 LYS~? 4.81 O2 EDO A 88 coo 100.54 -2.78 25.52 103.29 2.02 24.05 -4.46 59.86 10.42 -1.71 65.47 11.76 coo 111.02 -1.31 30.92 109.87 -2.78 29.89 -16.80 62.11 12.87 -15.55 62.93 14.38 coo 113.62 1.19 33.65 109.52 3.92 36.47 -19.67 57.49 14.47 -21.14 51.45 13.91 ULMN 3 1ohh_c08 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 2 3 # 2 C 175 LYS B 71 LYS~? 21.06 O1 EDO A 88 C 208 GLN A 87 GLN.? 9.05 O1 EDO A 88 C 209 LYS A 86 LYS~? 13.64 O1 EDO A 88 coo 100.54 -2.78 25.52 103.29 2.02 24.05 -4.46 59.86 10.42 -1.71 65.47 11.76 coo 111.02 -1.31 30.92 109.87 -2.78 29.89 -16.80 62.11 12.87 -15.55 62.93 14.38 coo 113.62 1.19 33.65 109.52 3.92 36.47 -18.60 60.01 17.15 -15.10 59.96 22.04 1ohh_c08 source 1ohh ATP SYNTHASE ALPHA CHAIN HEART ISOFORM, MITOCH: 2 hits 1ohh_c08 naa= 3 ULMN 3 1onr_c00 TRANSALDOLASE B user 1 3 # 1 A 17 ASP A 27 ASP.? 4.81 O2 EDO A 88 A 96 GLU A 34 GLU~? 13.90 C1 EDO A 88 A 132 LYS A 35 LYS~? 3.82 C1 EDO A 88 coo 31.23 12.29 16.44 30.82 11.56 18.39 -26.65 50.87 6.95 -25.73 50.39 8.79 coo 26.82 3.20 24.36 27.99 4.86 24.98 -30.48 62.02 2.95 -32.58 61.85 3.30 coo 29.99 0.62 22.18 30.38 6.69 20.81 -27.16 62.03 7.83 -24.89 58.41 11.08 ULMN 3 1onr_c00 TRANSALDOLASE B user 2 3 # 2 A 17 ASP A 27 ASP.? 4.81 O2 EDO A 88 A 96 GLU B 11 GLU^? 16.09 O2 EDO A 88 A 132 LYS B 12 LYS.? 22.50 O2 EDO A 88 coo 31.23 12.29 16.44 30.82 11.56 18.39 -26.65 50.87 6.95 -25.73 50.39 8.79 coo 26.82 3.20 24.36 27.99 4.86 24.98 -32.33 52.63 -2.59 -33.86 53.51 -1.46 coo 29.99 0.62 22.18 30.38 6.69 20.81 -33.93 48.03 -5.83 -30.65 43.44 -8.38 1onr_c00 source 1onr TRANSALDOLASE B : 2 hits 1onr_c00 naa= 3 ULMN 3 1onr_c01 TRANSALDOLASE B user 1 3 # 1 B 17 ASP A 27 ASP.? 4.81 O2 EDO A 88 B 96 GLU A 34 GLU~? 13.90 C1 EDO A 88 B 132 LYS A 35 LYS~? 3.82 C1 EDO A 88 coo 31.16 57.31 -0.94 30.73 56.64 1.01 -26.65 50.87 6.95 -25.73 50.39 8.79 coo 26.69 48.45 7.18 27.85 50.13 7.74 -30.48 62.02 2.95 -32.58 61.85 3.30 coo 29.82 45.80 5.07 30.26 51.81 3.56 -27.16 62.03 7.83 -24.89 58.41 11.08 ULMN 3 1onr_c01 TRANSALDOLASE B user 2 3 # 2 B 17 ASP A 27 ASP.? 4.81 O2 EDO A 88 B 96 GLU B 11 GLU^? 16.09 O2 EDO A 88 B 132 LYS B 12 LYS.? 22.50 O2 EDO A 88 coo 31.16 57.31 -0.94 30.73 56.64 1.01 -26.65 50.87 6.95 -25.73 50.39 8.79 coo 26.69 48.45 7.18 27.85 50.13 7.74 -32.33 52.63 -2.59 -33.86 53.51 -1.46 coo 29.82 45.80 5.07 30.26 51.81 3.56 -33.93 48.03 -5.83 -30.65 43.44 -8.38 1onr_c01 source 1onr TRANSALDOLASE B : 2 hits 1onr_c01 naa= 3 ULMN 3 1p1x_c00 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 1 3 # 1 A 102 ASP A 27 ASP.? 4.81 O2 EDO A 88 A 167 LYS A 31 LYS~? 12.16 C1 EDO A 88 A 201 LYS A 35 LYS~? 3.82 C1 EDO A 88 coo 26.53 8.31 20.37 28.45 8.41 19.40 -26.65 50.87 6.95 -25.73 50.39 8.79 coo 24.92 6.08 13.38 27.75 4.33 18.83 -30.40 57.71 4.72 -33.78 58.75 8.98 coo 29.08 5.53 11.69 30.46 5.61 17.93 -27.16 62.03 7.83 -24.89 58.41 11.08 ULMN 3 1p1x_c00 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 2 3 # 2 A 102 ASP A 37 ASP~? 13.07 O1 EDO A 88 A 167 LYS A 35 LYS~? 3.82 C1 EDO A 88 A 201 LYS A 31 LYS~? 12.16 C1 EDO A 88 coo 26.53 8.31 20.37 28.45 8.41 19.40 -25.14 65.39 3.92 -25.04 66.91 2.43 coo 24.92 6.08 13.38 27.75 4.33 18.83 -27.16 62.03 7.83 -24.89 58.41 11.08 coo 29.08 5.53 11.69 30.46 5.61 17.93 -30.40 57.71 4.72 -33.78 58.75 8.98 1p1x_c00 source 1p1x DEOXYRIBOSE-PHOSPHATE ALDOLASE : 2 hits 1p1x_c00 naa= 3 ULMN 3 1p1x_c01 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 1 3 # 1 B1102 ASP A 27 ASP.? 4.81 O2 EDO A 88 B1167 LYS A 31 LYS~? 12.16 C1 EDO A 88 B1201 LYS A 35 LYS~? 3.82 C1 EDO A 88 coo 26.10 12.11 49.61 24.19 12.48 50.51 -26.65 50.87 6.95 -25.73 50.39 8.79 coo 27.70 11.69 56.92 24.82 8.55 52.12 -30.40 57.71 4.72 -33.78 58.75 8.98 coo 23.50 11.64 58.67 22.19 10.19 52.59 -27.16 62.03 7.83 -24.89 58.41 11.08 ULMN 3 1p1x_c01 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 2 3 # 2 B1102 ASP A 37 ASP~? 13.07 O1 EDO A 88 B1167 LYS A 35 LYS~? 3.82 C1 EDO A 88 B1201 LYS A 31 LYS~? 12.16 C1 EDO A 88 coo 26.10 12.11 49.61 24.19 12.48 50.51 -25.14 65.39 3.92 -25.04 66.91 2.43 coo 27.70 11.69 56.92 24.82 8.55 52.12 -27.16 62.03 7.83 -24.89 58.41 11.08 coo 23.50 11.64 58.67 22.19 10.19 52.59 -30.40 57.71 4.72 -33.78 58.75 8.98 1p1x_c01 source 1p1x DEOXYRIBOSE-PHOSPHATE ALDOLASE : 2 hits 1p1x_c01 naa= 3 ULMN 3 1pfq_c00 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 1 3 # 1 A 630 SER A 24 SER^? 14.86 O2 EDO A 88 A 708 ASP A 27 ASP.? 4.81 O2 EDO A 88 A 740 HIS A 26 HIS.? 12.31 O2 EDO A 88 coo -7.09 7.44 6.22 -7.53 5.14 5.59 -27.05 44.01 0.12 -28.54 42.91 1.70 coo -5.35 2.36 14.19 -6.28 2.60 12.26 -26.65 50.87 6.95 -25.73 50.39 8.79 coo -8.70 2.86 9.96 -8.03 3.92 8.29 -27.15 43.88 6.97 -27.62 42.01 6.19 1pfq_c00 source 1pfq DIPEPTIDYL PEPTIDASE IV SOLUBLE FORM : 1 hits 1pfq_c00 naa= 3 ULMN 3 1pfq_c01 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 1 3 # 1 B 630 SER A 24 SER^? 14.86 O2 EDO A 88 B 708 ASP A 27 ASP.? 4.81 O2 EDO A 88 B 740 HIS A 26 HIS.? 12.31 O2 EDO A 88 coo 4.44 13.29 37.64 6.01 11.66 38.49 -27.05 44.01 0.12 -28.54 42.91 1.70 coo 6.39 7.18 30.33 6.92 8.20 32.17 -26.65 50.87 6.95 -25.73 50.39 8.79 coo 8.57 10.09 34.47 7.10 10.73 35.82 -27.15 43.88 6.97 -27.62 42.01 6.19 1pfq_c01 source 1pfq DIPEPTIDYL PEPTIDASE IV SOLUBLE FORM : 1 hits 1pfq_c01 naa= 3 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 1 3 # 1 A 70 ALA A 49 ALA~? 14.07 O1 EDO A 88 A 126 LEU B 56 LEU~? 15.22 C2 EDO A 88 A 158 GLU B 59 GLU~? 21.18 O1 EDO A 88 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -17.36 58.24 -2.24 -16.18 58.83 -3.07 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -14.60 53.94 -3.57 -16.13 54.71 -4.79 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -9.24 58.13 -5.40 -7.22 57.75 -6.04 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 2 3 # 2 A 70 ALA B 49 ALA~? 16.10 O2 EDO A 88 A 126 LEU A 56 LEU~? 13.04 O2 EDO A 88 A 158 GLU A 59 GLU~? 11.45 O2 EDO A 88 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -17.98 44.88 -3.70 -19.05 44.33 -2.76 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -18.85 48.59 -1.00 -20.22 48.88 -2.67 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -22.28 43.98 3.30 -23.32 43.37 5.05 1pjh_c00 source 1pjh ENOYL-COA ISOMERASE; ECI1P : 2 hits 1pjh_c00 naa= 3 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 1 3 # 1 B 70 ALA A 49 ALA~? 14.07 O1 EDO A 88 B 126 LEU B 56 LEU~? 15.22 C2 EDO A 88 B 158 GLU B 59 GLU~? 21.18 O1 EDO A 88 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -17.36 58.24 -2.24 -16.18 58.83 -3.07 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -14.60 53.94 -3.57 -16.13 54.71 -4.79 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -9.24 58.13 -5.40 -7.22 57.75 -6.04 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 2 3 # 2 B 70 ALA B 49 ALA~? 16.10 O2 EDO A 88 B 126 LEU A 56 LEU~? 13.04 O2 EDO A 88 B 158 GLU A 59 GLU~? 11.45 O2 EDO A 88 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -17.98 44.88 -3.70 -19.05 44.33 -2.76 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -18.85 48.59 -1.00 -20.22 48.88 -2.67 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -22.28 43.98 3.30 -23.32 43.37 5.05 1pjh_c01 source 1pjh ENOYL-COA ISOMERASE; ECI1P : 2 hits 1pjh_c01 naa= 3 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 1 3 # 1 C 70 ALA A 49 ALA~? 14.07 O1 EDO A 88 C 126 LEU B 56 LEU~? 15.22 C2 EDO A 88 C 158 GLU B 59 GLU~? 21.18 O1 EDO A 88 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -17.36 58.24 -2.24 -16.18 58.83 -3.07 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -14.60 53.94 -3.57 -16.13 54.71 -4.79 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -9.24 58.13 -5.40 -7.22 57.75 -6.04 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 2 3 # 2 C 70 ALA B 49 ALA~? 16.10 O2 EDO A 88 C 126 LEU A 56 LEU~? 13.04 O2 EDO A 88 C 158 GLU A 59 GLU~? 11.45 O2 EDO A 88 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -17.98 44.88 -3.70 -19.05 44.33 -2.76 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -18.85 48.59 -1.00 -20.22 48.88 -2.67 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -22.28 43.98 3.30 -23.32 43.37 5.05 1pjh_c02 source 1pjh ENOYL-COA ISOMERASE; ECI1P : 2 hits 1pjh_c02 naa= 3 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 1 3 # 1 A 248 ASP A 27 ASP.? 4.81 O2 EDO A 88 A 270 LYS A 31 LYS~? 12.16 C1 EDO A 88 A 382 MET A 82 MET?? 11.78 C2 EDO A 88 coo -27.63 121.99 45.48 -26.66 123.86 45.68 -26.65 50.87 6.95 -25.73 50.39 8.79 coo -32.20 115.91 49.56 -31.37 121.03 53.12 -30.40 57.71 4.72 -33.78 58.75 8.98 coo -23.75 127.89 58.42 -26.02 128.79 55.12 -16.30 54.03 16.27 -15.66 51.29 19.46 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 2 3 # 2 A 248 ASP B 27 ASP.? 26.46 C2 EDO A 88 A 270 LYS B 31 LYS~? 34.04 C2 EDO A 88 A 382 MET B 82 MET?? 27.39 C2 EDO A 88 coo -27.63 121.99 45.48 -26.66 123.86 45.68 -4.76 50.56 -10.13 -3.07 50.63 -8.85 coo -32.20 115.91 49.56 -31.37 121.03 53.12 -7.49 44.50 -14.70 -1.79 44.49 -16.08 coo -23.75 127.89 58.42 -26.02 128.79 55.12 0.17 45.16 1.96 3.60 45.07 4.22 1pjq_c02 source 1pjq SIROHEME SYNTHASE : 2 hits 1pjq_c02 naa= 3 ULMN 3 1pjq_c03 SIROHEME SYNTHASE user 1 3 # 1 B 248 ASP A 27 ASP.? 4.81 O2 EDO A 88 B 270 LYS A 55 LYS~? -3.15 O2 EDO A 88s B 382 MET A 82 MET?? 11.78 C2 EDO A 88 coo -11.82 154.51 43.38 -12.86 152.74 43.79 -26.65 50.87 6.95 -25.73 50.39 8.79 coo -5.09 158.39 43.41 -0.74 158.80 47.15 -20.05 50.35 3.45 -22.02 51.39 7.78 coo -2.79 145.52 50.38 -5.75 148.14 51.66 -16.30 54.03 16.27 -15.66 51.29 19.46 ULMN 3 1pjq_c03 SIROHEME SYNTHASE user 2 3 # 2 B 248 ASP A 41 ASP.? 14.91 O1 EDO A 88 B 270 LYS A 39 LYS.? 9.97 O1 EDO A 88 B 382 MET A 81 MET?? 5.44 C2 EDO A 88 coo -11.82 154.51 43.38 -12.86 152.74 43.79 -14.25 67.95 8.57 -13.10 69.71 8.75 coo -5.09 158.39 43.41 -0.74 158.80 47.15 -20.54 66.31 9.07 -25.61 65.89 11.03 coo -2.79 145.52 50.38 -5.75 148.14 51.66 -15.76 52.96 12.66 -16.75 51.96 9.66 ULMN 3 1pjq_c03 SIROHEME SYNTHASE user 3 3 # 3 B 248 ASP A 41 ASP.? 14.91 O1 EDO A 88 B 270 LYS A 39 LYS.? 9.97 O1 EDO A 88 B 382 MET A 82 MET?? 11.78 C2 EDO A 88 coo -11.82 154.51 43.38 -12.86 152.74 43.79 -14.25 67.95 8.57 -13.10 69.71 8.75 coo -5.09 158.39 43.41 -0.74 158.80 47.15 -20.54 66.31 9.07 -25.61 65.89 11.03 coo -2.79 145.52 50.38 -5.75 148.14 51.66 -16.30 54.03 16.27 -15.66 51.29 19.46 ULMN 3 1pjq_c03 SIROHEME SYNTHASE user 4 3 # 4 B 248 ASP A 41 ASP.? 14.91 O1 EDO A 88 B 270 LYS A 39 LYS.? 9.97 O1 EDO A 88 B 382 MET B 61 MET?? 15.32 O1 EDO A 88 coo -11.82 154.51 43.38 -12.86 152.74 43.79 -14.25 67.95 8.57 -13.10 69.71 8.75 coo -5.09 158.39 43.41 -0.74 158.80 47.15 -20.54 66.31 9.07 -25.61 65.89 11.03 coo -2.79 145.52 50.38 -5.75 148.14 51.66 -8.14 58.69 2.09 -6.73 55.59 4.61 ULMN 3 1pjq_c03 SIROHEME SYNTHASE user 5 3 # 5 B 248 ASP B 27 ASP.? 26.46 C2 EDO A 88 B 270 LYS B 55 LYS~? 22.80 C2 EDO A 88 B 382 MET B 82 MET?? 27.39 C2 EDO A 88 coo -11.82 154.51 43.38 -12.86 152.74 43.79 -4.76 50.56 -10.13 -3.07 50.63 -8.85 coo -5.09 158.39 43.41 -0.74 158.80 47.15 -10.41 51.47 -4.09 -5.84 50.62 -6.36 coo -2.79 145.52 50.38 -5.75 148.14 51.66 0.17 45.16 1.96 3.60 45.07 4.22 1pjq_c03 source 1pjq SIROHEME SYNTHASE : 5 hits 1pjq_c03 naa= 3 ULMN 3 1pmi_c00 PHOSPHOMANNOSE ISOMERASE user 1 3 # 1 111 GLN A 16 GLN.? 34.68 C2 EDO A 88 294 GLU B 22 GLU^? 25.61 O1 EDO A 88 304 ARG A 17 ARG.? 31.93 C2 EDO A 88 coo 15.89 18.45 46.53 15.82 16.91 48.02 -16.08 53.77 -23.29 -17.26 54.92 -24.66 coo 22.84 13.44 52.91 20.84 13.18 52.38 -17.79 60.61 -13.20 -17.15 61.81 -14.83 coo 8.71 17.11 46.51 7.23 17.64 49.20 -12.86 46.28 -20.15 -10.06 46.57 -18.92 ULMN 3 1pmi_c00 PHOSPHOMANNOSE ISOMERASE user 2 3 # 2 111 GLN B 16 GLN.? 24.35 O2 EDO A 88 294 GLU A 22 GLU^? 21.42 O2 EDO A 88 304 ARG B 17 ARG.? 14.88 O2 EDO A 88 coo 15.89 18.45 46.53 15.82 16.91 48.02 -37.18 51.51 -7.05 -37.66 50.47 -8.86 coo 22.84 13.44 52.91 20.84 13.18 52.38 -28.40 42.45 -5.63 -29.98 41.10 -5.71 coo 8.71 17.11 46.51 7.23 17.64 49.20 -34.10 57.90 -1.91 -33.96 56.91 1.01 1pmi_c00 source 1pmi PHOSPHOMANNOSE ISOMERASE : 2 hits 1pmi_c00 naa= 3 ULMN 3 1pow_c02 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 1 3 # 1 A 264 ARG A 17 ARG.? 31.93 C2 EDO A 88 A 479 PHE B 30 PHE~? 27.21 C2 EDO A 88 A 483 GLU A 11 GLU^? 30.56 C2 EDO A 88 coo 17.33 52.29 2.24 18.71 54.03 0.18 -12.86 46.28 -20.15 -10.06 46.57 -18.92 coo 20.06 57.44 1.28 18.39 56.19 3.12 -12.94 47.02 -15.56 -15.52 48.08 -15.37 coo 17.33 54.96 -3.04 16.34 56.76 -2.51 -13.41 51.24 -17.67 -12.24 50.07 -19.00 ULMN 3 1pow_c02 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 2 3 # 2 A 264 ARG A 17 ARG.? 31.93 C2 EDO A 88 A 479 PHE B 30 PHE~? 27.21 C2 EDO A 88 A 483 GLU B 34 GLU~? 32.51 C2 EDO A 88 coo 17.33 52.29 2.24 18.71 54.03 0.18 -12.86 46.28 -20.15 -10.06 46.57 -18.92 coo 20.06 57.44 1.28 18.39 56.19 3.12 -12.94 47.02 -15.56 -15.52 48.08 -15.37 coo 17.33 54.96 -3.04 16.34 56.76 -2.51 -10.00 40.79 -15.51 -9.28 41.58 -17.36 ULMN 3 1pow_c02 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 3 3 # 3 A 264 ARG B 17 ARG.? 14.88 O2 EDO A 88 A 479 PHE A 30 PHE~? 14.44 O2 EDO A 88 A 483 GLU A 34 GLU~? 13.90 C1 EDO A 88 coo 17.33 52.29 2.24 18.71 54.03 0.18 -34.10 57.90 -1.91 -33.96 56.91 1.01 coo 20.06 57.44 1.28 18.39 56.19 3.12 -29.96 56.34 -1.22 -29.15 55.58 -3.78 coo 17.33 54.96 -3.04 16.34 56.76 -2.51 -30.48 62.02 2.95 -32.58 61.85 3.30 ULMN 3 1pow_c02 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 4 3 # 4 A 264 ARG B 17 ARG.? 14.88 O2 EDO A 88 A 479 PHE A 30 PHE~? 14.44 O2 EDO A 88 A 483 GLU B 11 GLU^? 16.09 O2 EDO A 88 coo 17.33 52.29 2.24 18.71 54.03 0.18 -34.10 57.90 -1.91 -33.96 56.91 1.01 coo 20.06 57.44 1.28 18.39 56.19 3.12 -29.96 56.34 -1.22 -29.15 55.58 -3.78 coo 17.33 54.96 -3.04 16.34 56.76 -2.51 -32.33 52.63 -2.59 -33.86 53.51 -1.46 1pow_c02 source 1pow PYRUVATE OXIDASE (E.C.1.2.3.3) (WILD TYPE) : 4 hits 1pow_c02 naa= 3 ULMN 3 1pow_c03 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 1 3 # 1 B 264 ARG A 17 ARG.? 31.93 C2 EDO A 88 B 479 PHE B 30 PHE~? 27.21 C2 EDO A 88 B 483 GLU A 11 GLU^? 30.56 C2 EDO A 88 coo -26.72 93.28 20.13 -28.02 93.55 17.39 -12.86 46.28 -20.15 -10.06 46.57 -18.92 coo -29.34 90.48 15.69 -27.62 89.95 17.80 -12.94 47.02 -15.56 -15.52 48.08 -15.37 coo -26.63 95.49 14.65 -25.77 93.77 13.77 -13.41 51.24 -17.67 -12.24 50.07 -19.00 ULMN 3 1pow_c03 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 2 3 # 2 B 264 ARG A 17 ARG.? 31.93 C2 EDO A 88 B 479 PHE B 30 PHE~? 27.21 C2 EDO A 88 B 483 GLU B 34 GLU~? 32.51 C2 EDO A 88 coo -26.72 93.28 20.13 -28.02 93.55 17.39 -12.86 46.28 -20.15 -10.06 46.57 -18.92 coo -29.34 90.48 15.69 -27.62 89.95 17.80 -12.94 47.02 -15.56 -15.52 48.08 -15.37 coo -26.63 95.49 14.65 -25.77 93.77 13.77 -10.00 40.79 -15.51 -9.28 41.58 -17.36 ULMN 3 1pow_c03 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 3 3 # 3 B 264 ARG B 17 ARG.? 14.88 O2 EDO A 88 B 479 PHE A 30 PHE~? 14.44 O2 EDO A 88 B 483 GLU A 34 GLU~? 13.90 C1 EDO A 88 coo -26.72 93.28 20.13 -28.02 93.55 17.39 -34.10 57.90 -1.91 -33.96 56.91 1.01 coo -29.34 90.48 15.69 -27.62 89.95 17.80 -29.96 56.34 -1.22 -29.15 55.58 -3.78 coo -26.63 95.49 14.65 -25.77 93.77 13.77 -30.48 62.02 2.95 -32.58 61.85 3.30 ULMN 3 1pow_c03 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 4 3 # 4 B 264 ARG B 17 ARG.? 14.88 O2 EDO A 88 B 479 PHE A 30 PHE~? 14.44 O2 EDO A 88 B 483 GLU B 11 GLU^? 16.09 O2 EDO A 88 coo -26.72 93.28 20.13 -28.02 93.55 17.39 -34.10 57.90 -1.91 -33.96 56.91 1.01 coo -29.34 90.48 15.69 -27.62 89.95 17.80 -29.96 56.34 -1.22 -29.15 55.58 -3.78 coo -26.63 95.49 14.65 -25.77 93.77 13.77 -32.33 52.63 -2.59 -33.86 53.51 -1.46 1pow_c03 source 1pow PYRUVATE OXIDASE (E.C.1.2.3.3) (WILD TYPE) : 4 hits 1pow_c03 naa= 3 ULMN 3 1pp4_c02 RHAMNOGALACTURONAN ACETYLESTERASE user 1 3 # 1 A 74 ASN A 83 ASN~? 10.47 O1 EDO A 88 A 192 ASP A 41 ASP.? 14.91 O1 EDO A 88 A 195 HIS B 67 HIS~? 12.87 O1 EDO A 88 coo -4.84 51.77 30.37 -3.89 50.12 29.46 -12.86 57.40 15.39 -12.23 59.42 15.35 coo 2.03 47.14 19.75 1.72 46.26 21.64 -14.25 67.95 8.57 -13.10 69.71 8.75 coo 1.41 44.84 24.92 -0.49 45.70 25.19 -9.98 64.51 7.37 -11.90 65.11 7.97 1pp4_c02 source 1pp4 RHAMNOGALACTURONAN ACETYLESTERASE : 1 hits 1pp4_c02 naa= 3 ULMN 3 1pp4_c03 RHAMNOGALACTURONAN ACETYLESTERASE user 1 3 # 1 B 74 ASN A 83 ASN~? 10.47 O1 EDO A 88 B 192 ASP A 41 ASP.? 14.91 O1 EDO A 88 B 195 HIS B 67 HIS~? 12.87 O1 EDO A 88 coo -1.08 51.41 10.34 0.65 52.62 10.17 -12.86 57.40 15.39 -12.23 59.42 15.35 coo 11.36 52.33 5.59 10.18 53.87 6.47 -14.25 67.95 8.57 -13.10 69.71 8.75 coo 7.99 56.74 7.55 6.88 55.39 8.70 -9.98 64.51 7.37 -11.90 65.11 7.97 1pp4_c03 source 1pp4 RHAMNOGALACTURONAN ACETYLESTERASE : 1 hits 1pp4_c03 naa= 3 ULMN 3 1pym_c00 PHOSPHOENOLPYRUVATE MUTASE user 1 3 # 1 A 48 LEU A 25 LEU^? 9.79 O2 EDO A 88 A 58 ASP A 27 ASP.? 4.81 O2 EDO A 88 A 120 LYS A 31 LYS~? 12.16 C1 EDO A 88 coo 34.02 69.29 75.26 34.82 67.82 76.74 -25.73 47.85 2.71 -24.04 48.61 1.56 coo 34.46 72.45 78.57 32.82 72.75 77.28 -26.65 50.87 6.95 -25.73 50.39 8.79 coo 28.96 77.64 81.19 29.05 74.53 77.51 -30.40 57.71 4.72 -33.78 58.75 8.98 ULMN 3 1pym_c00 PHOSPHOENOLPYRUVATE MUTASE user 2 3 # 2 A 48 LEU A 33 LEU~? 9.98 O1 EDO A 88 A 58 ASP A 37 ASP~? 13.07 O1 EDO A 88 A 120 LYS A 39 LYS.? 9.97 O1 EDO A 88 coo 34.02 69.29 75.26 34.82 67.82 76.74 -25.67 59.45 1.65 -24.18 58.34 0.49 coo 34.46 72.45 78.57 32.82 72.75 77.28 -25.14 65.39 3.92 -25.04 66.91 2.43 coo 28.96 77.64 81.19 29.05 74.53 77.51 -20.54 66.31 9.07 -25.61 65.89 11.03 ULMN 3 1pym_c00 PHOSPHOENOLPYRUVATE MUTASE user 3 3 # 3 A 48 LEU B 25 LEU^? 22.53 C2 EDO A 88 A 58 ASP B 27 ASP.? 26.46 C2 EDO A 88 A 120 LYS B 31 LYS~? 34.04 C2 EDO A 88 coo 34.02 69.29 75.26 34.82 67.82 76.74 -8.40 54.30 -9.81 -9.83 53.52 -8.34 coo 34.46 72.45 78.57 32.82 72.75 77.28 -4.76 50.56 -10.13 -3.07 50.63 -8.85 coo 28.96 77.64 81.19 29.05 74.53 77.51 -7.49 44.50 -14.70 -1.79 44.49 -16.08 1pym_c00 source 1pym PHOSPHOENOLPYRUVATE MUTASE : 3 hits 1pym_c00 naa= 3 ULMN 3 1pym_c01 PHOSPHOENOLPYRUVATE MUTASE user 1 3 # 1 B 48 LEU A 25 LEU^? 9.79 O2 EDO A 88 B 58 ASP A 27 ASP.? 4.81 O2 EDO A 88 B 120 LYS A 31 LYS~? 12.16 C1 EDO A 88 coo 54.50 104.32 58.69 55.83 105.69 59.81 -25.73 47.85 2.71 -24.04 48.61 1.56 coo 57.63 101.19 59.83 56.60 100.89 57.99 -26.65 50.87 6.95 -25.73 50.39 8.79 coo 61.58 95.88 55.22 58.18 99.30 54.71 -30.40 57.71 4.72 -33.78 58.75 8.98 ULMN 3 1pym_c01 PHOSPHOENOLPYRUVATE MUTASE user 2 3 # 2 B 48 LEU A 33 LEU~? 9.98 O1 EDO A 88 B 58 ASP A 37 ASP~? 13.07 O1 EDO A 88 B 120 LYS A 39 LYS.? 9.97 O1 EDO A 88 coo 54.50 104.32 58.69 55.83 105.69 59.81 -25.67 59.45 1.65 -24.18 58.34 0.49 coo 57.63 101.19 59.83 56.60 100.89 57.99 -25.14 65.39 3.92 -25.04 66.91 2.43 coo 61.58 95.88 55.22 58.18 99.30 54.71 -20.54 66.31 9.07 -25.61 65.89 11.03 ULMN 3 1pym_c01 PHOSPHOENOLPYRUVATE MUTASE user 3 3 # 3 B 48 LEU B 25 LEU^? 22.53 C2 EDO A 88 B 58 ASP B 27 ASP.? 26.46 C2 EDO A 88 B 120 LYS B 31 LYS~? 34.04 C2 EDO A 88 coo 54.50 104.32 58.69 55.83 105.69 59.81 -8.40 54.30 -9.81 -9.83 53.52 -8.34 coo 57.63 101.19 59.83 56.60 100.89 57.99 -4.76 50.56 -10.13 -3.07 50.63 -8.85 coo 61.58 95.88 55.22 58.18 99.30 54.71 -7.49 44.50 -14.70 -1.79 44.49 -16.08 1pym_c01 source 1pym PHOSPHOENOLPYRUVATE MUTASE : 3 hits 1pym_c01 naa= 3 ULMN 3 1qfm_c00 PROLYL OLIGOPEPTIDASE user 1 3 # 1 A 554 SER A 24 SER^? 14.86 O2 EDO A 88 A 641 ASP A 27 ASP.? 4.81 O2 EDO A 88 A 680 HIS A 26 HIS.? 12.31 O2 EDO A 88 coo 34.48 40.33 79.08 36.40 39.98 80.55 -27.05 44.01 0.12 -28.54 42.91 1.70 coo 40.64 47.22 77.43 39.90 45.49 78.43 -26.65 50.87 6.95 -25.73 50.39 8.79 coo 38.53 44.50 81.45 37.60 42.73 80.84 -27.15 43.88 6.97 -27.62 42.01 6.19 1qfm_c00 source 1qfm PROLYL OLIGOPEPTIDASE : 1 hits 1qfm_c00 naa= 3 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 F 163 TYR A 5 TYR^? 13.23 O2 EDO A 88 F 236 ASP A 28 ASP~? 11.68 O2 EDO A 88 F 261 LYS A 55 LYS~? -3.15 O2 EDO A 88s coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 -28.09 49.40 -2.46 -28.96 50.64 -0.10 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -31.33 53.08 5.19 -32.37 54.22 3.74 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 -20.05 50.35 3.45 -22.02 51.39 7.78 1qgn_c13 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1qgn_c13 naa= 3 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 110 ARG A 17 ARG.? 31.93 C2 EDO A 88 C 163 TYR B 5 TYR^? 24.90 C2 EDO A 88 C 236 ASP B 27 ASP.? 26.46 C2 EDO A 88 coo 39.01 29.77 22.02 37.48 31.30 19.84 -12.86 46.28 -20.15 -10.06 46.57 -18.92 coo 39.51 34.34 13.63 37.63 32.61 14.79 -13.48 53.76 -13.02 -11.19 52.33 -13.67 coo 45.78 31.11 9.51 44.25 30.06 10.53 -4.76 50.56 -10.13 -3.07 50.63 -8.85 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 110 ARG B 17 ARG.? 14.88 O2 EDO A 88 C 163 TYR A 5 TYR^? 13.23 O2 EDO A 88 C 236 ASP A 27 ASP.? 4.81 O2 EDO A 88 coo 39.01 29.77 22.02 37.48 31.30 19.84 -34.10 57.90 -1.91 -33.96 56.91 1.01 coo 39.51 34.34 13.63 37.63 32.61 14.79 -28.09 49.40 -2.46 -28.96 50.64 -0.10 coo 45.78 31.11 9.51 44.25 30.06 10.53 -26.65 50.87 6.95 -25.73 50.39 8.79 1qgn_c16 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c16 naa= 3 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 110 ARG A 17 ARG.? 31.93 C2 EDO A 88 D 163 TYR B 5 TYR^? 24.90 C2 EDO A 88 D 236 ASP B 27 ASP.? 26.46 C2 EDO A 88 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 -12.86 46.28 -20.15 -10.06 46.57 -18.92 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 -13.48 53.76 -13.02 -11.19 52.33 -13.67 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -4.76 50.56 -10.13 -3.07 50.63 -8.85 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 110 ARG B 17 ARG.? 14.88 O2 EDO A 88 D 163 TYR A 5 TYR^? 13.23 O2 EDO A 88 D 236 ASP A 27 ASP.? 4.81 O2 EDO A 88 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 -34.10 57.90 -1.91 -33.96 56.91 1.01 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 -28.09 49.40 -2.46 -28.96 50.64 -0.10 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -26.65 50.87 6.95 -25.73 50.39 8.79 1qgn_c17 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c17 naa= 3 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 163 TYR A 5 TYR^? 13.23 O2 EDO A 88 A 236 ASP A 27 ASP.? 4.81 O2 EDO A 88 C 110 ARG B 17 ARG.? 14.88 O2 EDO A 88 coo 55.48 26.51 40.65 55.39 23.99 39.43 -28.09 49.40 -2.46 -28.96 50.64 -0.10 coo 48.87 29.19 44.63 49.10 27.34 43.63 -26.65 50.87 6.95 -25.73 50.39 8.79 coo 52.39 23.42 32.10 54.51 23.27 34.29 -34.10 57.90 -1.91 -33.96 56.91 1.01 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 163 TYR B 5 TYR^? 24.90 C2 EDO A 88 A 236 ASP B 27 ASP.? 26.46 C2 EDO A 88 C 110 ARG A 17 ARG.? 31.93 C2 EDO A 88 coo 55.48 26.51 40.65 55.39 23.99 39.43 -13.48 53.76 -13.02 -11.19 52.33 -13.67 coo 48.87 29.19 44.63 49.10 27.34 43.63 -4.76 50.56 -10.13 -3.07 50.63 -8.85 coo 52.39 23.42 32.10 54.51 23.27 34.29 -12.86 46.28 -20.15 -10.06 46.57 -18.92 1qgn_c18 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c18 naa= 3 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 163 TYR A 5 TYR^? 13.23 O2 EDO A 88 B 236 ASP A 27 ASP.? 4.81 O2 EDO A 88 D 110 ARG B 17 ARG.? 14.88 O2 EDO A 88 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 -28.09 49.40 -2.46 -28.96 50.64 -0.10 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -26.65 50.87 6.95 -25.73 50.39 8.79 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 -34.10 57.90 -1.91 -33.96 56.91 1.01 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 163 TYR B 5 TYR^? 24.90 C2 EDO A 88 B 236 ASP B 27 ASP.? 26.46 C2 EDO A 88 D 110 ARG A 17 ARG.? 31.93 C2 EDO A 88 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 -13.48 53.76 -13.02 -11.19 52.33 -13.67 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -4.76 50.56 -10.13 -3.07 50.63 -8.85 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 -12.86 46.28 -20.15 -10.06 46.57 -18.92 1qgn_c19 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c19 naa= 3 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 E 110 ARG A 17 ARG.? 31.93 C2 EDO A 88 G 163 TYR B 5 TYR^? 24.90 C2 EDO A 88 G 236 ASP B 27 ASP.? 26.46 C2 EDO A 88 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 -12.86 46.28 -20.15 -10.06 46.57 -18.92 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 -13.48 53.76 -13.02 -11.19 52.33 -13.67 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -4.76 50.56 -10.13 -3.07 50.63 -8.85 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 E 110 ARG B 17 ARG.? 14.88 O2 EDO A 88 G 163 TYR A 5 TYR^? 13.23 O2 EDO A 88 G 236 ASP A 27 ASP.? 4.81 O2 EDO A 88 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 -34.10 57.90 -1.91 -33.96 56.91 1.01 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 -28.09 49.40 -2.46 -28.96 50.64 -0.10 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -26.65 50.87 6.95 -25.73 50.39 8.79 1qgn_c20 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c20 naa= 3 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 F 110 ARG A 17 ARG.? 31.93 C2 EDO A 88 H 163 TYR B 5 TYR^? 24.90 C2 EDO A 88 H 236 ASP B 27 ASP.? 26.46 C2 EDO A 88 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 -12.86 46.28 -20.15 -10.06 46.57 -18.92 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 -13.48 53.76 -13.02 -11.19 52.33 -13.67 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -4.76 50.56 -10.13 -3.07 50.63 -8.85 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 F 110 ARG B 17 ARG.? 14.88 O2 EDO A 88 H 163 TYR A 5 TYR^? 13.23 O2 EDO A 88 H 236 ASP A 27 ASP.? 4.81 O2 EDO A 88 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 -34.10 57.90 -1.91 -33.96 56.91 1.01 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 -28.09 49.40 -2.46 -28.96 50.64 -0.10 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -26.65 50.87 6.95 -25.73 50.39 8.79 1qgn_c21 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c21 naa= 3 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 E 163 TYR A 5 TYR^? 13.23 O2 EDO A 88 E 236 ASP A 27 ASP.? 4.81 O2 EDO A 88 G 110 ARG B 17 ARG.? 14.88 O2 EDO A 88 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 -28.09 49.40 -2.46 -28.96 50.64 -0.10 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -26.65 50.87 6.95 -25.73 50.39 8.79 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 -34.10 57.90 -1.91 -33.96 56.91 1.01 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 E 163 TYR B 5 TYR^? 24.90 C2 EDO A 88 E 236 ASP B 27 ASP.? 26.46 C2 EDO A 88 G 110 ARG A 17 ARG.? 31.93 C2 EDO A 88 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 -13.48 53.76 -13.02 -11.19 52.33 -13.67 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -4.76 50.56 -10.13 -3.07 50.63 -8.85 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 -12.86 46.28 -20.15 -10.06 46.57 -18.92 1qgn_c22 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c22 naa= 3 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 F 163 TYR A 5 TYR^? 13.23 O2 EDO A 88 F 236 ASP A 27 ASP.? 4.81 O2 EDO A 88 H 110 ARG B 17 ARG.? 14.88 O2 EDO A 88 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 -28.09 49.40 -2.46 -28.96 50.64 -0.10 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -26.65 50.87 6.95 -25.73 50.39 8.79 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 -34.10 57.90 -1.91 -33.96 56.91 1.01 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 F 163 TYR B 5 TYR^? 24.90 C2 EDO A 88 F 236 ASP B 27 ASP.? 26.46 C2 EDO A 88 H 110 ARG A 17 ARG.? 31.93 C2 EDO A 88 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 -13.48 53.76 -13.02 -11.19 52.33 -13.67 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -4.76 50.56 -10.13 -3.07 50.63 -8.85 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 -12.86 46.28 -20.15 -10.06 46.57 -18.92 1qgn_c23 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c23 naa= 3 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 1 3 # 1 A 49 ASP A 37 ASP~? 13.07 O1 EDO A 88 A 147 THR A 47 THR~? 9.56 O1 EDO A 88 A 294 ASP A 41 ASP.? 14.91 O1 EDO A 88 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 -25.14 65.39 3.92 -25.04 66.91 2.43 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -18.11 62.28 1.75 -19.10 63.54 3.24 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 -14.25 67.95 8.57 -13.10 69.71 8.75 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 2 3 # 2 A 49 ASP A 41 ASP.? 14.91 O1 EDO A 88 A 147 THR A 43 THR~? 16.85 O1 EDO A 88 A 294 ASP A 37 ASP~? 13.07 O1 EDO A 88 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 -14.25 67.95 8.57 -13.10 69.71 8.75 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -16.43 67.99 0.38 -14.88 68.16 -1.11 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 -25.14 65.39 3.92 -25.04 66.91 2.43 1qgx_c02 source 1qgx 3',5'-ADENOSINE BISPHOSPHATASE : 2 hits 1qgx_c02 naa= 3 ULMN 3 1qho_c05 ALPHA-AMYLASE user 1 3 # 1 A 228 ASP A 41 ASP.? 14.91 O1 EDO A 88 A 261 ASP A 27 ASP.? 4.81 O2 EDO A 88 A 329 ASP A 37 ASP~? 13.07 O1 EDO A 88 coo 28.46 69.88 26.74 30.40 70.70 26.53 -14.25 67.95 8.57 -13.10 69.71 8.75 coo 34.02 79.89 42.60 34.73 78.01 41.86 -26.65 50.87 6.95 -25.73 50.39 8.79 coo 37.87 70.12 31.80 36.61 69.74 30.15 -25.14 65.39 3.92 -25.04 66.91 2.43 1qho_c05 source 1qho ALPHA-AMYLASE : 1 hits 1qho_c05 naa= 3 ULMN 3 1qj4_c00 HYDROXYNITRILE LYASE user 1 3 # 1 A 80 SER A 24 SER^? 14.86 O2 EDO A 88 A 207 ASP A 27 ASP.? 4.81 O2 EDO A 88 A 235 HIS A 26 HIS.? 12.31 O2 EDO A 88 coo 15.54 46.73 17.13 17.06 48.44 16.17 -27.05 44.01 0.12 -28.54 42.91 1.70 coo 23.60 50.31 20.82 21.66 50.51 20.06 -26.65 50.87 6.95 -25.73 50.39 8.79 coo 20.17 51.16 17.08 18.31 50.28 17.44 -27.15 43.88 6.97 -27.62 42.01 6.19 1qj4_c00 source 1qj4 HYDROXYNITRILE LYASE : 1 hits 1qj4_c00 naa= 3 ULMN 3 1qrz_c12 PLASMINOGEN user 1 3 # 1 A 603 HIS A 26 HIS.? 12.31 O2 EDO A 88 A 646 ASP A 28 ASP~? 11.68 O2 EDO A 88 A 741 SER A 24 SER^? 14.86 O2 EDO A 88 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -27.15 43.88 6.97 -27.62 42.01 6.19 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -31.33 53.08 5.19 -32.37 54.22 3.74 coo -16.10 -1.48 32.49 -17.38 0.37 33.40 -27.05 44.01 0.12 -28.54 42.91 1.70 1qrz_c12 source 1qrz PLASMINOGEN : 1 hits 1qrz_c12 naa= 3 ULMN 3 1qrz_c13 PLASMINOGEN user 1 3 # 1 B 603 HIS A 26 HIS.? 12.31 O2 EDO A 88 B 646 ASP A 27 ASP.? 4.81 O2 EDO A 88 B 741 SER A 24 SER^? 14.86 O2 EDO A 88 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -27.15 43.88 6.97 -27.62 42.01 6.19 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -26.65 50.87 6.95 -25.73 50.39 8.79 coo -43.75 -1.60 -6.12 -44.85 0.33 -5.15 -27.05 44.01 0.12 -28.54 42.91 1.70 ULMN 3 1qrz_c13 PLASMINOGEN user 2 3 # 2 B 603 HIS A 26 HIS.? 12.31 O2 EDO A 88 B 646 ASP A 28 ASP~? 11.68 O2 EDO A 88 B 741 SER A 24 SER^? 14.86 O2 EDO A 88 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -27.15 43.88 6.97 -27.62 42.01 6.19 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -31.33 53.08 5.19 -32.37 54.22 3.74 coo -43.75 -1.60 -6.12 -44.85 0.33 -5.15 -27.05 44.01 0.12 -28.54 42.91 1.70 1qrz_c13 source 1qrz PLASMINOGEN : 2 hits 1qrz_c13 naa= 3 ULMN 3 1qrz_c14 PLASMINOGEN user 1 3 # 1 C 603 HIS A 26 HIS.? 12.31 O2 EDO A 88 C 646 ASP A 27 ASP.? 4.81 O2 EDO A 88 C 741 SER A 24 SER^? 14.86 O2 EDO A 88 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -27.15 43.88 6.97 -27.62 42.01 6.19 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -26.65 50.87 6.95 -25.73 50.39 8.79 coo 4.71 -4.57 4.71 3.58 -6.49 5.69 -27.05 44.01 0.12 -28.54 42.91 1.70 ULMN 3 1qrz_c14 PLASMINOGEN user 2 3 # 2 C 603 HIS A 26 HIS.? 12.31 O2 EDO A 88 C 646 ASP A 28 ASP~? 11.68 O2 EDO A 88 C 741 SER A 24 SER^? 14.86 O2 EDO A 88 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -27.15 43.88 6.97 -27.62 42.01 6.19 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -31.33 53.08 5.19 -32.37 54.22 3.74 coo 4.71 -4.57 4.71 3.58 -6.49 5.69 -27.05 44.01 0.12 -28.54 42.91 1.70 1qrz_c14 source 1qrz PLASMINOGEN : 2 hits 1qrz_c14 naa= 3 ULMN 3 1qrz_c15 PLASMINOGEN user 1 3 # 1 D 603 HIS A 26 HIS.? 12.31 O2 EDO A 88 D 646 ASP A 27 ASP.? 4.81 O2 EDO A 88 D 741 SER A 24 SER^? 14.86 O2 EDO A 88 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -27.15 43.88 6.97 -27.62 42.01 6.19 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -26.65 50.87 6.95 -25.73 50.39 8.79 coo -49.16 -4.56 43.16 -50.44 -6.45 43.96 -27.05 44.01 0.12 -28.54 42.91 1.70 ULMN 3 1qrz_c15 PLASMINOGEN user 2 3 # 2 D 603 HIS A 26 HIS.? 12.31 O2 EDO A 88 D 646 ASP A 28 ASP~? 11.68 O2 EDO A 88 D 741 SER A 24 SER^? 14.86 O2 EDO A 88 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -27.15 43.88 6.97 -27.62 42.01 6.19 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -31.33 53.08 5.19 -32.37 54.22 3.74 coo -49.16 -4.56 43.16 -50.44 -6.45 43.96 -27.05 44.01 0.12 -28.54 42.91 1.70 1qrz_c15 source 1qrz PLASMINOGEN : 2 hits 1qrz_c15 naa= 3 ULMN 3 1qrz_c20 PLASMINOGEN user 1 3 # 1 A 603 HIS B 26 HIS.? 29.20 O1 EDO A 88 A 646 ASP B 28 ASP~? 30.32 C2 EDO A 88 A 739 GLY B 58 GLY~? 16.42 C2 EDO A 88 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -1.78 55.32 -10.54 -0.01 54.91 -11.57 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -6.22 49.12 -15.05 -7.63 48.42 -16.47 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -8.62 54.48 -0.50 -9.18 54.97 -0.85 1qrz_c20 source 1qrz PLASMINOGEN : 1 hits 1qrz_c20 naa= 3 ULMN 3 1qrz_c21 PLASMINOGEN user 1 3 # 1 B 603 HIS A 26 HIS.? 12.31 O2 EDO A 88 B 646 ASP A 28 ASP~? 11.68 O2 EDO A 88 B 739 GLY A 53 GLY~? 11.45 C2 EDO A 88 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -27.15 43.88 6.97 -27.62 42.01 6.19 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -31.33 53.08 5.19 -32.37 54.22 3.74 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -16.69 52.63 -0.43 -17.18 52.70 0.21 ULMN 3 1qrz_c21 PLASMINOGEN user 2 3 # 2 B 603 HIS B 26 HIS.? 29.20 O1 EDO A 88 B 646 ASP B 28 ASP~? 30.32 C2 EDO A 88 B 739 GLY B 58 GLY~? 16.42 C2 EDO A 88 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -1.78 55.32 -10.54 -0.01 54.91 -11.57 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -6.22 49.12 -15.05 -7.63 48.42 -16.47 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -8.62 54.48 -0.50 -9.18 54.97 -0.85 1qrz_c21 source 1qrz PLASMINOGEN : 2 hits 1qrz_c21 naa= 3 ULMN 3 1qrz_c22 PLASMINOGEN user 1 3 # 1 C 603 HIS B 26 HIS.? 29.20 O1 EDO A 88 C 646 ASP B 28 ASP~? 30.32 C2 EDO A 88 C 739 GLY B 58 GLY~? 16.42 C2 EDO A 88 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -1.78 55.32 -10.54 -0.01 54.91 -11.57 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -6.22 49.12 -15.05 -7.63 48.42 -16.47 coo 7.82 1.25 3.03 7.30 1.31 3.65 -8.62 54.48 -0.50 -9.18 54.97 -0.85 1qrz_c22 source 1qrz PLASMINOGEN : 1 hits 1qrz_c22 naa= 3 ULMN 3 1qrz_c23 PLASMINOGEN user 1 3 # 1 D 603 HIS B 26 HIS.? 29.20 O1 EDO A 88 D 646 ASP B 28 ASP~? 30.32 C2 EDO A 88 D 739 GLY B 58 GLY~? 16.42 C2 EDO A 88 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -1.78 55.32 -10.54 -0.01 54.91 -11.57 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -6.22 49.12 -15.05 -7.63 48.42 -16.47 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -8.62 54.48 -0.50 -9.18 54.97 -0.85 1qrz_c23 source 1qrz PLASMINOGEN : 1 hits 1qrz_c23 naa= 3 ULMN 3 1qz9_c02 KYNURENINASE user 1 3 # 1 A 129 PHE A 30 PHE~? 14.44 O2 EDO A 88 A 201 ASP A 28 ASP~? 11.68 O2 EDO A 88 A 227 LYS A 55 LYS~? -3.15 O2 EDO A 88s coo 23.39 49.81 32.16 21.33 51.68 32.26 -29.96 56.34 -1.22 -29.15 55.58 -3.78 coo 25.52 45.12 37.98 23.98 46.65 37.85 -31.33 53.08 5.19 -32.37 54.22 3.74 coo 12.68 46.83 36.69 18.26 48.67 34.51 -20.05 50.35 3.45 -22.02 51.39 7.78 ULMN 3 1qz9_c02 KYNURENINASE user 2 3 # 2 A 129 PHE A 30 PHE~? 14.44 O2 EDO A 88 A 201 ASP A 28 ASP~? 11.68 O2 EDO A 88 A 227 LYS B 12 LYS.? 22.50 O2 EDO A 88 coo 23.39 49.81 32.16 21.33 51.68 32.26 -29.96 56.34 -1.22 -29.15 55.58 -3.78 coo 25.52 45.12 37.98 23.98 46.65 37.85 -31.33 53.08 5.19 -32.37 54.22 3.74 coo 12.68 46.83 36.69 18.26 48.67 34.51 -33.93 48.03 -5.83 -30.65 43.44 -8.38 ULMN 3 1qz9_c02 KYNURENINASE user 3 3 # 3 A 129 PHE B 30 PHE~? 27.21 C2 EDO A 88 A 201 ASP B 28 ASP~? 30.32 C2 EDO A 88 A 227 LYS B 55 LYS~? 22.80 C2 EDO A 88 coo 23.39 49.81 32.16 21.33 51.68 32.26 -12.94 47.02 -15.56 -15.52 48.08 -15.37 coo 25.52 45.12 37.98 23.98 46.65 37.85 -6.22 49.12 -15.05 -7.63 48.42 -16.47 coo 12.68 46.83 36.69 18.26 48.67 34.51 -10.41 51.47 -4.09 -5.84 50.62 -6.36 1qz9_c02 source 1qz9 KYNURENINASE : 3 hits 1qz9_c02 naa= 3 ULMN 3 1rgq_c01 NS4A PEPTIDE user 1 3 # 1 B 60 HIS B 67 HIS~? 12.87 O1 EDO A 88 B 84 ASP A 41 ASP.? 14.91 O1 EDO A 88 B 140 GLY B 58 GLY~? 16.42 C2 EDO A 88 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 -9.98 64.51 7.37 -11.90 65.11 7.97 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 -14.25 67.95 8.57 -13.10 69.71 8.75 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 -8.62 54.48 -0.50 -9.18 54.97 -0.85 1rgq_c01 source 1rgq NS4A PEPTIDE : 1 hits 1rgq_c01 naa= 3 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 1 3 # 1 A 137 GLU A 34 GLU~? 13.90 C1 EDO A 88 A 288 HIS B 67 HIS~? 12.87 O1 EDO A 88 A 329 LYS B 71 LYS~? 21.06 O1 EDO A 88 coo 29.27 18.78 14.99 27.16 18.62 14.76 -30.48 62.02 2.95 -32.58 61.85 3.30 coo 49.52 10.06 10.36 50.99 9.65 8.92 -9.98 64.51 7.37 -11.90 65.11 7.97 coo 57.80 12.92 13.83 53.77 8.42 12.15 -4.46 59.86 10.42 -1.71 65.47 11.76 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 2 3 # 2 A 137 GLU B 22 GLU^? 25.61 O1 EDO A 88 A 288 HIS B 67 HIS~? 12.87 O1 EDO A 88 A 329 LYS B 71 LYS~? 21.06 O1 EDO A 88 coo 29.27 18.78 14.99 27.16 18.62 14.76 -17.79 60.61 -13.20 -17.15 61.81 -14.83 coo 49.52 10.06 10.36 50.99 9.65 8.92 -9.98 64.51 7.37 -11.90 65.11 7.97 coo 57.80 12.92 13.83 53.77 8.42 12.15 -4.46 59.86 10.42 -1.71 65.47 11.76 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 3 3 # 3 A 137 GLU B 34 GLU~? 32.51 C2 EDO A 88 A 288 HIS A 67 HIS~? 22.73 O2 EDO A 88 A 329 LYS A 71 LYS~? 25.13 O2 EDO A 88 coo 29.27 18.78 14.99 27.16 18.62 14.76 -10.00 40.79 -15.51 -9.28 41.58 -17.36 coo 49.52 10.06 10.36 50.99 9.65 8.92 -10.81 35.78 4.36 -9.61 35.51 2.67 coo 57.80 12.92 13.83 53.77 8.42 12.15 -9.57 38.72 11.51 -8.72 32.82 12.46 1roz_c00 source 1roz DEOXYHYPUSINE SYNTHASE : 3 hits 1roz_c00 naa= 3 ULMN 3 1rtf_c03 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 1 3 # 1 B 57 HIS A 26 HIS.? 12.31 O2 EDO A 88 B 102 ASP A 27 ASP.? 4.81 O2 EDO A 88 B 195 SER A 24 SER^? 14.86 O2 EDO A 88 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -27.15 43.88 6.97 -27.62 42.01 6.19 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -26.65 50.87 6.95 -25.73 50.39 8.79 coo -2.83 25.96 36.71 -4.77 27.03 37.63 -27.05 44.01 0.12 -28.54 42.91 1.70 1rtf_c03 source 1rtf TWO CHAIN TISSUE PLASMINOGEN ACTIVATOR : 1 hits 1rtf_c03 naa= 3 ULMN 3 1sca_c00 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 1 3 # 1 32 ASP A 27 ASP.? 4.81 O2 EDO A 88 64 HIS A 26 HIS.? 12.31 O2 EDO A 88 221 SER A 24 SER^? 14.86 O2 EDO A 88 coo 80.16 73.25 62.48 80.01 71.25 61.82 -26.65 50.87 6.95 -25.73 50.39 8.79 coo 78.27 67.69 61.83 79.58 67.76 60.19 -27.15 43.88 6.97 -27.62 42.01 6.19 coo 83.63 66.07 58.16 81.31 66.75 57.98 -27.05 44.01 0.12 -28.54 42.91 1.70 1sca_c00 source 1sca SUBTILISIN CARLSBERG (E.C.3.4.21.62) (AQUEOUS : 1 hits 1sca_c00 naa= 3 ULMN 3 1sll_c00 SIALIDASE L user 1 3 # 1 318 ASP A 27 ASP.? 4.81 O2 EDO A 88 595 GLU B 11 GLU^? 16.09 O2 EDO A 88 713 TYR A 5 TYR^? 13.23 O2 EDO A 88 coo 5.64 2.82 38.49 4.59 4.19 37.25 -26.65 50.87 6.95 -25.73 50.39 8.79 coo 4.35 13.73 37.63 3.39 12.18 36.55 -32.33 52.63 -2.59 -33.86 53.51 -1.46 coo 3.76 10.25 31.38 3.16 9.87 34.10 -28.09 49.40 -2.46 -28.96 50.64 -0.10 ULMN 3 1sll_c00 SIALIDASE L user 2 3 # 2 318 ASP B 27 ASP.? 26.46 C2 EDO A 88 595 GLU A 11 GLU^? 30.56 C2 EDO A 88 713 TYR B 5 TYR^? 24.90 C2 EDO A 88 coo 5.64 2.82 38.49 4.59 4.19 37.25 -4.76 50.56 -10.13 -3.07 50.63 -8.85 coo 4.35 13.73 37.63 3.39 12.18 36.55 -13.41 51.24 -17.67 -12.24 50.07 -19.00 coo 3.76 10.25 31.38 3.16 9.87 34.10 -13.48 53.76 -13.02 -11.19 52.33 -13.67 1sll_c00 source 1sll SIALIDASE L : 2 hits 1sll_c00 naa= 3 ULMN 3 1stc_c02 CAMP-DEPENDENT PROTEIN KINASE user 1 3 # 1 E 166 ASP A 37 ASP~? 13.07 O1 EDO A 88 E 168 LYS A 39 LYS.? 9.97 O1 EDO A 88 E 201 THR A 43 THR~? 16.85 O1 EDO A 88 coo 5.36 16.20 22.10 3.88 17.00 23.31 -25.14 65.39 3.92 -25.04 66.91 2.43 coo 5.06 22.32 18.11 1.02 22.08 22.74 -20.54 66.31 9.07 -25.61 65.89 11.03 coo -1.79 18.29 19.05 -1.19 20.28 19.71 -16.43 67.99 0.38 -14.88 68.16 -1.11 ULMN 3 1stc_c02 CAMP-DEPENDENT PROTEIN KINASE user 2 3 # 2 E 166 ASP A 37 ASP~? 13.07 O1 EDO A 88 E 168 LYS A 39 LYS.? 9.97 O1 EDO A 88 E 201 THR A 47 THR~? 9.56 O1 EDO A 88 coo 5.36 16.20 22.10 3.88 17.00 23.31 -25.14 65.39 3.92 -25.04 66.91 2.43 coo 5.06 22.32 18.11 1.02 22.08 22.74 -20.54 66.31 9.07 -25.61 65.89 11.03 coo -1.79 18.29 19.05 -1.19 20.28 19.71 -18.11 62.28 1.75 -19.10 63.54 3.24 ULMN 3 1stc_c02 CAMP-DEPENDENT PROTEIN KINASE user 3 3 # 3 E 166 ASP A 41 ASP.? 14.91 O1 EDO A 88 E 168 LYS A 39 LYS.? 9.97 O1 EDO A 88 E 201 THR A 43 THR~? 16.85 O1 EDO A 88 coo 5.36 16.20 22.10 3.88 17.00 23.31 -14.25 67.95 8.57 -13.10 69.71 8.75 coo 5.06 22.32 18.11 1.02 22.08 22.74 -20.54 66.31 9.07 -25.61 65.89 11.03 coo -1.79 18.29 19.05 -1.19 20.28 19.71 -16.43 67.99 0.38 -14.88 68.16 -1.11 ULMN 3 1stc_c02 CAMP-DEPENDENT PROTEIN KINASE user 4 3 # 4 E 166 ASP A 41 ASP.? 14.91 O1 EDO A 88 E 168 LYS A 39 LYS.? 9.97 O1 EDO A 88 E 201 THR A 47 THR~? 9.56 O1 EDO A 88 coo 5.36 16.20 22.10 3.88 17.00 23.31 -14.25 67.95 8.57 -13.10 69.71 8.75 coo 5.06 22.32 18.11 1.02 22.08 22.74 -20.54 66.31 9.07 -25.61 65.89 11.03 coo -1.79 18.29 19.05 -1.19 20.28 19.71 -18.11 62.28 1.75 -19.10 63.54 3.24 1stc_c02 source 1stc CAMP-DEPENDENT PROTEIN KINASE : 4 hits 1stc_c02 naa= 3 ULMN 3 1t4c_c02 FORMYL-COENZYME A TRANSFERASE user 1 3 # 1 A 261 GLY A 58 GLY~? 9.83 O2 EDO A 88 B 17 GLN A 64 GLN~? 21.06 O2 EDO A 88 B 140 GLU A 59 GLU~? 11.45 O2 EDO A 88 coo 61.49 19.86 5.96 61.52 19.46 5.16 -17.11 46.78 5.39 -17.45 46.41 4.77 coo 63.76 11.90 7.93 65.18 13.07 6.77 -16.03 37.05 3.20 -16.05 34.96 2.72 coo 66.44 19.00 7.38 67.69 17.67 8.37 -22.28 43.98 3.30 -23.32 43.37 5.05 1t4c_c02 source 1t4c FORMYL-COENZYME A TRANSFERASE : 1 hits 1t4c_c02 naa= 3 ULMN 3 1uag_c01 UDP-N-ACETYLMURAMOYL-L-ALANINE-:D-GLuser 1 3 # 1 115 LYS A 85 LYS~? 4.81 O2 EDO A 88 138 ASN A 83 ASN~? 10.47 O1 EDO A 88 183 HIS B 67 HIS~? 12.87 O1 EDO A 88 coo 36.44 -9.55 24.75 39.00 -9.24 20.52 -19.67 57.49 14.47 -21.14 51.45 13.91 coo 42.86 -4.84 22.91 42.38 -4.90 20.84 -12.86 57.40 15.39 -12.23 59.42 15.35 coo 43.51 -9.99 13.57 42.49 -8.60 14.69 -9.98 64.51 7.37 -11.90 65.11 7.97 ULMN 3 1uag_c01 UDP-N-ACETYLMURAMOYL-L-ALANINE-:D-GLuser 2 3 # 2 115 LYS A 86 LYS~? 13.64 O1 EDO A 88 138 ASN A 83 ASN~? 10.47 O1 EDO A 88 183 HIS B 67 HIS~? 12.87 O1 EDO A 88 coo 36.44 -9.55 24.75 39.00 -9.24 20.52 -18.60 60.01 17.15 -15.10 59.96 22.04 coo 42.86 -4.84 22.91 42.38 -4.90 20.84 -12.86 57.40 15.39 -12.23 59.42 15.35 coo 43.51 -9.99 13.57 42.49 -8.60 14.69 -9.98 64.51 7.37 -11.90 65.11 7.97 ULMN 3 1uag_c01 UDP-N-ACETYLMURAMOYL-L-ALANINE-:D-GLuser 3 3 # 3 115 LYS B 85 LYS~? 25.46 C2 EDO A 88 138 ASN B 83 ASN~? 24.91 C2 EDO A 88 183 HIS A 67 HIS~? 22.73 O2 EDO A 88 coo 36.44 -9.55 24.75 39.00 -9.24 20.52 -1.24 41.95 -2.07 0.00 48.03 -2.24 coo 42.86 -4.84 22.91 42.38 -4.90 20.84 -1.80 41.72 4.79 -0.30 41.99 6.34 coo 43.51 -9.99 13.57 42.49 -8.60 14.69 -10.81 35.78 4.36 -9.61 35.51 2.67 ULMN 3 1uag_c01 UDP-N-ACETYLMURAMOYL-L-ALANINE-:D-GLuser 4 3 # 4 115 LYS B 86 LYS~? 28.97 C2 EDO A 88 138 ASN B 83 ASN~? 24.91 C2 EDO A 88 183 HIS A 67 HIS~? 22.73 O2 EDO A 88 coo 36.44 -9.55 24.75 39.00 -9.24 20.52 0.22 38.74 -0.51 2.70 39.48 4.80 coo 42.86 -4.84 22.91 42.38 -4.90 20.84 -1.80 41.72 4.79 -0.30 41.99 6.34 coo 43.51 -9.99 13.57 42.49 -8.60 14.69 -10.81 35.78 4.36 -9.61 35.51 2.67 1uag_c01 source 1uag UDP-N-ACETYLMURAMOYL-L-ALANINE-:D-GLUTAMATE LI: 4 hits 1uag_c01 naa= 3 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 1 3 # 1 199 ASP A 41 ASP.? 14.91 O1 EDO A 88 218 GLU A 11 GLU^? 30.56 C2 EDO A 88 329 ASP A 37 ASP~? 13.07 O1 EDO A 88 coo 49.16 35.16 15.19 51.08 34.43 15.65 -14.25 67.95 8.57 -13.10 69.71 8.75 coo 70.09 11.71 8.46 70.56 12.89 6.77 -13.41 51.24 -17.67 -12.24 50.07 -19.00 coo 59.16 37.82 13.95 57.63 37.03 15.12 -25.14 65.39 3.92 -25.04 66.91 2.43 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 2 3 # 2 199 ASP A 41 ASP.? 14.91 O1 EDO A 88 218 GLU B 45 GLU~? 23.69 O2 EDO A 88 329 ASP A 37 ASP~? 13.07 O1 EDO A 88 coo 49.16 35.16 15.19 51.08 34.43 15.65 -14.25 67.95 8.57 -13.10 69.71 8.75 coo 70.09 11.71 8.46 70.56 12.89 6.77 -22.69 38.92 -6.32 -22.61 36.80 -6.71 coo 59.16 37.82 13.95 57.63 37.03 15.12 -25.14 65.39 3.92 -25.04 66.91 2.43 1uok_c04 source 1uok OLIGO-1,6-GLUCOSIDASE : 2 hits 1uok_c04 naa= 3 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 1 3 # 1 199 ASP A 37 ASP~? 13.07 O1 EDO A 88 242 GLU B 10 GLU^? 22.83 O2 EDO A 88 329 ASP A 41 ASP.? 14.91 O1 EDO A 88 coo 49.16 35.16 15.19 51.08 34.43 15.65 -25.14 65.39 3.92 -25.04 66.91 2.43 coo 30.42 34.74 5.00 29.09 35.09 3.38 -29.59 50.76 -9.46 -29.70 50.98 -11.60 coo 59.16 37.82 13.95 57.63 37.03 15.12 -14.25 67.95 8.57 -13.10 69.71 8.75 1uok_c05 source 1uok OLIGO-1,6-GLUCOSIDASE : 1 hits 1uok_c05 naa= 3 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 1 3 # 1 A 16 TYR B 5 TYR^? 24.90 C2 EDO A 88 A 40 ASP B 27 ASP.? 26.46 C2 EDO A 88 A 103 LEU B 29 LEU~? 23.21 C2 EDO A 88 coo 12.09 16.13 10.57 11.28 18.80 10.73 -13.48 53.76 -13.02 -11.19 52.33 -13.67 coo 7.55 25.51 14.34 9.65 25.73 14.24 -4.76 50.56 -10.13 -3.07 50.63 -8.85 coo 11.83 18.73 16.99 10.99 19.71 15.26 -11.06 49.55 -11.46 -12.52 49.36 -9.88 1vzz_c00 source 1vzz STEROID DELTA-ISOMERASE : 1 hits 1vzz_c00 naa= 3 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 1 3 # 1 B 16 TYR A 5 TYR^? 13.23 O2 EDO A 88 B 40 ASP A 28 ASP~? 11.68 O2 EDO A 88 B 103 LEU A 25 LEU^? 9.79 O2 EDO A 88 coo 14.25 20.09 37.35 13.48 17.40 37.38 -28.09 49.40 -2.46 -28.96 50.64 -0.10 coo 9.39 10.77 34.53 11.50 10.63 34.41 -31.33 53.08 5.19 -32.37 54.22 3.74 coo 12.89 17.60 31.13 12.34 16.51 32.90 -25.73 47.85 2.71 -24.04 48.61 1.56 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 2 3 # 2 B 16 TYR B 5 TYR^? 24.90 C2 EDO A 88 B 40 ASP B 27 ASP.? 26.46 C2 EDO A 88 B 103 LEU B 29 LEU~? 23.21 C2 EDO A 88 coo 14.25 20.09 37.35 13.48 17.40 37.38 -13.48 53.76 -13.02 -11.19 52.33 -13.67 coo 9.39 10.77 34.53 11.50 10.63 34.41 -4.76 50.56 -10.13 -3.07 50.63 -8.85 coo 12.89 17.60 31.13 12.34 16.51 32.90 -11.06 49.55 -11.46 -12.52 49.36 -9.88 1vzz_c01 source 1vzz STEROID DELTA-ISOMERASE : 2 hits 1vzz_c01 naa= 3 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 1 3 # 1 A 183 GLY A 53 GLY~? 11.45 C2 EDO A 88 B 419 GLY B 53 GLY~? 14.25 C2 EDO A 88 B 420 ALA B 49 ALA~? 16.10 O2 EDO A 88 coo 26.12 -67.67-130.71 26.18 -67.32-131.45 -16.69 52.63 -0.43 -17.18 52.70 0.21 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 -15.31 49.67 -2.05 -14.58 49.52 -2.41 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 -17.98 44.88 -3.70 -19.05 44.33 -2.76 1xny_c00 source 1xny PROPIONYL-COA CARBOXYLASE COMPLEX B SUBUNIT : 1 hits 1xny_c00 naa= 3 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 1 3 # 1 A 420 ALA A 49 ALA~? 14.07 O1 EDO A 88 B 182 GLY B 53 GLY~? 14.25 C2 EDO A 88 B 183 GLY A 53 GLY~? 11.45 C2 EDO A 88 coo 38.36-101.47-135.52 39.62-101.29-136.35 -17.36 58.24 -2.24 -16.18 58.83 -3.07 coo 41.93-102.35-126.87 41.52-101.89-126.30 -15.31 49.67 -2.05 -14.58 49.52 -2.41 coo 38.37-101.99-128.11 38.63-102.24-127.37 -16.69 52.63 -0.43 -17.18 52.70 0.21 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 2 3 # 2 A 420 ALA B 49 ALA~? 16.10 O2 EDO A 88 B 182 GLY A 53 GLY~? 11.45 C2 EDO A 88 B 183 GLY B 53 GLY~? 14.25 C2 EDO A 88 coo 38.36-101.47-135.52 39.62-101.29-136.35 -17.98 44.88 -3.70 -19.05 44.33 -2.76 coo 41.93-102.35-126.87 41.52-101.89-126.30 -16.69 52.63 -0.43 -17.18 52.70 0.21 coo 38.37-101.99-128.11 38.63-102.24-127.37 -15.31 49.67 -2.05 -14.58 49.52 -2.41 1xny_c01 source 1xny PROPIONYL-COA CARBOXYLASE COMPLEX B SUBUNIT : 2 hits 1xny_c01 naa= 3 ULMN 3 1zoi_c00 ESTERASE user 1 3 # 1 A 97 SER A 24 SER^? 14.86 O2 EDO A 88 A 227 ASP A 27 ASP.? 4.81 O2 EDO A 88 A 256 HIS A 26 HIS.? 12.31 O2 EDO A 88 coo 64.84 24.93 59.62 66.28 24.42 57.72 -27.05 44.01 0.12 -28.54 42.91 1.70 coo 73.80 27.56 60.96 72.24 26.45 60.08 -26.65 50.87 6.95 -25.73 50.39 8.79 coo 70.86 23.63 59.28 68.91 24.23 58.80 -27.15 43.88 6.97 -27.62 42.01 6.19 1zoi_c00 source 1zoi ESTERASE : 1 hits 1zoi_c00 naa= 3 ULMN 3 1zoi_c01 ESTERASE user 1 3 # 1 B 97 SER A 24 SER^? 14.86 O2 EDO A 88 B 227 ASP A 27 ASP.? 4.81 O2 EDO A 88 B 256 HIS A 26 HIS.? 12.31 O2 EDO A 88 coo 64.71 -1.59 29.78 66.19 -2.95 31.16 -27.05 44.01 0.12 -28.54 42.91 1.70 coo 73.58 -1.50 26.67 72.07 -1.71 28.10 -26.65 50.87 6.95 -25.73 50.39 8.79 coo 70.69 -1.01 30.98 68.78 -1.84 30.74 -27.15 43.88 6.97 -27.62 42.01 6.19 1zoi_c01 source 1zoi ESTERASE : 1 hits 1zoi_c01 naa= 3 ULMN 3 1zoi_c02 ESTERASE user 1 3 # 1 C 97 SER A 24 SER^? 14.86 O2 EDO A 88 C 227 ASP A 27 ASP.? 4.81 O2 EDO A 88 C 256 HIS A 26 HIS.? 12.31 O2 EDO A 88 coo 65.79 -14.04 67.57 66.89 -11.91 68.05 -27.05 44.01 0.12 -28.54 42.91 1.70 coo 74.87 -16.69 68.52 73.28 -15.36 68.17 -26.65 50.87 6.95 -25.73 50.39 8.79 coo 71.71 -13.16 66.29 69.81 -13.09 67.19 -27.15 43.88 6.97 -27.62 42.01 6.19 1zoi_c02 source 1zoi ESTERASE : 1 hits 1zoi_c02 naa= 3 ULMN 3 1zrz_c02 PROTEIN KINASE C, IOTA user 1 3 # 1 A 369 ASP A 37 ASP~? 13.07 O1 EDO A 88 A 371 LYS A 39 LYS.? 9.97 O1 EDO A 88 A 407 THR A 47 THR~? 9.56 O1 EDO A 88 coo -5.17 31.09 15.73 -7.07 31.12 16.73 -25.14 65.39 3.92 -25.04 66.91 2.43 coo -4.43 30.92 22.89 -6.61 31.91 19.71 -20.54 66.31 9.07 -25.61 65.89 11.03 coo -8.38 36.02 19.06 -8.83 34.10 19.89 -18.11 62.28 1.75 -19.10 63.54 3.24 1zrz_c02 source 1zrz PROTEIN KINASE C, IOTA : 1 hits 1zrz_c02 naa= 3 ULMN 3 2acu_c01 ALDOSE REDUCTASE (E.C.1.1.1.21) MUTAuser 1 3 # 1 A 43 ASP A 27 ASP.? 4.81 O2 EDO A 88 A 48 HIS A 26 HIS.? 12.31 O2 EDO A 88 A 77 LYS A 55 LYS~? -3.15 O2 EDO A 88s coo 13.04 30.41 72.50 12.95 30.65 70.36 -26.65 50.87 6.95 -25.73 50.39 8.79 coo 12.77 23.50 68.33 13.58 25.42 68.49 -27.15 43.88 6.97 -27.62 42.01 6.19 coo 7.53 29.84 65.06 12.29 29.41 67.79 -20.05 50.35 3.45 -22.02 51.39 7.78 2acu_c01 source 2acu ALDOSE REDUCTASE (E.C.1.1.1.21) MUTANT WITH TY: 1 hits 2acu_c01 naa= 3 ULMN 3 2ag0_c04 BENZALDEHYDE LYASE user 1 3 # 1 B 29 HIS A 26 HIS.? 12.31 O2 EDO A 88 B 50 GLU A 22 GLU^? 21.42 O2 EDO A 88 B 113 GLN A 63 GLN~? 15.85 O2 EDO A 88 coo 37.74 -17.01 11.59 38.11 -17.83 13.49 -27.15 43.88 6.97 -27.62 42.01 6.19 coo 46.64 -18.37 3.41 46.45 -20.27 4.34 -28.40 42.45 -5.63 -29.98 41.10 -5.71 coo 42.38 -20.40 13.90 41.08 -20.72 12.22 -21.44 39.34 4.26 -22.05 39.81 2.30 2ag0_c04 source 2ag0 BENZALDEHYDE LYASE : 1 hits 2ag0_c04 naa= 3 ULMN 3 2ag0_c08 BENZALDEHYDE LYASE user 1 3 # 1 B 29 HIS A 26 HIS.? 12.31 O2 EDO A 88 B 50 GLU A 22 GLU^? 21.42 O2 EDO A 88 B 113 GLN A 63 GLN~? 15.85 O2 EDO A 88 coo 37.74 -17.01 11.59 38.11 -17.83 13.49 -27.15 43.88 6.97 -27.62 42.01 6.19 coo 46.64 -18.37 3.41 46.45 -20.27 4.34 -28.40 42.45 -5.63 -29.98 41.10 -5.71 coo 42.38 -20.40 13.90 41.08 -20.72 12.22 -21.44 39.34 4.26 -22.05 39.81 2.30 2ag0_c08 source 2ag0 BENZALDEHYDE LYASE : 1 hits 2ag0_c08 naa= 3 ULMN 3 2ag0_c09 BENZALDEHYDE LYASE user 1 3 # 1 A 29 HIS A 26 HIS.? 12.31 O2 EDO A 88 A 50 GLU A 22 GLU^? 21.42 O2 EDO A 88 A 113 GLN A 63 GLN~? 15.85 O2 EDO A 88 coo 73.37 -13.43 4.64 73.06 -11.77 3.39 -27.15 43.88 6.97 -27.62 42.01 6.19 coo 63.97 -21.08 5.81 64.12 -20.78 3.71 -28.40 42.45 -5.63 -29.98 41.10 -5.71 coo 68.60 -11.76 1.04 69.76 -13.55 1.03 -21.44 39.34 4.26 -22.05 39.81 2.30 2ag0_c09 source 2ag0 BENZALDEHYDE LYASE : 1 hits 2ag0_c09 naa= 3 ULMN 3 2ag0_c10 BENZALDEHYDE LYASE user 1 3 # 1 C 29 HIS A 26 HIS.? 12.31 O2 EDO A 88 C 50 GLU A 22 GLU^? 21.42 O2 EDO A 88 C 113 GLN A 63 GLN~? 15.85 O2 EDO A 88 coo 74.92 8.52 28.42 74.88 6.86 29.70 -27.15 43.88 6.97 -27.62 42.01 6.19 coo 65.25 15.95 28.73 65.73 15.63 30.78 -28.40 42.45 -5.63 -29.98 41.10 -5.71 coo 70.80 6.73 32.72 71.88 8.55 32.53 -21.44 39.34 4.26 -22.05 39.81 2.30 2ag0_c10 source 2ag0 BENZALDEHYDE LYASE : 1 hits 2ag0_c10 naa= 3 ULMN 3 2ag0_c11 BENZALDEHYDE LYASE user 1 3 # 1 D 29 HIS A 26 HIS.? 12.31 O2 EDO A 88 D 50 GLU A 22 GLU^? 21.42 O2 EDO A 88 D 113 GLN A 63 GLN~? 15.85 O2 EDO A 88 coo 38.66 11.31 27.15 38.67 12.13 25.22 -27.15 43.88 6.97 -27.62 42.01 6.19 coo 48.72 12.85 33.83 48.36 14.77 32.95 -28.40 42.45 -5.63 -29.98 41.10 -5.71 coo 42.85 14.77 24.15 41.85 15.11 26.02 -21.44 39.34 4.26 -22.05 39.81 2.30 2ag0_c11 source 2ag0 BENZALDEHYDE LYASE : 1 hits 2ag0_c11 naa= 3 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 1 3 # 1 J 182 LYS A 35 LYS~? 3.82 C1 EDO A 88 J 184 LYS A 39 LYS.? 9.97 O1 EDO A 88 J 345 ASP A 27 ASP.? 4.81 O2 EDO A 88 coo 25.22 70.55 14.03 27.64 73.07 18.65 -27.16 62.03 7.83 -24.89 58.41 11.08 coo 31.73 69.87 11.50 32.73 70.19 16.40 -20.54 66.31 9.07 -25.61 65.89 11.03 coo 25.87 58.42 18.79 23.95 58.54 17.90 -26.65 50.87 6.95 -25.73 50.39 8.79 2dw7_c41 source 2dw7 BLL6730 PROTEIN : 1 hits 2dw7_c41 naa= 3 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 1 3 # 1 A 157 PHE A 30 PHE~? 14.44 O2 EDO A 88 A 245 ASP A 27 ASP.? 4.81 O2 EDO A 88 A 273 LYS A 85 LYS~? 4.81 O2 EDO A 88 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 -29.96 56.34 -1.22 -29.15 55.58 -3.78 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -26.65 50.87 6.95 -25.73 50.39 8.79 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -19.67 57.49 14.47 -21.14 51.45 13.91 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 2 3 # 2 A 157 PHE B 30 PHE~? 27.21 C2 EDO A 88 A 245 ASP B 27 ASP.? 26.46 C2 EDO A 88 A 273 LYS B 85 LYS~? 25.46 C2 EDO A 88 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 -12.94 47.02 -15.56 -15.52 48.08 -15.37 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -4.76 50.56 -10.13 -3.07 50.63 -8.85 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -1.24 41.95 -2.07 0.00 48.03 -2.24 2gsa_c04 source 2gsa GLUTAMATE SEMIALDEHYDE AMINOTRANSFERASE : 2 hits 2gsa_c04 naa= 3 ULMN 3 2hdh_c02 L-3-HYDROXYACYL COA DEHYDROGENASE user 1 3 # 1 B 137 SER A 24 SER^? 14.86 O2 EDO A 88 B 158 HIS A 26 HIS.? 12.31 O2 EDO A 88 B 208 ASN A 3 ASN^? 12.24 O2 EDO A 88 coo 50.29 50.10 71.46 47.85 50.06 71.46 -27.05 44.01 0.12 -28.54 42.91 1.70 coo 48.67 45.40 71.68 47.67 46.90 70.60 -27.15 43.88 6.97 -27.62 42.01 6.19 coo 48.91 49.12 65.17 47.29 49.14 66.54 -30.96 48.32 2.04 -31.97 49.04 3.78 2hdh_c02 source 2hdh L-3-HYDROXYACYL COA DEHYDROGENASE : 1 hits 2hdh_c02 naa= 3 ULMN 3 2lip_c00 LIPASE user 1 3 # 1 87 SER A 24 SER^? 14.86 O2 EDO A 88 264 ASP A 27 ASP.? 4.81 O2 EDO A 88 286 HIS A 26 HIS.? 12.31 O2 EDO A 88 coo 10.47 25.91 18.67 10.67 27.13 20.84 -27.05 44.01 0.12 -28.54 42.91 1.70 coo 2.34 22.49 22.56 3.80 23.95 22.00 -26.65 50.87 6.95 -25.73 50.39 8.79 coo 7.10 24.11 23.40 8.18 25.09 21.87 -27.15 43.88 6.97 -27.62 42.01 6.19 2lip_c00 source 2lip LIPASE : 1 hits 2lip_c00 naa= 3 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 1 3 # 1 A 177 PHE A 50 PHE~? 7.73 O1 EDO A 88 A 263 ASP A 41 ASP.? 14.91 O1 EDO A 88 A 292 LYS A 85 LYS~? 4.81 O2 EDO A 88 coo 51.51 50.32 16.39 52.13 49.68 13.75 -15.30 58.35 3.55 -15.30 57.87 6.26 coo 54.43 44.82 23.74 55.21 45.06 21.80 -14.25 67.95 8.57 -13.10 69.71 8.75 coo 63.95 45.30 16.71 59.11 49.15 16.05 -19.67 57.49 14.47 -21.14 51.45 13.91 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 2 3 # 2 A 177 PHE A 50 PHE~? 7.73 O1 EDO A 88 A 263 ASP A 41 ASP.? 14.91 O1 EDO A 88 A 292 LYS A 86 LYS~? 13.64 O1 EDO A 88 coo 51.51 50.32 16.39 52.13 49.68 13.75 -15.30 58.35 3.55 -15.30 57.87 6.26 coo 54.43 44.82 23.74 55.21 45.06 21.80 -14.25 67.95 8.57 -13.10 69.71 8.75 coo 63.95 45.30 16.71 59.11 49.15 16.05 -18.60 60.01 17.15 -15.10 59.96 22.04 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 3 3 # 3 A 177 PHE A 50 PHE~? 7.73 O1 EDO A 88 A 263 ASP A 41 ASP.? 14.91 O1 EDO A 88 A 292 LYS B 71 LYS~? 21.06 O1 EDO A 88 coo 51.51 50.32 16.39 52.13 49.68 13.75 -15.30 58.35 3.55 -15.30 57.87 6.26 coo 54.43 44.82 23.74 55.21 45.06 21.80 -14.25 67.95 8.57 -13.10 69.71 8.75 coo 63.95 45.30 16.71 59.11 49.15 16.05 -4.46 59.86 10.42 -1.71 65.47 11.76 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 4 3 # 4 A 177 PHE B 70 PHE~? 11.90 O1 EDO A 88 A 263 ASP A 41 ASP.? 14.91 O1 EDO A 88 A 292 LYS A 85 LYS~? 4.81 O2 EDO A 88 coo 51.51 50.32 16.39 52.13 49.68 13.75 -8.93 59.39 6.56 -11.26 59.36 5.03 coo 54.43 44.82 23.74 55.21 45.06 21.80 -14.25 67.95 8.57 -13.10 69.71 8.75 coo 63.95 45.30 16.71 59.11 49.15 16.05 -19.67 57.49 14.47 -21.14 51.45 13.91 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 5 3 # 5 A 177 PHE B 70 PHE~? 11.90 O1 EDO A 88 A 263 ASP A 41 ASP.? 14.91 O1 EDO A 88 A 292 LYS A 86 LYS~? 13.64 O1 EDO A 88 coo 51.51 50.32 16.39 52.13 49.68 13.75 -8.93 59.39 6.56 -11.26 59.36 5.03 coo 54.43 44.82 23.74 55.21 45.06 21.80 -14.25 67.95 8.57 -13.10 69.71 8.75 coo 63.95 45.30 16.71 59.11 49.15 16.05 -18.60 60.01 17.15 -15.10 59.96 22.04 2oat_c03 source 2oat ORNITHINE AMINOTRANSFERASE : 5 hits 2oat_c03 naa= 3 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 1 3 # 1 B 177 PHE A 50 PHE~? 7.73 O1 EDO A 88 B 263 ASP A 41 ASP.? 14.91 O1 EDO A 88 B 292 LYS A 85 LYS~? 4.81 O2 EDO A 88 coo 49.99 26.05 6.28 51.46 26.87 8.49 -15.30 58.35 3.55 -15.30 57.87 6.26 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -14.25 67.95 8.57 -13.10 69.71 8.75 coo 60.53 31.67 0.97 57.79 27.51 3.63 -19.67 57.49 14.47 -21.14 51.45 13.91 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 2 3 # 2 B 177 PHE A 50 PHE~? 7.73 O1 EDO A 88 B 263 ASP A 41 ASP.? 14.91 O1 EDO A 88 B 292 LYS A 86 LYS~? 13.64 O1 EDO A 88 coo 49.99 26.05 6.28 51.46 26.87 8.49 -15.30 58.35 3.55 -15.30 57.87 6.26 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -14.25 67.95 8.57 -13.10 69.71 8.75 coo 60.53 31.67 0.97 57.79 27.51 3.63 -18.60 60.01 17.15 -15.10 59.96 22.04 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 3 3 # 3 B 177 PHE A 50 PHE~? 7.73 O1 EDO A 88 B 263 ASP A 41 ASP.? 14.91 O1 EDO A 88 B 292 LYS B 71 LYS~? 21.06 O1 EDO A 88 coo 49.99 26.05 6.28 51.46 26.87 8.49 -15.30 58.35 3.55 -15.30 57.87 6.26 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -14.25 67.95 8.57 -13.10 69.71 8.75 coo 60.53 31.67 0.97 57.79 27.51 3.63 -4.46 59.86 10.42 -1.71 65.47 11.76 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 4 3 # 4 B 177 PHE B 70 PHE~? 11.90 O1 EDO A 88 B 263 ASP A 41 ASP.? 14.91 O1 EDO A 88 B 292 LYS A 85 LYS~? 4.81 O2 EDO A 88 coo 49.99 26.05 6.28 51.46 26.87 8.49 -8.93 59.39 6.56 -11.26 59.36 5.03 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -14.25 67.95 8.57 -13.10 69.71 8.75 coo 60.53 31.67 0.97 57.79 27.51 3.63 -19.67 57.49 14.47 -21.14 51.45 13.91 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 5 3 # 5 B 177 PHE B 70 PHE~? 11.90 O1 EDO A 88 B 263 ASP A 41 ASP.? 14.91 O1 EDO A 88 B 292 LYS A 86 LYS~? 13.64 O1 EDO A 88 coo 49.99 26.05 6.28 51.46 26.87 8.49 -8.93 59.39 6.56 -11.26 59.36 5.03 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -14.25 67.95 8.57 -13.10 69.71 8.75 coo 60.53 31.67 0.97 57.79 27.51 3.63 -18.60 60.01 17.15 -15.10 59.96 22.04 2oat_c04 source 2oat ORNITHINE AMINOTRANSFERASE : 5 hits 2oat_c04 naa= 3 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 1 3 # 1 C 177 PHE A 50 PHE~? 7.73 O1 EDO A 88 C 263 ASP A 41 ASP.? 14.91 O1 EDO A 88 C 292 LYS A 85 LYS~? 4.81 O2 EDO A 88 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 -15.30 58.35 3.55 -15.30 57.87 6.26 coo 19.84 12.02 9.33 18.68 11.23 7.75 -14.25 67.95 8.57 -13.10 69.71 8.75 coo 12.82 3.49 4.98 17.80 5.59 1.90 -19.67 57.49 14.47 -21.14 51.45 13.91 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 2 3 # 2 C 177 PHE A 50 PHE~? 7.73 O1 EDO A 88 C 263 ASP A 41 ASP.? 14.91 O1 EDO A 88 C 292 LYS A 86 LYS~? 13.64 O1 EDO A 88 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 -15.30 58.35 3.55 -15.30 57.87 6.26 coo 19.84 12.02 9.33 18.68 11.23 7.75 -14.25 67.95 8.57 -13.10 69.71 8.75 coo 12.82 3.49 4.98 17.80 5.59 1.90 -18.60 60.01 17.15 -15.10 59.96 22.04 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 3 3 # 3 C 177 PHE A 50 PHE~? 7.73 O1 EDO A 88 C 263 ASP A 41 ASP.? 14.91 O1 EDO A 88 C 292 LYS B 71 LYS~? 21.06 O1 EDO A 88 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 -15.30 58.35 3.55 -15.30 57.87 6.26 coo 19.84 12.02 9.33 18.68 11.23 7.75 -14.25 67.95 8.57 -13.10 69.71 8.75 coo 12.82 3.49 4.98 17.80 5.59 1.90 -4.46 59.86 10.42 -1.71 65.47 11.76 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 4 3 # 4 C 177 PHE B 70 PHE~? 11.90 O1 EDO A 88 C 263 ASP A 41 ASP.? 14.91 O1 EDO A 88 C 292 LYS A 85 LYS~? 4.81 O2 EDO A 88 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 -8.93 59.39 6.56 -11.26 59.36 5.03 coo 19.84 12.02 9.33 18.68 11.23 7.75 -14.25 67.95 8.57 -13.10 69.71 8.75 coo 12.82 3.49 4.98 17.80 5.59 1.90 -19.67 57.49 14.47 -21.14 51.45 13.91 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 5 3 # 5 C 177 PHE B 70 PHE~? 11.90 O1 EDO A 88 C 263 ASP A 41 ASP.? 14.91 O1 EDO A 88 C 292 LYS A 86 LYS~? 13.64 O1 EDO A 88 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 -8.93 59.39 6.56 -11.26 59.36 5.03 coo 19.84 12.02 9.33 18.68 11.23 7.75 -14.25 67.95 8.57 -13.10 69.71 8.75 coo 12.82 3.49 4.98 17.80 5.59 1.90 -18.60 60.01 17.15 -15.10 59.96 22.04 2oat_c05 source 2oat ORNITHINE AMINOTRANSFERASE : 5 hits 2oat_c05 naa= 3 ULMN 3 2phk_c02 MC-PEPTIDE user 1 3 # 1 A 149 ASP A 37 ASP~? 13.07 O1 EDO A 88 A 151 LYS A 39 LYS.? 9.97 O1 EDO A 88 A 186 THR A 47 THR~? 9.56 O1 EDO A 88 coo 41.42 17.90 44.98 43.39 18.36 45.61 -25.14 65.39 3.92 -25.04 66.91 2.43 coo 45.75 16.58 39.61 47.43 18.26 45.54 -20.54 66.31 9.07 -25.61 65.89 11.03 coo 45.88 23.02 44.72 46.99 21.16 44.68 -18.11 62.28 1.75 -19.10 63.54 3.24 ULMN 3 2phk_c02 MC-PEPTIDE user 2 3 # 2 A 149 ASP A 41 ASP.? 14.91 O1 EDO A 88 A 151 LYS A 39 LYS.? 9.97 O1 EDO A 88 A 186 THR A 43 THR~? 16.85 O1 EDO A 88 coo 41.42 17.90 44.98 43.39 18.36 45.61 -14.25 67.95 8.57 -13.10 69.71 8.75 coo 45.75 16.58 39.61 47.43 18.26 45.54 -20.54 66.31 9.07 -25.61 65.89 11.03 coo 45.88 23.02 44.72 46.99 21.16 44.68 -16.43 67.99 0.38 -14.88 68.16 -1.11 2phk_c02 source 2phk MC-PEPTIDE : 2 hits 2phk_c02 naa= 3 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 1 3 # 1 141 ASP A 28 ASP~? 11.68 O2 EDO A 88 166 GLY B 53 GLY~? 14.25 C2 EDO A 88 169 GLU B 59 GLU~? 21.18 O1 EDO A 88 coo 8.28 6.87 1.62 10.08 5.77 1.34 -31.33 53.08 5.19 -32.37 54.22 3.74 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -15.31 49.67 -2.05 -14.58 49.52 -2.41 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -9.24 58.13 -5.40 -7.22 57.75 -6.04 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 2 3 # 2 141 ASP A 41 ASP.? 14.91 O1 EDO A 88 166 GLY A 53 GLY~? 11.45 C2 EDO A 88 169 GLU A 59 GLU~? 11.45 O2 EDO A 88 coo 8.28 6.87 1.62 10.08 5.77 1.34 -14.25 67.95 8.57 -13.10 69.71 8.75 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -16.69 52.63 -0.43 -17.18 52.70 0.21 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -22.28 43.98 3.30 -23.32 43.37 5.05 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 3 3 # 3 141 ASP B 28 ASP~? 30.32 C2 EDO A 88 166 GLY A 53 GLY~? 11.45 C2 EDO A 88 169 GLU A 59 GLU~? 11.45 O2 EDO A 88 coo 8.28 6.87 1.62 10.08 5.77 1.34 -6.22 49.12 -15.05 -7.63 48.42 -16.47 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -16.69 52.63 -0.43 -17.18 52.70 0.21 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -22.28 43.98 3.30 -23.32 43.37 5.05 2tdt_c00 source 2tdt TETRAHYDRODIPICOLINATE N-SUCCINYLTRANSFERASE : 3 hits 2tdt_c00 naa= 3 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 1 3 # 1 A 122 TYR A 5 TYR^? 13.23 O2 EDO A 88 A 214 ASP A 27 ASP.? 4.81 O2 EDO A 88 A 256 LYS A 85 LYS~? 4.81 O2 EDO A 88 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 -28.09 49.40 -2.46 -28.96 50.64 -0.10 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 -26.65 50.87 6.95 -25.73 50.39 8.79 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 -19.67 57.49 14.47 -21.14 51.45 13.91 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 2 3 # 2 A 122 TYR B 5 TYR^? 24.90 C2 EDO A 88 A 214 ASP B 27 ASP.? 26.46 C2 EDO A 88 A 256 LYS B 85 LYS~? 25.46 C2 EDO A 88 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 -13.48 53.76 -13.02 -11.19 52.33 -13.67 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 -4.76 50.56 -10.13 -3.07 50.63 -8.85 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 -1.24 41.95 -2.07 0.00 48.03 -2.24 2tpl_c04 source 2tpl TYROSINE PHENOL-LYASE : 2 hits 2tpl_c04 naa= 3 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 1 3 # 1 B 122 TYR A 5 TYR^? 13.23 O2 EDO A 88 B 214 ASP A 27 ASP.? 4.81 O2 EDO A 88 B 256 LYS A 85 LYS~? 4.81 O2 EDO A 88 coo -32.67 22.74 10.17 -32.85 23.98 7.70 -28.09 49.40 -2.46 -28.96 50.64 -0.10 coo -26.88 17.61 16.89 -26.08 17.11 15.00 -26.65 50.87 6.95 -25.73 50.39 8.79 coo -16.04 12.06 11.09 -17.97 10.54 5.71 -19.67 57.49 14.47 -21.14 51.45 13.91 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 2 3 # 2 B 122 TYR B 5 TYR^? 24.90 C2 EDO A 88 B 214 ASP B 27 ASP.? 26.46 C2 EDO A 88 B 256 LYS B 85 LYS~? 25.46 C2 EDO A 88 coo -32.67 22.74 10.17 -32.85 23.98 7.70 -13.48 53.76 -13.02 -11.19 52.33 -13.67 coo -26.88 17.61 16.89 -26.08 17.11 15.00 -4.76 50.56 -10.13 -3.07 50.63 -8.85 coo -16.04 12.06 11.09 -17.97 10.54 5.71 -1.24 41.95 -2.07 0.00 48.03 -2.24 2tpl_c05 source 2tpl TYROSINE PHENOL-LYASE : 2 hits 2tpl_c05 naa= 3 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 1 1 # 1 A 461 ASN A 3 ASN^? 12.24 O2 EDO A 88 coo 5.80 63.03 55.85 5.52 65.03 56.45 -30.96 48.32 2.04 -31.97 49.04 3.78 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 2 1 # 2 A 461 ASN A 83 ASN~? 10.47 O1 EDO A 88 coo 5.80 63.03 55.85 5.52 65.03 56.45 -12.86 57.40 15.39 -12.23 59.42 15.35 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 3 1 # 3 A 461 ASN B 3 ASN^? 29.42 C2 EDO A 88 coo 5.80 63.03 55.85 5.52 65.03 56.45 -8.54 54.49 -14.85 -6.79 53.63 -15.72 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 4 1 # 4 A 461 ASN B 83 ASN~? 24.91 C2 EDO A 88 coo 5.80 63.03 55.85 5.52 65.03 56.45 -1.80 41.72 4.79 -0.30 41.99 6.34 1kbk_p00 source 1kbk ALPHA-AMYLASE, PANCREATIC : 4 hits 1kbk_p00 naa= 1 ULMN 3 2c3x_p00 ALPHA-AMYLASE G-6 user 1 3 # 1 A 26 HIS A 15 HIS.? 36.41 C2 EDO A 88 A 76 ASN B 3 ASN^? 29.42 C2 EDO A 88 A 81 ASP B 28 ASP~? 30.32 C2 EDO A 88 coo 4.09 43.69 67.89 2.45 42.40 68.10 -10.83 48.67 -23.74 -8.99 48.18 -24.64 coo 4.75 48.17 75.81 4.99 47.30 77.74 -8.54 54.49 -14.85 -6.79 53.63 -15.72 coo 0.57 50.41 73.18 0.46 48.28 73.56 -6.22 49.12 -15.05 -7.63 48.42 -16.47 ULMN 3 2c3x_p00 ALPHA-AMYLASE G-6 user 2 3 # 2 A 26 HIS A 26 HIS.? 12.31 O2 EDO A 88 A 76 ASN A 3 ASN^? 12.24 O2 EDO A 88 A 81 ASP A 28 ASP~? 11.68 O2 EDO A 88 coo 4.09 43.69 67.89 2.45 42.40 68.10 -27.15 43.88 6.97 -27.62 42.01 6.19 coo 4.75 48.17 75.81 4.99 47.30 77.74 -30.96 48.32 2.04 -31.97 49.04 3.78 coo 0.57 50.41 73.18 0.46 48.28 73.56 -31.33 53.08 5.19 -32.37 54.22 3.74 ULMN 3 2c3x_p00 ALPHA-AMYLASE G-6 user 3 3 # 3 A 26 HIS B 26 HIS.? 29.20 O1 EDO A 88 A 76 ASN B 3 ASN^? 29.42 C2 EDO A 88 A 81 ASP B 28 ASP~? 30.32 C2 EDO A 88 coo 4.09 43.69 67.89 2.45 42.40 68.10 -1.78 55.32 -10.54 -0.01 54.91 -11.57 coo 4.75 48.17 75.81 4.99 47.30 77.74 -8.54 54.49 -14.85 -6.79 53.63 -15.72 coo 0.57 50.41 73.18 0.46 48.28 73.56 -6.22 49.12 -15.05 -7.63 48.42 -16.47 2c3x_p00 source 2c3x ALPHA-AMYLASE G-6 : 3 hits 2c3x_p00 naa= 3 ULMN 3 1b01_d00 GENE REGULATION/DNA user 1 3 # 1 B 4 ARG A 17 ARG.? 31.93 C2 EDO A 88 B 6 THR A 18 THR^? 29.12 O2 EDO A 88 B 8 THR A 8 THR^? 23.58 O2 EDO A 88 coo 40.52 16.08 100.90 37.97 16.41 102.60 -12.86 46.28 -20.15 -10.06 46.57 -18.92 coo 36.11 13.64 95.03 34.54 14.86 95.91 -18.73 47.99 -17.30 -20.35 48.27 -18.66 coo 32.72 8.05 92.39 31.25 9.11 91.35 -22.63 49.63 -11.64 -24.06 49.62 -13.30 ULMN 3 1b01_d00 GENE REGULATION/DNA user 2 3 # 2 B 4 ARG B 17 ARG.? 14.88 O2 EDO A 88 B 6 THR B 18 THR^? 21.02 O2 EDO A 88 B 8 THR B 8 THR^? 21.75 O2 EDO A 88 coo 40.52 16.08 100.90 37.97 16.41 102.60 -34.10 57.90 -1.91 -33.96 56.91 1.01 coo 36.11 13.64 95.03 34.54 14.86 95.91 -30.25 56.49 -7.39 -30.39 55.85 -9.47 coo 32.72 8.05 92.39 31.25 9.11 91.35 -24.11 54.23 -9.95 -25.46 54.68 -11.65 1b01_d00 source 1b01 GENE REGULATION/DNA : 2 hits 1b01_d00 naa= 3 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 1 3 # 1 I 303 TYR A 5 TYR^? 13.23 O2 EDO A 88 I 306 VAL B 9 VAL^? 16.04 O2 EDO A 88 I 308 VAL A 52 VAL~? 11.14 C2 EDO A 88 coo 26.18 35.24 6.87 24.33 35.18 8.97 -28.09 49.40 -2.46 -28.96 50.64 -0.10 coo 23.55 29.53 9.81 23.15 27.39 10.24 -25.88 52.88 -6.87 -24.98 52.76 -4.87 coo 16.43 30.18 9.35 15.05 30.67 11.01 -20.13 54.22 -0.34 -21.03 54.53 -2.32 1cqt_d00 source 1cqt GENE REGULATION/DNA : 1 hits 1cqt_d00 naa= 3 ULMN 4 1kqq_d00 TRANSCRIPTION/DNA user 1 4 # 1 A 92 THR A 8 THR^? 23.58 O2 EDO A 88 A 93 SER A 20 SER^? 23.95 O2 EDO A 88 A 96 LEU A 19 LEU^? 24.09 O2 EDO A 88 A 131 ARG A 17 ARG.? 31.93 C2 EDO A 88 coo 3.35 5.93 10.54 2.79 5.49 12.55 -22.63 49.63 -11.64 -24.06 49.62 -13.30 coo 3.53 2.76 8.43 3.13 1.02 10.05 -22.75 45.49 -12.51 -25.02 46.25 -12.74 coo 5.64 -0.49 6.46 5.57 -2.53 7.21 -18.28 45.53 -13.40 -17.54 46.15 -11.48 coo 12.62 -3.51 13.26 13.87 -0.97 14.34 -12.86 46.28 -20.15 -10.06 46.57 -18.92 ULMN 4 1kqq_d00 TRANSCRIPTION/DNA user 2 4 # 2 A 92 THR B 8 THR^? 21.75 O2 EDO A 88 A 93 SER B 20 SER^? 21.95 C2 EDO A 88 A 96 LEU B 19 LEU^? 15.59 C2 EDO A 88 A 131 ARG B 17 ARG.? 14.88 O2 EDO A 88 coo 3.35 5.93 10.54 2.79 5.49 12.55 -24.11 54.23 -9.95 -25.46 54.68 -11.65 coo 3.53 2.76 8.43 3.13 1.02 10.05 -24.09 58.44 -9.47 -23.94 57.89 -11.81 coo 5.64 -0.49 6.46 5.57 -2.53 7.21 -26.30 58.32 -5.53 -24.78 57.28 -4.36 coo 12.62 -3.51 13.26 13.87 -0.97 14.34 -34.10 57.90 -1.91 -33.96 56.91 1.01 1kqq_d00 source 1kqq TRANSCRIPTION/DNA : 2 hits 1kqq_d00 naa= 4 ULMN 3 2hos_d00 TRANSCRIPTION/DNA user 1 3 # 1 A 5 ARG B 78 ARG~? 23.79 O1 EDO A 88 A 50 LYS B 86 LYS~? 28.97 C2 EDO A 88 A 51 ASN B 83 ASN~? 24.91 C2 EDO A 88 coo 28.68 23.77 42.74 27.76 26.72 42.93 1.00 53.33 4.39 2.31 53.17 7.17 coo 14.40 30.33 40.28 14.25 28.31 45.36 0.22 38.74 -0.51 2.70 39.48 4.80 coo 19.09 30.55 41.51 19.09 28.89 42.82 -1.80 41.72 4.79 -0.30 41.99 6.34 2hos_d00 source 2hos TRANSCRIPTION/DNA : 1 hits 2hos_d00 naa= 3 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 1 3 # 1 B 34 SER A 24 SER^? 14.86 O2 EDO A 88 B 37 ASN A 3 ASN^? 12.24 O2 EDO A 88 B 45 THR B 8 THR^? 21.75 O2 EDO A 88 coo -19.49 41.97 71.08 -17.37 40.80 71.17 -27.05 44.01 0.12 -28.54 42.91 1.70 coo -23.05 39.62 69.74 -22.86 39.59 67.61 -30.96 48.32 2.04 -31.97 49.04 3.78 coo -30.87 34.84 80.57 -28.94 34.51 81.49 -24.11 54.23 -9.95 -25.46 54.68 -11.65 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 2 3 # 2 B 34 SER A 24 SER^? 14.86 O2 EDO A 88 B 37 ASN A 3 ASN^? 12.24 O2 EDO A 88 B 45 THR B 18 THR^? 21.02 O2 EDO A 88 coo -19.49 41.97 71.08 -17.37 40.80 71.17 -27.05 44.01 0.12 -28.54 42.91 1.70 coo -23.05 39.62 69.74 -22.86 39.59 67.61 -30.96 48.32 2.04 -31.97 49.04 3.78 coo -30.87 34.84 80.57 -28.94 34.51 81.49 -30.25 56.49 -7.39 -30.39 55.85 -9.47 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 3 3 # 3 B 34 SER B 24 SER^? 25.27 O1 EDO A 88 B 37 ASN B 3 ASN^? 29.42 C2 EDO A 88 B 45 THR A 8 THR^? 23.58 O2 EDO A 88 coo -19.49 41.97 71.08 -17.37 40.80 71.17 -10.38 58.47 -10.73 -8.49 59.58 -11.78 coo -23.05 39.62 69.74 -22.86 39.59 67.61 -8.54 54.49 -14.85 -6.79 53.63 -15.72 coo -30.87 34.84 80.57 -28.94 34.51 81.49 -22.63 49.63 -11.64 -24.06 49.62 -13.30 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 4 3 # 4 B 34 SER B 24 SER^? 25.27 O1 EDO A 88 B 37 ASN B 3 ASN^? 29.42 C2 EDO A 88 B 45 THR A 18 THR^? 29.12 O2 EDO A 88 coo -19.49 41.97 71.08 -17.37 40.80 71.17 -10.38 58.47 -10.73 -8.49 59.58 -11.78 coo -23.05 39.62 69.74 -22.86 39.59 67.61 -8.54 54.49 -14.85 -6.79 53.63 -15.72 coo -30.87 34.84 80.57 -28.94 34.51 81.49 -18.73 47.99 -17.30 -20.35 48.27 -18.66 2z3x_d00 source 2z3x DNA BINDING PROTEIN/DNA : 4 hits 2z3x_d00 naa= 3 ULMN 3 2qs9_o00 RETINOBLASTOMA-BINDING PROTEIN 9 user 1 3 # 1 A 75 SER A 24 SER^? 14.86 O2 EDO A 88 A 138 ASP A 27 ASP.? 4.81 O2 EDO A 88 A 165 HIS A 26 HIS.? 12.31 O2 EDO A 88 coo -3.36 14.75 15.05 -1.15 14.48 16.07 -27.05 44.01 0.12 -28.54 42.91 1.70 coo -1.70 6.81 20.56 -1.10 8.43 19.35 -26.65 50.87 6.95 -25.73 50.39 8.79 coo 0.22 9.72 16.41 -0.34 11.71 16.80 -27.15 43.88 6.97 -27.62 42.01 6.19 2qs9_o00 source 2QS9 RETINOBLASTOMA-BINDING PROTEIN 9 : 1 hits 2qs9_o00 naa= 3 ULMN 3 2qs9_o01 RETINOBLASTOMA-BINDING PROTEIN 9 user 1 3 # 1 B 75 SER A 24 SER^? 14.86 O2 EDO A 88 B 138 ASP A 27 ASP.? 4.81 O2 EDO A 88 B 165 HIS A 26 HIS.? 12.31 O2 EDO A 88 coo 6.59 48.30 3.28 6.43 48.98 5.63 -27.05 44.01 0.12 -28.54 42.91 1.70 coo 13.13 55.06 6.15 11.38 53.90 6.43 -26.65 50.87 6.95 -25.73 50.39 8.79 coo 7.83 53.78 5.96 7.73 51.68 6.00 -27.15 43.88 6.97 -27.62 42.01 6.19 2qs9_o01 source 2QS9 RETINOBLASTOMA-BINDING PROTEIN 9 : 1 hits 2qs9_o01 naa= 3 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 1 3 # 1 A 130 SER A 74 SER~? 16.95 O2 EDO A 88 A 166 PHE A 57 PHE~? 12.26 C2 EDO A 88 A 182 PHE B 77 PHE~? 16.10 C2 EDO A 88 coo -46.28 37.24 81.97 -44.96 39.32 82.40 -11.23 43.70 12.54 -11.15 41.78 13.99 coo -36.62 39.62 84.60 -38.76 41.24 85.25 -13.72 47.97 2.47 -12.13 49.16 4.44 coo -36.55 45.66 79.22 -38.34 43.94 80.53 -6.20 51.56 4.90 -7.58 51.30 2.49 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 2 3 # 2 A 130 SER A 74 SER~? 16.95 O2 EDO A 88 A 166 PHE A 80 PHE~? 9.40 O1 EDO A 88 A 182 PHE B 57 PHE~? 11.47 C2 EDO A 88 coo -46.28 37.24 81.97 -44.96 39.32 82.40 -11.23 43.70 12.54 -11.15 41.78 13.99 coo -36.62 39.62 84.60 -38.76 41.24 85.25 -11.65 53.92 10.45 -12.13 55.60 8.28 coo -36.55 45.66 79.22 -38.34 43.94 80.53 -12.21 53.70 2.45 -11.20 54.09 5.00 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 3 3 # 3 A 130 SER A 74 SER~? 16.95 O2 EDO A 88 A 166 PHE A 80 PHE~? 9.40 O1 EDO A 88 A 182 PHE B 77 PHE~? 16.10 C2 EDO A 88 coo -46.28 37.24 81.97 -44.96 39.32 82.40 -11.23 43.70 12.54 -11.15 41.78 13.99 coo -36.62 39.62 84.60 -38.76 41.24 85.25 -11.65 53.92 10.45 -12.13 55.60 8.28 coo -36.55 45.66 79.22 -38.34 43.94 80.53 -6.20 51.56 4.90 -7.58 51.30 2.49 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 4 3 # 4 A 130 SER A 74 SER~? 16.95 O2 EDO A 88 A 166 PHE B 73 PHE~? 13.06 C2 EDO A 88 A 182 PHE B 57 PHE~? 11.47 C2 EDO A 88 coo -46.28 37.24 81.97 -44.96 39.32 82.40 -11.23 43.70 12.54 -11.15 41.78 13.99 coo -36.62 39.62 84.60 -38.76 41.24 85.25 -7.98 53.56 9.40 -9.22 51.34 8.27 coo -36.55 45.66 79.22 -38.34 43.94 80.53 -12.21 53.70 2.45 -11.20 54.09 5.00 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 5 3 # 5 A 130 SER A 74 SER~? 16.95 O2 EDO A 88 A 166 PHE B 77 PHE~? 16.10 C2 EDO A 88 A 182 PHE A 57 PHE~? 12.26 C2 EDO A 88 coo -46.28 37.24 81.97 -44.96 39.32 82.40 -11.23 43.70 12.54 -11.15 41.78 13.99 coo -36.62 39.62 84.60 -38.76 41.24 85.25 -6.20 51.56 4.90 -7.58 51.30 2.49 coo -36.55 45.66 79.22 -38.34 43.94 80.53 -13.72 47.97 2.47 -12.13 49.16 4.44 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 6 3 # 6 A 130 SER A 74 SER~? 16.95 O2 EDO A 88 A 166 PHE B 77 PHE~? 16.10 C2 EDO A 88 A 182 PHE B 57 PHE~? 11.47 C2 EDO A 88 coo -46.28 37.24 81.97 -44.96 39.32 82.40 -11.23 43.70 12.54 -11.15 41.78 13.99 coo -36.62 39.62 84.60 -38.76 41.24 85.25 -6.20 51.56 4.90 -7.58 51.30 2.49 coo -36.55 45.66 79.22 -38.34 43.94 80.53 -12.21 53.70 2.45 -11.20 54.09 5.00 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 7 3 # 7 A 130 SER A 74 SER~? 16.95 O2 EDO A 88 A 166 PHE B 80 PHE~? 17.65 C2 EDO A 88 A 182 PHE A 57 PHE~? 12.26 C2 EDO A 88 coo -46.28 37.24 81.97 -44.96 39.32 82.40 -11.23 43.70 12.54 -11.15 41.78 13.99 coo -36.62 39.62 84.60 -38.76 41.24 85.25 -6.45 45.70 5.22 -8.68 44.44 4.14 coo -36.55 45.66 79.22 -38.34 43.94 80.53 -13.72 47.97 2.47 -12.13 49.16 4.44 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 8 3 # 8 A 130 SER A 74 SER~? 16.95 O2 EDO A 88 A 166 PHE B 80 PHE~? 17.65 C2 EDO A 88 A 182 PHE B 50 PHE~? 17.81 C2 EDO A 88 coo -46.28 37.24 81.97 -44.96 39.32 82.40 -11.23 43.70 12.54 -11.15 41.78 13.99 coo -36.62 39.62 84.60 -38.76 41.24 85.25 -6.45 45.70 5.22 -8.68 44.44 4.14 coo -36.55 45.66 79.22 -38.34 43.94 80.53 -12.81 43.27 -0.64 -10.49 43.54 0.89 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 9 3 # 9 A 130 SER B 74 SER~? 19.22 O1 EDO A 88 A 166 PHE A 73 PHE~? 15.45 C2 EDO A 88 A 182 PHE A 57 PHE~? 12.26 C2 EDO A 88 coo -46.28 37.24 81.97 -44.96 39.32 82.40 -3.17 54.89 8.06 -1.80 56.73 8.77 coo -36.62 39.62 84.60 -38.76 41.24 85.25 -8.14 45.48 8.70 -8.43 48.06 7.64 coo -36.55 45.66 79.22 -38.34 43.94 80.53 -13.72 47.97 2.47 -12.13 49.16 4.44 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 10 3 # 10 A 130 SER B 74 SER~? 19.22 O1 EDO A 88 A 166 PHE A 77 PHE~? 9.83 C2 EDO A 88 A 182 PHE A 57 PHE~? 12.26 C2 EDO A 88 coo -46.28 37.24 81.97 -44.96 39.32 82.40 -3.17 54.89 8.06 -1.80 56.73 8.77 coo -36.62 39.62 84.60 -38.76 41.24 85.25 -12.84 48.09 9.66 -14.85 49.03 7.92 coo -36.55 45.66 79.22 -38.34 43.94 80.53 -13.72 47.97 2.47 -12.13 49.16 4.44 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 11 3 # 11 A 130 SER B 74 SER~? 19.22 O1 EDO A 88 A 166 PHE A 80 PHE~? 9.40 O1 EDO A 88 A 182 PHE A 50 PHE~? 7.73 O1 EDO A 88 coo -46.28 37.24 81.97 -44.96 39.32 82.40 -3.17 54.89 8.06 -1.80 56.73 8.77 coo -36.62 39.62 84.60 -38.76 41.24 85.25 -11.65 53.92 10.45 -12.13 55.60 8.28 coo -36.55 45.66 79.22 -38.34 43.94 80.53 -15.30 58.35 3.55 -15.30 57.87 6.26 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 12 3 # 12 A 130 SER B 74 SER~? 19.22 O1 EDO A 88 A 166 PHE B 57 PHE~? 11.47 C2 EDO A 88 A 182 PHE A 77 PHE~? 9.83 C2 EDO A 88 coo -46.28 37.24 81.97 -44.96 39.32 82.40 -3.17 54.89 8.06 -1.80 56.73 8.77 coo -36.62 39.62 84.60 -38.76 41.24 85.25 -12.21 53.70 2.45 -11.20 54.09 5.00 coo -36.55 45.66 79.22 -38.34 43.94 80.53 -12.84 48.09 9.66 -14.85 49.03 7.92 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 13 3 # 13 A 130 SER B 74 SER~? 19.22 O1 EDO A 88 A 166 PHE B 80 PHE~? 17.65 C2 EDO A 88 A 182 PHE A 57 PHE~? 12.26 C2 EDO A 88 coo -46.28 37.24 81.97 -44.96 39.32 82.40 -3.17 54.89 8.06 -1.80 56.73 8.77 coo -36.62 39.62 84.60 -38.76 41.24 85.25 -6.45 45.70 5.22 -8.68 44.44 4.14 coo -36.55 45.66 79.22 -38.34 43.94 80.53 -13.72 47.97 2.47 -12.13 49.16 4.44 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 14 3 # 14 A 130 SER B 74 SER~? 19.22 O1 EDO A 88 A 166 PHE B 80 PHE~? 17.65 C2 EDO A 88 A 182 PHE A 77 PHE~? 9.83 C2 EDO A 88 coo -46.28 37.24 81.97 -44.96 39.32 82.40 -3.17 54.89 8.06 -1.80 56.73 8.77 coo -36.62 39.62 84.60 -38.76 41.24 85.25 -6.45 45.70 5.22 -8.68 44.44 4.14 coo -36.55 45.66 79.22 -38.34 43.94 80.53 -12.84 48.09 9.66 -14.85 49.03 7.92 2r11_o00 source 2R11 CARBOXYLESTERASE NP : 14 hits 2r11_o00 naa= 3 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 1 3 # 1 B 130 SER A 74 SER~? 16.95 O2 EDO A 88 B 166 PHE A 57 PHE~? 12.26 C2 EDO A 88 B 182 PHE B 77 PHE~? 16.10 C2 EDO A 88 coo -19.94 46.29 97.83 -22.38 46.56 97.60 -11.23 43.70 12.54 -11.15 41.78 13.99 coo -29.59 43.40 95.66 -28.22 45.54 94.50 -13.72 47.97 2.47 -12.13 49.16 4.44 coo -32.72 50.15 98.46 -30.32 48.85 97.77 -6.20 51.56 4.90 -7.58 51.30 2.49 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 2 3 # 2 B 130 SER A 74 SER~? 16.95 O2 EDO A 88 B 166 PHE A 80 PHE~? 9.40 O1 EDO A 88 B 182 PHE B 57 PHE~? 11.47 C2 EDO A 88 coo -19.94 46.29 97.83 -22.38 46.56 97.60 -11.23 43.70 12.54 -11.15 41.78 13.99 coo -29.59 43.40 95.66 -28.22 45.54 94.50 -11.65 53.92 10.45 -12.13 55.60 8.28 coo -32.72 50.15 98.46 -30.32 48.85 97.77 -12.21 53.70 2.45 -11.20 54.09 5.00 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 3 3 # 3 B 130 SER A 74 SER~? 16.95 O2 EDO A 88 B 166 PHE A 80 PHE~? 9.40 O1 EDO A 88 B 182 PHE B 77 PHE~? 16.10 C2 EDO A 88 coo -19.94 46.29 97.83 -22.38 46.56 97.60 -11.23 43.70 12.54 -11.15 41.78 13.99 coo -29.59 43.40 95.66 -28.22 45.54 94.50 -11.65 53.92 10.45 -12.13 55.60 8.28 coo -32.72 50.15 98.46 -30.32 48.85 97.77 -6.20 51.56 4.90 -7.58 51.30 2.49 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 4 3 # 4 B 130 SER A 74 SER~? 16.95 O2 EDO A 88 B 166 PHE B 73 PHE~? 13.06 C2 EDO A 88 B 182 PHE B 57 PHE~? 11.47 C2 EDO A 88 coo -19.94 46.29 97.83 -22.38 46.56 97.60 -11.23 43.70 12.54 -11.15 41.78 13.99 coo -29.59 43.40 95.66 -28.22 45.54 94.50 -7.98 53.56 9.40 -9.22 51.34 8.27 coo -32.72 50.15 98.46 -30.32 48.85 97.77 -12.21 53.70 2.45 -11.20 54.09 5.00 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 5 3 # 5 B 130 SER A 74 SER~? 16.95 O2 EDO A 88 B 166 PHE B 77 PHE~? 16.10 C2 EDO A 88 B 182 PHE B 57 PHE~? 11.47 C2 EDO A 88 coo -19.94 46.29 97.83 -22.38 46.56 97.60 -11.23 43.70 12.54 -11.15 41.78 13.99 coo -29.59 43.40 95.66 -28.22 45.54 94.50 -6.20 51.56 4.90 -7.58 51.30 2.49 coo -32.72 50.15 98.46 -30.32 48.85 97.77 -12.21 53.70 2.45 -11.20 54.09 5.00 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 6 3 # 6 B 130 SER A 74 SER~? 16.95 O2 EDO A 88 B 166 PHE B 80 PHE~? 17.65 C2 EDO A 88 B 182 PHE B 50 PHE~? 17.81 C2 EDO A 88 coo -19.94 46.29 97.83 -22.38 46.56 97.60 -11.23 43.70 12.54 -11.15 41.78 13.99 coo -29.59 43.40 95.66 -28.22 45.54 94.50 -6.45 45.70 5.22 -8.68 44.44 4.14 coo -32.72 50.15 98.46 -30.32 48.85 97.77 -12.81 43.27 -0.64 -10.49 43.54 0.89 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 7 3 # 7 B 130 SER B 74 SER~? 19.22 O1 EDO A 88 B 166 PHE A 73 PHE~? 15.45 C2 EDO A 88 B 182 PHE A 57 PHE~? 12.26 C2 EDO A 88 coo -19.94 46.29 97.83 -22.38 46.56 97.60 -3.17 54.89 8.06 -1.80 56.73 8.77 coo -29.59 43.40 95.66 -28.22 45.54 94.50 -8.14 45.48 8.70 -8.43 48.06 7.64 coo -32.72 50.15 98.46 -30.32 48.85 97.77 -13.72 47.97 2.47 -12.13 49.16 4.44 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 8 3 # 8 B 130 SER B 74 SER~? 19.22 O1 EDO A 88 B 166 PHE A 77 PHE~? 9.83 C2 EDO A 88 B 182 PHE A 57 PHE~? 12.26 C2 EDO A 88 coo -19.94 46.29 97.83 -22.38 46.56 97.60 -3.17 54.89 8.06 -1.80 56.73 8.77 coo -29.59 43.40 95.66 -28.22 45.54 94.50 -12.84 48.09 9.66 -14.85 49.03 7.92 coo -32.72 50.15 98.46 -30.32 48.85 97.77 -13.72 47.97 2.47 -12.13 49.16 4.44 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 9 3 # 9 B 130 SER B 74 SER~? 19.22 O1 EDO A 88 B 166 PHE A 80 PHE~? 9.40 O1 EDO A 88 B 182 PHE A 50 PHE~? 7.73 O1 EDO A 88 coo -19.94 46.29 97.83 -22.38 46.56 97.60 -3.17 54.89 8.06 -1.80 56.73 8.77 coo -29.59 43.40 95.66 -28.22 45.54 94.50 -11.65 53.92 10.45 -12.13 55.60 8.28 coo -32.72 50.15 98.46 -30.32 48.85 97.77 -15.30 58.35 3.55 -15.30 57.87 6.26 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 10 3 # 10 B 130 SER B 74 SER~? 19.22 O1 EDO A 88 B 166 PHE A 80 PHE~? 9.40 O1 EDO A 88 B 182 PHE A 77 PHE~? 9.83 C2 EDO A 88 coo -19.94 46.29 97.83 -22.38 46.56 97.60 -3.17 54.89 8.06 -1.80 56.73 8.77 coo -29.59 43.40 95.66 -28.22 45.54 94.50 -11.65 53.92 10.45 -12.13 55.60 8.28 coo -32.72 50.15 98.46 -30.32 48.85 97.77 -12.84 48.09 9.66 -14.85 49.03 7.92 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 11 3 # 11 B 130 SER B 74 SER~? 19.22 O1 EDO A 88 B 166 PHE B 57 PHE~? 11.47 C2 EDO A 88 B 182 PHE A 77 PHE~? 9.83 C2 EDO A 88 coo -19.94 46.29 97.83 -22.38 46.56 97.60 -3.17 54.89 8.06 -1.80 56.73 8.77 coo -29.59 43.40 95.66 -28.22 45.54 94.50 -12.21 53.70 2.45 -11.20 54.09 5.00 coo -32.72 50.15 98.46 -30.32 48.85 97.77 -12.84 48.09 9.66 -14.85 49.03 7.92 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 12 3 # 12 B 130 SER B 74 SER~? 19.22 O1 EDO A 88 B 166 PHE B 80 PHE~? 17.65 C2 EDO A 88 B 182 PHE A 57 PHE~? 12.26 C2 EDO A 88 coo -19.94 46.29 97.83 -22.38 46.56 97.60 -3.17 54.89 8.06 -1.80 56.73 8.77 coo -29.59 43.40 95.66 -28.22 45.54 94.50 -6.45 45.70 5.22 -8.68 44.44 4.14 coo -32.72 50.15 98.46 -30.32 48.85 97.77 -13.72 47.97 2.47 -12.13 49.16 4.44 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 13 3 # 13 B 130 SER B 74 SER~? 19.22 O1 EDO A 88 B 166 PHE B 80 PHE~? 17.65 C2 EDO A 88 B 182 PHE A 77 PHE~? 9.83 C2 EDO A 88 coo -19.94 46.29 97.83 -22.38 46.56 97.60 -3.17 54.89 8.06 -1.80 56.73 8.77 coo -29.59 43.40 95.66 -28.22 45.54 94.50 -6.45 45.70 5.22 -8.68 44.44 4.14 coo -32.72 50.15 98.46 -30.32 48.85 97.77 -12.84 48.09 9.66 -14.85 49.03 7.92 2r11_o01 source 2R11 CARBOXYLESTERASE NP : 13 hits 2r11_o01 naa= 3 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 1 3 # 1 C 130 SER A 74 SER~? 16.95 O2 EDO A 88 C 166 PHE A 57 PHE~? 12.26 C2 EDO A 88 C 182 PHE B 77 PHE~? 16.10 C2 EDO A 88 coo -2.19 64.27 51.12 -3.34 62.10 50.60 -11.23 43.70 12.54 -11.15 41.78 13.99 coo -11.14 61.91 46.89 -9.88 60.30 48.76 -13.72 47.97 2.47 -12.13 49.16 4.44 coo -7.71 55.92 42.70 -7.18 57.60 44.85 -6.20 51.56 4.90 -7.58 51.30 2.49 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 2 3 # 2 C 130 SER A 74 SER~? 16.95 O2 EDO A 88 C 166 PHE A 80 PHE~? 9.40 O1 EDO A 88 C 182 PHE B 57 PHE~? 11.47 C2 EDO A 88 coo -2.19 64.27 51.12 -3.34 62.10 50.60 -11.23 43.70 12.54 -11.15 41.78 13.99 coo -11.14 61.91 46.89 -9.88 60.30 48.76 -11.65 53.92 10.45 -12.13 55.60 8.28 coo -7.71 55.92 42.70 -7.18 57.60 44.85 -12.21 53.70 2.45 -11.20 54.09 5.00 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 3 3 # 3 C 130 SER A 74 SER~? 16.95 O2 EDO A 88 C 166 PHE A 80 PHE~? 9.40 O1 EDO A 88 C 182 PHE B 77 PHE~? 16.10 C2 EDO A 88 coo -2.19 64.27 51.12 -3.34 62.10 50.60 -11.23 43.70 12.54 -11.15 41.78 13.99 coo -11.14 61.91 46.89 -9.88 60.30 48.76 -11.65 53.92 10.45 -12.13 55.60 8.28 coo -7.71 55.92 42.70 -7.18 57.60 44.85 -6.20 51.56 4.90 -7.58 51.30 2.49 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 4 3 # 4 C 130 SER A 74 SER~? 16.95 O2 EDO A 88 C 166 PHE B 73 PHE~? 13.06 C2 EDO A 88 C 182 PHE B 57 PHE~? 11.47 C2 EDO A 88 coo -2.19 64.27 51.12 -3.34 62.10 50.60 -11.23 43.70 12.54 -11.15 41.78 13.99 coo -11.14 61.91 46.89 -9.88 60.30 48.76 -7.98 53.56 9.40 -9.22 51.34 8.27 coo -7.71 55.92 42.70 -7.18 57.60 44.85 -12.21 53.70 2.45 -11.20 54.09 5.00 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 5 3 # 5 C 130 SER A 74 SER~? 16.95 O2 EDO A 88 C 166 PHE B 77 PHE~? 16.10 C2 EDO A 88 C 182 PHE A 57 PHE~? 12.26 C2 EDO A 88 coo -2.19 64.27 51.12 -3.34 62.10 50.60 -11.23 43.70 12.54 -11.15 41.78 13.99 coo -11.14 61.91 46.89 -9.88 60.30 48.76 -6.20 51.56 4.90 -7.58 51.30 2.49 coo -7.71 55.92 42.70 -7.18 57.60 44.85 -13.72 47.97 2.47 -12.13 49.16 4.44 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 6 3 # 6 C 130 SER A 74 SER~? 16.95 O2 EDO A 88 C 166 PHE B 77 PHE~? 16.10 C2 EDO A 88 C 182 PHE B 57 PHE~? 11.47 C2 EDO A 88 coo -2.19 64.27 51.12 -3.34 62.10 50.60 -11.23 43.70 12.54 -11.15 41.78 13.99 coo -11.14 61.91 46.89 -9.88 60.30 48.76 -6.20 51.56 4.90 -7.58 51.30 2.49 coo -7.71 55.92 42.70 -7.18 57.60 44.85 -12.21 53.70 2.45 -11.20 54.09 5.00 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 7 3 # 7 C 130 SER A 74 SER~? 16.95 O2 EDO A 88 C 166 PHE B 80 PHE~? 17.65 C2 EDO A 88 C 182 PHE A 57 PHE~? 12.26 C2 EDO A 88 coo -2.19 64.27 51.12 -3.34 62.10 50.60 -11.23 43.70 12.54 -11.15 41.78 13.99 coo -11.14 61.91 46.89 -9.88 60.30 48.76 -6.45 45.70 5.22 -8.68 44.44 4.14 coo -7.71 55.92 42.70 -7.18 57.60 44.85 -13.72 47.97 2.47 -12.13 49.16 4.44 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 8 3 # 8 C 130 SER A 74 SER~? 16.95 O2 EDO A 88 C 166 PHE B 80 PHE~? 17.65 C2 EDO A 88 C 182 PHE B 50 PHE~? 17.81 C2 EDO A 88 coo -2.19 64.27 51.12 -3.34 62.10 50.60 -11.23 43.70 12.54 -11.15 41.78 13.99 coo -11.14 61.91 46.89 -9.88 60.30 48.76 -6.45 45.70 5.22 -8.68 44.44 4.14 coo -7.71 55.92 42.70 -7.18 57.60 44.85 -12.81 43.27 -0.64 -10.49 43.54 0.89 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 9 3 # 9 C 130 SER B 74 SER~? 19.22 O1 EDO A 88 C 166 PHE A 73 PHE~? 15.45 C2 EDO A 88 C 182 PHE A 57 PHE~? 12.26 C2 EDO A 88 coo -2.19 64.27 51.12 -3.34 62.10 50.60 -3.17 54.89 8.06 -1.80 56.73 8.77 coo -11.14 61.91 46.89 -9.88 60.30 48.76 -8.14 45.48 8.70 -8.43 48.06 7.64 coo -7.71 55.92 42.70 -7.18 57.60 44.85 -13.72 47.97 2.47 -12.13 49.16 4.44 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 10 3 # 10 C 130 SER B 74 SER~? 19.22 O1 EDO A 88 C 166 PHE A 77 PHE~? 9.83 C2 EDO A 88 C 182 PHE A 57 PHE~? 12.26 C2 EDO A 88 coo -2.19 64.27 51.12 -3.34 62.10 50.60 -3.17 54.89 8.06 -1.80 56.73 8.77 coo -11.14 61.91 46.89 -9.88 60.30 48.76 -12.84 48.09 9.66 -14.85 49.03 7.92 coo -7.71 55.92 42.70 -7.18 57.60 44.85 -13.72 47.97 2.47 -12.13 49.16 4.44 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 11 3 # 11 C 130 SER B 74 SER~? 19.22 O1 EDO A 88 C 166 PHE A 80 PHE~? 9.40 O1 EDO A 88 C 182 PHE A 50 PHE~? 7.73 O1 EDO A 88 coo -2.19 64.27 51.12 -3.34 62.10 50.60 -3.17 54.89 8.06 -1.80 56.73 8.77 coo -11.14 61.91 46.89 -9.88 60.30 48.76 -11.65 53.92 10.45 -12.13 55.60 8.28 coo -7.71 55.92 42.70 -7.18 57.60 44.85 -15.30 58.35 3.55 -15.30 57.87 6.26 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 12 3 # 12 C 130 SER B 74 SER~? 19.22 O1 EDO A 88 C 166 PHE B 57 PHE~? 11.47 C2 EDO A 88 C 182 PHE A 77 PHE~? 9.83 C2 EDO A 88 coo -2.19 64.27 51.12 -3.34 62.10 50.60 -3.17 54.89 8.06 -1.80 56.73 8.77 coo -11.14 61.91 46.89 -9.88 60.30 48.76 -12.21 53.70 2.45 -11.20 54.09 5.00 coo -7.71 55.92 42.70 -7.18 57.60 44.85 -12.84 48.09 9.66 -14.85 49.03 7.92 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 13 3 # 13 C 130 SER B 74 SER~? 19.22 O1 EDO A 88 C 166 PHE B 80 PHE~? 17.65 C2 EDO A 88 C 182 PHE A 57 PHE~? 12.26 C2 EDO A 88 coo -2.19 64.27 51.12 -3.34 62.10 50.60 -3.17 54.89 8.06 -1.80 56.73 8.77 coo -11.14 61.91 46.89 -9.88 60.30 48.76 -6.45 45.70 5.22 -8.68 44.44 4.14 coo -7.71 55.92 42.70 -7.18 57.60 44.85 -13.72 47.97 2.47 -12.13 49.16 4.44 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 14 3 # 14 C 130 SER B 74 SER~? 19.22 O1 EDO A 88 C 166 PHE B 80 PHE~? 17.65 C2 EDO A 88 C 182 PHE A 77 PHE~? 9.83 C2 EDO A 88 coo -2.19 64.27 51.12 -3.34 62.10 50.60 -3.17 54.89 8.06 -1.80 56.73 8.77 coo -11.14 61.91 46.89 -9.88 60.30 48.76 -6.45 45.70 5.22 -8.68 44.44 4.14 coo -7.71 55.92 42.70 -7.18 57.60 44.85 -12.84 48.09 9.66 -14.85 49.03 7.92 2r11_o02 source 2R11 CARBOXYLESTERASE NP : 14 hits 2r11_o02 naa= 3 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 1 3 # 1 D 130 SER A 74 SER~? 16.95 O2 EDO A 88 D 166 PHE A 57 PHE~? 12.26 C2 EDO A 88 D 182 PHE B 57 PHE~? 11.47 C2 EDO A 88 coo -32.42 55.27 46.18 -30.51 54.94 47.67 -11.23 43.70 12.54 -11.15 41.78 13.99 coo -23.62 58.20 50.84 -23.76 56.14 48.96 -13.72 47.97 2.47 -12.13 49.16 4.44 coo -23.08 51.44 54.96 -24.43 52.71 52.88 -12.21 53.70 2.45 -11.20 54.09 5.00 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 2 3 # 2 D 130 SER A 74 SER~? 16.95 O2 EDO A 88 D 166 PHE A 57 PHE~? 12.26 C2 EDO A 88 D 182 PHE B 77 PHE~? 16.10 C2 EDO A 88 coo -32.42 55.27 46.18 -30.51 54.94 47.67 -11.23 43.70 12.54 -11.15 41.78 13.99 coo -23.62 58.20 50.84 -23.76 56.14 48.96 -13.72 47.97 2.47 -12.13 49.16 4.44 coo -23.08 51.44 54.96 -24.43 52.71 52.88 -6.20 51.56 4.90 -7.58 51.30 2.49 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 3 3 # 3 D 130 SER A 74 SER~? 16.95 O2 EDO A 88 D 166 PHE A 80 PHE~? 9.40 O1 EDO A 88 D 182 PHE B 57 PHE~? 11.47 C2 EDO A 88 coo -32.42 55.27 46.18 -30.51 54.94 47.67 -11.23 43.70 12.54 -11.15 41.78 13.99 coo -23.62 58.20 50.84 -23.76 56.14 48.96 -11.65 53.92 10.45 -12.13 55.60 8.28 coo -23.08 51.44 54.96 -24.43 52.71 52.88 -12.21 53.70 2.45 -11.20 54.09 5.00 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 4 3 # 4 D 130 SER A 74 SER~? 16.95 O2 EDO A 88 D 166 PHE A 80 PHE~? 9.40 O1 EDO A 88 D 182 PHE B 77 PHE~? 16.10 C2 EDO A 88 coo -32.42 55.27 46.18 -30.51 54.94 47.67 -11.23 43.70 12.54 -11.15 41.78 13.99 coo -23.62 58.20 50.84 -23.76 56.14 48.96 -11.65 53.92 10.45 -12.13 55.60 8.28 coo -23.08 51.44 54.96 -24.43 52.71 52.88 -6.20 51.56 4.90 -7.58 51.30 2.49 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 5 3 # 5 D 130 SER A 74 SER~? 16.95 O2 EDO A 88 D 166 PHE B 73 PHE~? 13.06 C2 EDO A 88 D 182 PHE B 57 PHE~? 11.47 C2 EDO A 88 coo -32.42 55.27 46.18 -30.51 54.94 47.67 -11.23 43.70 12.54 -11.15 41.78 13.99 coo -23.62 58.20 50.84 -23.76 56.14 48.96 -7.98 53.56 9.40 -9.22 51.34 8.27 coo -23.08 51.44 54.96 -24.43 52.71 52.88 -12.21 53.70 2.45 -11.20 54.09 5.00 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 6 3 # 6 D 130 SER A 74 SER~? 16.95 O2 EDO A 88 D 166 PHE B 77 PHE~? 16.10 C2 EDO A 88 D 182 PHE B 57 PHE~? 11.47 C2 EDO A 88 coo -32.42 55.27 46.18 -30.51 54.94 47.67 -11.23 43.70 12.54 -11.15 41.78 13.99 coo -23.62 58.20 50.84 -23.76 56.14 48.96 -6.20 51.56 4.90 -7.58 51.30 2.49 coo -23.08 51.44 54.96 -24.43 52.71 52.88 -12.21 53.70 2.45 -11.20 54.09 5.00 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 7 3 # 7 D 130 SER A 74 SER~? 16.95 O2 EDO A 88 D 166 PHE B 80 PHE~? 17.65 C2 EDO A 88 D 182 PHE B 50 PHE~? 17.81 C2 EDO A 88 coo -32.42 55.27 46.18 -30.51 54.94 47.67 -11.23 43.70 12.54 -11.15 41.78 13.99 coo -23.62 58.20 50.84 -23.76 56.14 48.96 -6.45 45.70 5.22 -8.68 44.44 4.14 coo -23.08 51.44 54.96 -24.43 52.71 52.88 -12.81 43.27 -0.64 -10.49 43.54 0.89 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 8 3 # 8 D 130 SER B 74 SER~? 19.22 O1 EDO A 88 D 166 PHE A 73 PHE~? 15.45 C2 EDO A 88 D 182 PHE A 57 PHE~? 12.26 C2 EDO A 88 coo -32.42 55.27 46.18 -30.51 54.94 47.67 -3.17 54.89 8.06 -1.80 56.73 8.77 coo -23.62 58.20 50.84 -23.76 56.14 48.96 -8.14 45.48 8.70 -8.43 48.06 7.64 coo -23.08 51.44 54.96 -24.43 52.71 52.88 -13.72 47.97 2.47 -12.13 49.16 4.44 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 9 3 # 9 D 130 SER B 74 SER~? 19.22 O1 EDO A 88 D 166 PHE A 77 PHE~? 9.83 C2 EDO A 88 D 182 PHE A 57 PHE~? 12.26 C2 EDO A 88 coo -32.42 55.27 46.18 -30.51 54.94 47.67 -3.17 54.89 8.06 -1.80 56.73 8.77 coo -23.62 58.20 50.84 -23.76 56.14 48.96 -12.84 48.09 9.66 -14.85 49.03 7.92 coo -23.08 51.44 54.96 -24.43 52.71 52.88 -13.72 47.97 2.47 -12.13 49.16 4.44 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 10 3 # 10 D 130 SER B 74 SER~? 19.22 O1 EDO A 88 D 166 PHE A 80 PHE~? 9.40 O1 EDO A 88 D 182 PHE A 50 PHE~? 7.73 O1 EDO A 88 coo -32.42 55.27 46.18 -30.51 54.94 47.67 -3.17 54.89 8.06 -1.80 56.73 8.77 coo -23.62 58.20 50.84 -23.76 56.14 48.96 -11.65 53.92 10.45 -12.13 55.60 8.28 coo -23.08 51.44 54.96 -24.43 52.71 52.88 -15.30 58.35 3.55 -15.30 57.87 6.26 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 11 3 # 11 D 130 SER B 74 SER~? 19.22 O1 EDO A 88 D 166 PHE A 80 PHE~? 9.40 O1 EDO A 88 D 182 PHE A 77 PHE~? 9.83 C2 EDO A 88 coo -32.42 55.27 46.18 -30.51 54.94 47.67 -3.17 54.89 8.06 -1.80 56.73 8.77 coo -23.62 58.20 50.84 -23.76 56.14 48.96 -11.65 53.92 10.45 -12.13 55.60 8.28 coo -23.08 51.44 54.96 -24.43 52.71 52.88 -12.84 48.09 9.66 -14.85 49.03 7.92 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 12 3 # 12 D 130 SER B 74 SER~? 19.22 O1 EDO A 88 D 166 PHE B 57 PHE~? 11.47 C2 EDO A 88 D 182 PHE A 57 PHE~? 12.26 C2 EDO A 88 coo -32.42 55.27 46.18 -30.51 54.94 47.67 -3.17 54.89 8.06 -1.80 56.73 8.77 coo -23.62 58.20 50.84 -23.76 56.14 48.96 -12.21 53.70 2.45 -11.20 54.09 5.00 coo -23.08 51.44 54.96 -24.43 52.71 52.88 -13.72 47.97 2.47 -12.13 49.16 4.44 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 13 3 # 13 D 130 SER B 74 SER~? 19.22 O1 EDO A 88 D 166 PHE B 57 PHE~? 11.47 C2 EDO A 88 D 182 PHE A 77 PHE~? 9.83 C2 EDO A 88 coo -32.42 55.27 46.18 -30.51 54.94 47.67 -3.17 54.89 8.06 -1.80 56.73 8.77 coo -23.62 58.20 50.84 -23.76 56.14 48.96 -12.21 53.70 2.45 -11.20 54.09 5.00 coo -23.08 51.44 54.96 -24.43 52.71 52.88 -12.84 48.09 9.66 -14.85 49.03 7.92 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 14 3 # 14 D 130 SER B 74 SER~? 19.22 O1 EDO A 88 D 166 PHE B 80 PHE~? 17.65 C2 EDO A 88 D 182 PHE A 57 PHE~? 12.26 C2 EDO A 88 coo -32.42 55.27 46.18 -30.51 54.94 47.67 -3.17 54.89 8.06 -1.80 56.73 8.77 coo -23.62 58.20 50.84 -23.76 56.14 48.96 -6.45 45.70 5.22 -8.68 44.44 4.14 coo -23.08 51.44 54.96 -24.43 52.71 52.88 -13.72 47.97 2.47 -12.13 49.16 4.44 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 15 3 # 15 D 130 SER B 74 SER~? 19.22 O1 EDO A 88 D 166 PHE B 80 PHE~? 17.65 C2 EDO A 88 D 182 PHE A 77 PHE~? 9.83 C2 EDO A 88 coo -32.42 55.27 46.18 -30.51 54.94 47.67 -3.17 54.89 8.06 -1.80 56.73 8.77 coo -23.62 58.20 50.84 -23.76 56.14 48.96 -6.45 45.70 5.22 -8.68 44.44 4.14 coo -23.08 51.44 54.96 -24.43 52.71 52.88 -12.84 48.09 9.66 -14.85 49.03 7.92 2r11_o03 source 2R11 CARBOXYLESTERASE NP : 15 hits 2r11_o03 naa= 3 ULMN 3 2xmz_o00 HYDROLASE, ALPHA/BETA HYDROLASE FOLDuser 1 3 # 1 A 89 SER A 24 SER^? 14.86 O2 EDO A 88 A 216 ASP A 27 ASP.? 4.81 O2 EDO A 88 A 243 HIS A 26 HIS.? 12.31 O2 EDO A 88 coo 11.52 10.39 18.97 12.10 9.11 20.95 -27.05 44.01 0.12 -28.54 42.91 1.70 coo 20.60 4.89 19.19 18.56 4.62 19.55 -26.65 50.87 6.95 -25.73 50.39 8.79 coo 16.75 7.77 21.42 14.85 7.46 20.58 -27.15 43.88 6.97 -27.62 42.01 6.19 2xmz_o00 source 2XMZ HYDROLASE, ALPHA/BETA HYDROLASE FOLD FAMILY : 1 hits 2xmz_o00 naa= 3 ULMN 3 3nwu_o00 SERINE PROTEASE HTRA1 user 1 3 # 1 A 220 HIS B 26 HIS.? 29.20 O1 EDO A 88 A 250 ASP B 27 ASP.? 26.46 C2 EDO A 88 A 328 SER B 24 SER^? 25.27 O1 EDO A 88 coo -31.63 42.33 -9.10 -32.09 43.47 -7.39 -1.78 55.32 -10.54 -0.01 54.91 -11.57 coo -28.83 47.26 -8.07 -29.71 45.89 -9.37 -4.76 50.56 -10.13 -3.07 50.63 -8.85 coo -31.38 44.75 -19.08 -33.61 43.88 -19.06 -10.38 58.47 -10.73 -8.49 59.58 -11.78 3nwu_o00 source 3NWU SERINE PROTEASE HTRA1 : 1 hits 3nwu_o00 naa= 3 ULMN 3 3nwu_o01 SERINE PROTEASE HTRA1 user 1 3 # 1 B 220 HIS B 26 HIS.? 29.20 O1 EDO A 88 B 250 ASP B 27 ASP.? 26.46 C2 EDO A 88 B 328 SER B 24 SER^? 25.27 O1 EDO A 88 coo -60.95 64.74 -17.31 -62.53 64.43 -18.66 -1.78 55.32 -10.54 -0.01 54.91 -11.57 coo -61.22 67.85 -22.15 -60.12 66.82 -20.67 -4.76 50.56 -10.13 -3.07 50.63 -8.85 coo -50.80 64.58 -18.50 -51.05 62.31 -17.80 -10.38 58.47 -10.73 -8.49 59.58 -11.78 3nwu_o01 source 3NWU SERINE PROTEASE HTRA1 : 1 hits 3nwu_o01 naa= 3 ULMN 3 3nwu_o02 SERINE PROTEASE HTRA1 user 1 3 # 1 C 220 HIS B 26 HIS.? 29.20 O1 EDO A 88 C 250 ASP B 27 ASP.? 26.46 C2 EDO A 88 C 328 SER B 24 SER^? 25.27 O1 EDO A 88 coo -51.93 36.48 -40.55 -50.74 34.79 -40.19 -1.78 55.32 -10.54 -0.01 54.91 -11.57 coo -46.79 36.05 -43.01 -48.32 37.22 -42.10 -4.76 50.56 -10.13 -3.07 50.63 -8.85 coo -50.01 46.48 -39.48 -50.98 46.14 -37.32 -10.38 58.47 -10.73 -8.49 59.58 -11.78 3nwu_o02 source 3NWU SERINE PROTEASE HTRA1 : 1 hits 3nwu_o02 naa= 3 ULMN 3 3o4g_o00 ACYLAMINO-ACID-RELEASING ENZYME user 1 3 # 1 A 445 SER A 24 SER^? 14.86 O2 EDO A 88 A 524 ASP A 27 ASP.? 4.81 O2 EDO A 88 A 556 HIS A 26 HIS.? 12.31 O2 EDO A 88 coo 12.47 10.19 -6.98 12.48 12.40 -7.89 -27.05 44.01 0.12 -28.54 42.91 1.70 coo 3.92 10.81 -9.94 5.89 11.57 -9.70 -26.65 50.87 6.95 -25.73 50.39 8.79 coo 7.59 13.76 -7.91 9.53 12.97 -7.82 -27.15 43.88 6.97 -27.62 42.01 6.19 3o4g_o00 source 3O4G ACYLAMINO-ACID-RELEASING ENZYME : 1 hits 3o4g_o00 naa= 3 ULMN 3 3o4g_o02 ACYLAMINO-ACID-RELEASING ENZYME user 1 3 # 1 C 445 SER A 24 SER^? 14.86 O2 EDO A 88 C 524 ASP A 27 ASP.? 4.81 O2 EDO A 88 C 556 HIS A 26 HIS.? 12.31 O2 EDO A 88 coo -35.83 1.21 57.61 -37.94 0.15 57.18 -27.05 44.01 0.12 -28.54 42.91 1.70 coo -39.65 7.59 52.45 -39.69 5.70 53.46 -26.65 50.87 6.95 -25.73 50.39 8.79 coo -39.51 2.45 52.87 -38.69 1.68 54.64 -27.15 43.88 6.97 -27.62 42.01 6.19 3o4g_o02 source 3O4G ACYLAMINO-ACID-RELEASING ENZYME : 1 hits 3o4g_o02 naa= 3 ULMN 3 3qwd_o00 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 1 3 # 1 A 98 SER A 24 SER^? 14.86 O2 EDO A 88 A 123 HIS A 26 HIS.? 12.31 O2 EDO A 88 A 172 ASP A 27 ASP.? 4.81 O2 EDO A 88 coo 45.74 29.80 42.79 47.58 31.06 41.64 -27.05 44.01 0.12 -28.54 42.91 1.70 coo 44.17 25.61 37.60 45.21 25.56 35.81 -27.15 43.88 6.97 -27.62 42.01 6.19 coo 39.85 24.35 34.94 41.12 25.58 33.83 -26.65 50.87 6.95 -25.73 50.39 8.79 3qwd_o00 source 3QWD ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT: 1 hits 3qwd_o00 naa= 3 ULMN 3 3qwd_o01 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 1 3 # 1 B 98 SER A 24 SER^? 14.86 O2 EDO A 88 B 123 HIS A 26 HIS.? 12.31 O2 EDO A 88 B 172 ASP A 27 ASP.? 4.81 O2 EDO A 88 coo 71.87 39.14 40.71 71.75 41.26 39.36 -27.05 44.01 0.12 -28.54 42.91 1.70 coo 73.25 34.64 35.72 73.65 35.23 33.78 -27.15 43.88 6.97 -27.62 42.01 6.19 coo 70.98 30.38 33.77 70.74 32.03 32.50 -26.65 50.87 6.95 -25.73 50.39 8.79 3qwd_o01 source 3QWD ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT: 1 hits 3qwd_o01 naa= 3 ULMN 3 3qwd_o02 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 1 3 # 1 C 98 SER A 24 SER^? 14.86 O2 EDO A 88 C 123 HIS A 26 HIS.? 12.31 O2 EDO A 88 C 172 ASP A 27 ASP.? 4.81 O2 EDO A 88 coo 80.36 64.80 34.44 78.44 65.95 33.29 -27.05 44.01 0.12 -28.54 42.91 1.70 coo 83.70 62.42 29.01 83.15 62.88 27.08 -27.15 43.88 6.97 -27.62 42.01 6.19 coo 85.17 57.73 27.21 83.46 58.45 26.25 -26.65 50.87 6.95 -25.73 50.39 8.79 3qwd_o02 source 3QWD ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT: 1 hits 3qwd_o02 naa= 3 ULMN 3 3qwd_o03 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 1 3 # 1 D 98 SER A 24 SER^? 14.86 O2 EDO A 88 D 123 HIS A 26 HIS.? 12.31 O2 EDO A 88 D 172 ASP A 27 ASP.? 4.81 O2 EDO A 88 coo 65.12 87.33 28.49 62.90 86.32 27.74 -27.05 44.01 0.12 -28.54 42.91 1.70 coo 67.96 87.91 22.28 66.90 87.63 20.52 -27.15 43.88 6.97 -27.62 42.01 6.19 coo 72.12 85.84 19.92 70.35 84.94 19.30 -26.65 50.87 6.95 -25.73 50.39 8.79 3qwd_o03 source 3QWD ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT: 1 hits 3qwd_o03 naa= 3 ULMN 3 3qwd_o04 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 1 3 # 1 E 98 SER A 24 SER^? 14.86 O2 EDO A 88 E 123 HIS A 26 HIS.? 12.31 O2 EDO A 88 E 172 ASP A 27 ASP.? 4.81 O2 EDO A 88 coo 37.23 89.57 27.33 36.32 87.23 27.07 -27.05 44.01 0.12 -28.54 42.91 1.70 coo 37.64 91.40 20.82 36.88 90.22 19.31 -27.15 43.88 6.97 -27.62 42.01 6.19 coo 41.40 92.80 17.47 40.89 90.79 17.30 -26.65 50.87 6.95 -25.73 50.39 8.79 3qwd_o04 source 3QWD ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT: 1 hits 3qwd_o04 naa= 3 ULMN 3 3qwd_o05 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 1 3 # 1 F 98 SER A 24 SER^? 14.86 O2 EDO A 88 F 123 HIS A 26 HIS.? 12.31 O2 EDO A 88 F 172 ASP A 27 ASP.? 4.81 O2 EDO A 88 coo 17.74 70.20 32.16 18.92 67.99 31.89 -27.05 44.01 0.12 -28.54 42.91 1.70 coo 15.23 70.97 25.89 15.37 69.49 24.46 -27.15 43.88 6.97 -27.62 42.01 6.19 coo 15.81 74.47 22.06 16.86 72.70 21.69 -26.65 50.87 6.95 -25.73 50.39 8.79 3qwd_o05 source 3QWD ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT: 1 hits 3qwd_o05 naa= 3 ULMN 3 3qwd_o06 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 1 3 # 1 G 98 SER A 24 SER^? 14.86 O2 EDO A 88 G 123 HIS A 26 HIS.? 12.31 O2 EDO A 88 G 172 ASP A 27 ASP.? 4.81 O2 EDO A 88 coo 21.77 43.27 39.21 24.15 42.72 38.52 -27.05 44.01 0.12 -28.54 42.91 1.70 coo 18.42 41.13 33.64 19.33 40.10 32.10 -27.15 43.88 6.97 -27.62 42.01 6.19 coo 15.38 43.36 30.02 17.34 43.09 29.34 -26.65 50.87 6.95 -25.73 50.39 8.79 3qwd_o06 source 3QWD ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT: 1 hits 3qwd_o06 naa= 3 ULMN 3 3qwd_o07 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 1 3 # 1 H 98 SER A 24 SER^? 14.86 O2 EDO A 88 H 123 HIS A 26 HIS.? 12.31 O2 EDO A 88 H 172 ASP A 27 ASP.? 4.81 O2 EDO A 88 coo 156.20 56.60 78.78 153.83 56.16 78.10 -27.05 44.01 0.12 -28.54 42.91 1.70 coo 159.24 56.62 72.66 158.17 56.50 70.89 -27.15 43.88 6.97 -27.62 42.01 6.19 coo 162.98 53.88 70.28 161.08 53.28 69.65 -26.65 50.87 6.95 -25.73 50.39 8.79 3qwd_o07 source 3QWD ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT: 1 hits 3qwd_o07 naa= 3 ULMN 3 3qwd_o08 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 1 3 # 1 I 98 SER A 24 SER^? 14.86 O2 EDO A 88 I 123 HIS A 26 HIS.? 12.31 O2 EDO A 88 I 172 ASP A 27 ASP.? 4.81 O2 EDO A 88 coo 129.29 63.53 77.27 127.98 61.40 77.00 -27.05 44.01 0.12 -28.54 42.91 1.70 coo 129.99 65.24 70.73 129.03 64.19 69.22 -27.15 43.88 6.97 -27.62 42.01 6.19 coo 133.90 66.07 67.39 133.05 64.19 67.15 -26.65 50.87 6.95 -25.73 50.39 8.79 3qwd_o08 source 3QWD ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT: 1 hits 3qwd_o08 naa= 3 ULMN 3 3qwd_o09 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 1 3 # 1 J 98 SER A 24 SER^? 14.86 O2 EDO A 88 J 123 HIS A 26 HIS.? 12.31 O2 EDO A 88 J 172 ASP A 27 ASP.? 4.81 O2 EDO A 88 coo 106.76 47.89 81.70 107.53 45.50 81.44 -27.05 44.01 0.12 -28.54 42.91 1.70 coo 104.68 49.18 75.33 104.59 47.70 73.89 -27.15 43.88 6.97 -27.62 42.01 6.19 coo 105.94 52.49 71.50 106.71 50.57 71.17 -26.65 50.87 6.95 -25.73 50.39 8.79 3qwd_o09 source 3QWD ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT: 1 hits 3qwd_o09 naa= 3 ULMN 3 3qwd_o10 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 1 3 # 1 K 98 SER A 24 SER^? 14.86 O2 EDO A 88 K 123 HIS A 26 HIS.? 12.31 O2 EDO A 88 K 172 ASP A 27 ASP.? 4.81 O2 EDO A 88 coo 105.44 20.79 88.82 107.67 19.79 88.18 -27.05 44.01 0.12 -28.54 42.91 1.70 coo 101.74 19.42 83.14 102.50 18.27 81.61 -27.15 43.88 6.97 -27.62 42.01 6.19 coo 99.17 22.17 79.49 101.04 21.51 78.80 -26.65 50.87 6.95 -25.73 50.39 8.79 3qwd_o10 source 3QWD ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT: 1 hits 3qwd_o10 naa= 3 ULMN 3 3qwd_o11 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 1 3 # 1 L 98 SER A 24 SER^? 14.86 O2 EDO A 88 L 123 HIS A 26 HIS.? 12.31 O2 EDO A 88 L 172 ASP A 27 ASP.? 4.81 O2 EDO A 88 coo 126.72 3.21 92.89 128.70 4.33 91.79 -27.05 44.01 0.12 -28.54 42.91 1.70 coo 124.38 -0.64 87.74 125.44 -0.88 85.98 -27.15 43.88 6.97 -27.62 42.01 6.19 coo 120.03 -1.09 84.87 121.54 -0.11 83.83 -26.65 50.87 6.95 -25.73 50.39 8.79 3qwd_o11 source 3QWD ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT: 1 hits 3qwd_o11 naa= 3 ULMN 3 3qwd_o12 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 1 3 # 1 M 98 SER A 24 SER^? 14.86 O2 EDO A 88 M 123 HIS A 26 HIS.? 12.31 O2 EDO A 88 M 172 ASP A 27 ASP.? 4.81 O2 EDO A 88 coo 154.12 8.07 91.14 154.40 10.16 89.78 -27.05 44.01 0.12 -28.54 42.91 1.70 coo 154.65 3.37 86.18 155.13 3.88 84.24 -27.15 43.88 6.97 -27.62 42.01 6.19 coo 151.68 -0.46 84.21 151.70 1.23 82.98 -26.65 50.87 6.95 -25.73 50.39 8.79 3qwd_o12 source 3QWD ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT: 1 hits 3qwd_o12 naa= 3 ULMN 3 3qwd_o13 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 1 3 # 1 N 98 SER A 24 SER^? 14.86 O2 EDO A 88 N 123 HIS A 26 HIS.? 12.31 O2 EDO A 88 N 172 ASP A 27 ASP.? 4.81 O2 EDO A 88 coo 167.14 31.88 84.83 165.46 33.38 83.69 -27.05 44.01 0.12 -28.54 42.91 1.70 coo 170.00 29.01 79.37 169.53 29.60 77.44 -27.15 43.88 6.97 -27.62 42.01 6.19 coo 170.55 24.16 77.55 169.03 25.18 76.56 -26.65 50.87 6.95 -25.73 50.39 8.79 3qwd_o13 source 3QWD ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT: 1 hits 3qwd_o13 naa= 3